|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.00574901
|
|
|
IDDM
|
[NCBI]
|
0.00573942
|
|
|
APOE
|
[NCBI]
|
0.00565156
|
|
|
MAFD6
|
[NCBI]
|
0.00433053
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.00304817
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.00268761
|
|
|
MAFD1
|
[NCBI]
|
0.00198552
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.00195508
|
|
|
MTACR1
|
[NCBI]
|
0.00195508
|
|
|
AUTS6
|
[NCBI]
|
0.00154462
|
|
|
small cell cancer of the lung
|
[NCBI]
|
0.00131865
|
|
|
EGF
|
[NCBI]
|
0.00126933
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.00117468
|
|
|
HDL3
|
[NCBI]
|
0.00117468
|
|
|
myopia 14
|
[NCBI]
|
0.00117468
|
|
|
alzheimer disease 7
|
[NCBI]
|
0.00117468
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.00113711
|
|
|
VEGF
|
[NCBI]
|
0.00110962
|
|
|
FSHMD1A
|
[NCBI]
|
0.00104733
|
|
|
PSORS2
|
[NCBI]
|
0.000962348
|
|
|
AUTS7
|
[NCBI]
|
0.00081843
|
|
|
b-cell malignancy, low-grade
|
[NCBI]
|
0.00081843
|
|
|
pentosuria
|
[NCBI]
|
0.00081843
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.00081843
|
|
|
IDDM13
|
[NCBI]
|
0.00081843
|
|
|
NGFB
|
[NCBI]
|
0.000797264
|
|
|
IS1
|
[NCBI]
|
0.000670762
|
|
|
parkinson disease 12
|
[NCBI]
|
0.000662387
|
|
|
SCZD5
|
[NCBI]
|
0.000662387
|
|
|
PRL
|
[NCBI]
|
0.000642328
|
|
|
autism
|
[NCBI]
|
0.000633315
|
|
|
sjogren syndrome
|
[NCBI]
|
0.00060208
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.00060208
|
|
|
KTCN2
|
[NCBI]
|
0.000587081
|
|
|
HSCR7
|
[NCBI]
|
0.000587081
|
|
|
tear protein, anodal
|
[NCBI]
|
0.000587081
|
|
|
myositis
|
[NCBI]
|
0.000587081
|
|
|
Sf
|
[NCBI]
|
0.000587081
|
|
|
STHAG5
|
[NCBI]
|
0.000587081
|
|
|
prostate cancer, hereditary, 7
|
[NCBI]
|
0.000587081
|
|
|
AGMX2
|
[NCBI]
|
0.000587081
|
|
|
amobarbital, deficient n-hydroxylation of
|
[NCBI]
|
0.000587081
|
|
|
BMND7
|
[NCBI]
|
0.000587081
|
|
|
graying of hair, precocious
|
[NCBI]
|
0.000587081
|
|
|
aneurysm, intracranial berry, 4
|
[NCBI]
|
0.000587081
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000587081
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000587081
|
|
|
AMCX5
|
[NCBI]
|
0.000587081
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000587081
|
|
|
OTSC2
|
[NCBI]
|
0.000587081
|
|
|
HSCR6
|
[NCBI]
|
0.000587081
|
|
|
UL
|
[NCBI]
|
0.000587081
|
|
|
dyskeratosis, hereditary benign intraepithelial
|
[NCBI]
|
0.000587081
|
|
|
prostate cancer, hereditary, 4
|
[NCBI]
|
0.000587081
|
|
|
SRS
|
[NCBI]
|
0.000586857
|
|
|
TSD
|
[NCBI]
|
0.000582315
|
|
|
OFC1
|
[NCBI]
|
0.000575518
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000558111
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.000558111
|
|
|
AUTS5
|
[NCBI]
|
0.000558111
|
|
|
WT3
|
[NCBI]
|
0.000558111
|
|
|
DYT7
|
[NCBI]
|
0.000558111
|
|
|
AVP
|
[NCBI]
|
0.000512248
|
|
|
IDDM4
|
[NCBI]
|
0.000509766
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000498743
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.000480321
|
|
|
HPC10
|
[NCBI]
|
0.000480321
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.000480321
|
|
|
CNC2
|
[NCBI]
|
0.000480321
|
|
|
NPY
|
[NCBI]
|
0.00047988
|
|
|
KLK3
|
[NCBI]
|
0.000472939
|
|
|
PTH
|
[NCBI]
|
0.00045049
|
|
|
GFAP
|
[NCBI]
|
0.000444208
|
|
|
EPO
|
[NCBI]
|
0.00043198
|
|
|
APS2
|
[NCBI]
|
0.000418838
|
|
|
BRCD1
|
[NCBI]
|
0.000418838
|
|
|
PCNA
|
[NCBI]
|
0.000412002
|
|
|
IGAD1
|
[NCBI]
|
0.000403287
|
|
|
CEACAM5
|
[NCBI]
|
0.000396097
|
|
|
TPMT
|
[NCBI]
|
0.000391335
|
|
|
SLE
|
[NCBI]
|
0.000387259
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000385133
|
|
|
PI
|
[NCBI]
|
0.000380559
|
|
|
MS
|
[NCBI]
|
0.000380347
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000368454
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000368454
|
|
|
MDD
|
[NCBI]
|
0.000362358
|
|
|
MBL2
|
[NCBI]
|
0.000360915
|
|
|
DRD4
|
[NCBI]
|
0.000359446
|
|
|
HGF
|
[NCBI]
|
0.000357151
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
0.000355751
|
|
|
GC
|
[NCBI]
|
0.000355492
|
|
|
CRH
|
[NCBI]
|
0.000355278
|
|
|
ACE
|
[NCBI]
|
0.000340475
|
|
|
HD
|
[NCBI]
|
0.000337129
|
|
|
ACHE
|
[NCBI]
|
0.000332698
|
|
|
friedreich ataxia 2
|
[NCBI]
|
0.000330958
|
|
|
FSHMD1B
|
[NCBI]
|
0.000330958
|
|
|
rosselli-gulienetti syndrome
|
[NCBI]
|
0.000330958
|
|
|
CELIAC5
|
[NCBI]
|
0.000330958
|
|
|
MAFD4
|
[NCBI]
|
0.000330958
|
|
|
ptosis, hereditary congenital 2
|
[NCBI]
|
0.000330958
|
|
|
CRCS1
|
[NCBI]
|
0.000330958
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.000330958
|
|
|
CRSA
|
[NCBI]
|
0.000330958
|
|
|
epidermolysis bullosa inversa dystrophica
|
[NCBI]
|
0.000330958
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant, with thyroid disease
|
[NCBI]
|
0.000330958
|
|
|
IDDM6
|
[NCBI]
|
0.000330958
|
|
|
epilepsy, myoclonic, benign adult familial, type 2
|
[NCBI]
|
0.000330958
|
|
|
tumor suppressor gene on chromosome 11
|
[NCBI]
|
0.000330958
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000330958
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.000330958
|
|
|
DYX9
|
[NCBI]
|
0.000330958
|
|
|
EGFR
|
[NCBI]
|
0.000319863
|
|
|
MAOA
|
[NCBI]
|
0.000313164
|
|
|
MC1R
|
[NCBI]
|
0.000309016
|
|
|
COMT
|
[NCBI]
|
0.000303348
|
|
|
VDR
|
[NCBI]
|
0.000291761
|
|
|
PARK3
|
[NCBI]
|
0.000289928
|
|
|
HPCX
|
[NCBI]
|
0.000289928
|
|
|
HP
|
[NCBI]
|
0.000283705
|
|
|
breast cancer
|
[NCBI]
|
0.000280776
|
|
|
IGER
|
[NCBI]
|
0.000278209
|
|
|
phenylketonuria
|
[NCBI]
|
0.000277195
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000274777
|
|
|
CCR5
|
[NCBI]
|
0.000274073
|
|
|
MJD
|
[NCBI]
|
0.000263932
|
|
|
graves disease
|
[NCBI]
|
0.000259245
|
|
|
CCK
|
[NCBI]
|
0.000253434
|
|
|
ARSA
|
[NCBI]
|
0.000245525
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000245453
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000240089
|
|
|
migraine with or without aura, susceptibility to, 3
|
[NCBI]
|
0.000239948
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.000239948
|
|
|
PSORS3
|
[NCBI]
|
0.000239948
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000239948
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal recessive
|
[NCBI]
|
0.000239948
|
|
|
PARK10
|
[NCBI]
|
0.000239948
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000239948
|
|
|
IDDM18
|
[NCBI]
|
0.000239948
|
|
|
frontofacionasal dysostosis
|
[NCBI]
|
0.000239948
|
|
|
CFM1
|
[NCBI]
|
0.000239948
|
|
|
PSORS5
|
[NCBI]
|
0.000239948
|
|
|
migraine without aura, susceptibility to, 4
|
[NCBI]
|
0.000239948
|
|
|
myopia 6
|
[NCBI]
|
0.000239948
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
0.000239948
|
|
|
CHDS8
|
[NCBI]
|
0.000239948
|
|
|
IDDM11
|
[NCBI]
|
0.000239948
|
|
|
malignant hyperthermia, susceptibility to, 3
|
[NCBI]
|
0.000239948
|
|
|
IBD9
|
[NCBI]
|
0.000239948
|
|
|
AFP
|
[NCBI]
|
0.000239868
|
|
|
DRPLA
|
[NCBI]
|
0.000238381
|
|
|
SCA1
|
[NCBI]
|
0.000237222
|
|
|
PSORS1
|
[NCBI]
|
0.000234759
|
|
|
CYP2D6
|
[NCBI]
|
0.000232198
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000230068
|
|
|
NPPA
|
[NCBI]
|
0.0002263
|
|
|
neural tube defects
|
[NCBI]
|
0.000226266
|
|
|
PCOS1
|
[NCBI]
|
0.000224978
|
|
|
PGM1
|
[NCBI]
|
0.000221712
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000202978
|
|
|
CAT
|
[NCBI]
|
0.000199065
|
|
|
BWS
|
[NCBI]
|
0.000197424
|
|
|
PTK2
|
[NCBI]
|
0.000196195
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000196117
|
|
|
TF
|
[NCBI]
|
0.000191737
|
|
|
RMS1
|
[NCBI]
|
0.000191509
|
|
|
ESD
|
[NCBI]
|
0.000191407
|
|
|
ARMD4
|
[NCBI]
|
0.000189839
|
|
|
APRT
|
[NCBI]
|
0.000189821
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
0.00018702
|
|
|
AD
|
[NCBI]
|
0.000186601
|
|
|
TH
|
[NCBI]
|
0.000186427
|
|
|
HEXA
|
[NCBI]
|
0.000185951
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000185135
|
|
|
EXT3
|
[NCBI]
|
0.000184037
|
|
|
CCV
|
[NCBI]
|
0.000184037
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000184037
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
0.000184037
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
0.000184037
|
|
|
PPPP
|
[NCBI]
|
0.000184037
|
|
|
pulmonary function
|
[NCBI]
|
0.000184037
|
|
|
CORD8
|
[NCBI]
|
0.000184037
|
|
|
LGMD1D
|
[NCBI]
|
0.000184037
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.000184037
|
|
|
EA4
|
[NCBI]
|
0.000184037
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000184037
|
|
|
PARK11
|
[NCBI]
|
0.000184037
|
|
|
CORD5
|
[NCBI]
|
0.000184037
|
|
|
OB10P
|
[NCBI]
|
0.000184037
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000184037
|
|
|
FRDA
|
[NCBI]
|
0.000181106
|
|
|
FANCD1
|
[NCBI]
|
0.000174681
|
|
|
FY
|
[NCBI]
|
0.000174557
|
|
|
SCA6
|
[NCBI]
|
0.000173851
|
|
|
F3
|
[NCBI]
|
0.000170338
|
|
|
ABCA4
|
[NCBI]
|
0.000169372
|
|
|
EIG
|
[NCBI]
|
0.000169163
|
|
|
COL1A1
|
[NCBI]
|
0.000164953
|
|
|
HFE
|
[NCBI]
|
0.000164553
|
|
|
hypertension, essential
|
[NCBI]
|
0.000164507
|
|
|
MICA
|
[NCBI]
|
0.000161987
|
|
|
ABO
|
[NCBI]
|
0.000161987
|
|
|
CRC
|
[NCBI]
|
0.000160842
|
|
|
RA
|
[NCBI]
|
0.00016045
|
|
|
GBA
|
[NCBI]
|
0.000159584
|
|
|
IBD1
|
[NCBI]
|
0.000158672
|
|
|
WT1
|
[NCBI]
|
0.000158122
|
|
|
prostate cancer
|
[NCBI]
|
0.000157922
|
|
|
SCA7
|
[NCBI]
|
0.000155248
|
|
|
HSCR1
|
[NCBI]
|
0.000154972
|
|
|
BBS
|
[NCBI]
|
0.000154559
|
|
|
FABP2
|
[NCBI]
|
0.000153875
|
|
|
HLA-DQA1
|
[NCBI]
|
0.000153875
|
|
|
APOB
|
[NCBI]
|
0.000152827
|
|
|
TNF
|
[NCBI]
|
0.000150688
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
0.000150359
|
|
|
CFH
|
[NCBI]
|
0.00014815
|
|
|
alzheimer disease 2
|
[NCBI]
|
0.00014549
|
|
|
CELIAC2
|
[NCBI]
|
0.000144795
|
|
|
tongue, pigmented fungiform papillae of
|
[NCBI]
|
0.000144795
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000144795
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
0.000144795
|
|
|
ETM2
|
[NCBI]
|
0.000144795
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000144795
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.000144795
|
|
|
AD14
|
[NCBI]
|
0.000144795
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000144795
|
|
|
EFMR
|
[NCBI]
|
0.000144795
|
|
|
CORD7
|
[NCBI]
|
0.000144795
|
|
|
acromegaloid facial appearance syndrome
|
[NCBI]
|
0.000144795
|
|
|
IBD3
|
[NCBI]
|
0.000144795
|
|
|
scheuermann disease
|
[NCBI]
|
0.000144795
|
|
|
SCA4
|
[NCBI]
|
0.000144795
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
0.000144795
|
|
|
USH2B
|
[NCBI]
|
0.000144795
|
|
|
OFC3
|
[NCBI]
|
0.000144795
|
|
|
AD13
|
[NCBI]
|
0.000144795
|
|
|
MG
|
[NCBI]
|
0.000144597
|
|
|
ALD
|
[NCBI]
|
0.00014292
|
|
|
HLA-B
|
[NCBI]
|
0.000142149
|
|
|
DFNB3
|
[NCBI]
|
0.000141924
|
|
|
HLA-DQB1
|
[NCBI]
|
0.000138389
|
|
|
lactase persistence
|
[NCBI]
|
0.000138251
|
|
|
SCZD
|
[NCBI]
|
0.000138026
|
|
|
H19
|
[NCBI]
|
0.000137699
|
|
|
IGF2
|
[NCBI]
|
0.000136779
|
|
|
testicular tumors
|
[NCBI]
|
0.000135409
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.000135151
|
|
|
LDLR
|
[NCBI]
|
0.00013484
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000134354
|
|
|
galactosemia
|
[NCBI]
|
0.000132663
|
|
|
CHAT
|
[NCBI]
|
0.000131885
|
|
|
sialuria, finnish type
|
[NCBI]
|
0.000130411
|
|
|
GALT
|
[NCBI]
|
0.000130342
|
|
|
SCA12
|
[NCBI]
|
0.000130064
|
|
|
NF1
|
[NCBI]
|
0.000129008
|
|
|
TNFSF6
|
[NCBI]
|
0.000128666
|
|
|
HLA-DRB1
|
[NCBI]
|
0.000128257
|
|
|
HTR2A
|
[NCBI]
|
0.000125242
|
|
|
hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration
|
[NCBI]
|
0.000124674
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.00012457
|
|
|
GNRH1
|
[NCBI]
|
0.00012439
|
|
|
AS
|
[NCBI]
|
0.000123173
|
|
|
GAA
|
[NCBI]
|
0.000121523
|
|
|
HLA-A
|
[NCBI]
|
0.000120544
|
|
|
ATLD
|
[NCBI]
|
0.000120008
|
|
|
SLC11A1
|
[NCBI]
|
0.000119221
|
|
|
proteus syndrome
|
[NCBI]
|
0.000118674
|
|
|
MTHFR
|
[NCBI]
|
0.000115985
|
|
|
thiourea tasting
|
[NCBI]
|
0.000115394
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.000115372
|
|
|
SCAX1
|
[NCBI]
|
0.000115372
|
|
|
SCZD10
|
[NCBI]
|
0.000115372
|
|
|
blood group--lutheran inhibitor
|
[NCBI]
|
0.000115372
|
|
|
STHAG4
|
[NCBI]
|
0.000115372
|
|
|
aniridia, cerebellar ataxia, and mental deficiency
|
[NCBI]
|
0.000115372
|
|
|
LTA
|
[NCBI]
|
0.000113547
|
|
|
GJB2
|
[NCBI]
|
0.000112786
|
|
|
meningioma, familial
|
[NCBI]
|
0.00011109
|
|
|
SHEP2
|
[NCBI]
|
0.00011051
|
|
|
FUT2
|
[NCBI]
|
0.000109046
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.0001076
|
|
|
CDKN2A
|
[NCBI]
|
0.000107436
|
|
|
CYP2C19
|
[NCBI]
|
0.000105782
|
|
|
GNAS
|
[NCBI]
|
0.000105346
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
0.000105107
|
|
|
apc gene
|
[NCBI]
|
0.000104829
|
|
|
GAPDH
|
[NCBI]
|
0.000104799
|
|
|
gaucher disease, type ii
|
[NCBI]
|
0.000103639
|
|
|
TG
|
[NCBI]
|
0.000103313
|
|
|
GPI
|
[NCBI]
|
0.000101351
|
|
|
INSR
|
[NCBI]
|
0.000101154
|
|
|
GDNF
|
[NCBI]
|
0.000100503
|
|
|
TNFRSF11B
|
[NCBI]
|
9.94196e-05
|
|
|
C4A
|
[NCBI]
|
9.93245e-05
|
|
|
BRCA1
|
[NCBI]
|
9.56681e-05
|
|
|
APOH
|
[NCBI]
|
9.56311e-05
|
|
|
FMO2
|
[NCBI]
|
9.48958e-05
|
|
|
CORD3
|
[NCBI]
|
9.48958e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
9.48958e-05
|
|
|
ALAD
|
[NCBI]
|
9.47796e-05
|
|
|
IDUA
|
[NCBI]
|
9.47295e-05
|
|
|
ADCYAP1
|
[NCBI]
|
9.45076e-05
|
|
|
PPARG
|
[NCBI]
|
9.42716e-05
|
|
|
MAFD2
|
[NCBI]
|
9.41713e-05
|
|
|
PON1
|
[NCBI]
|
9.327e-05
|
|
|
RET
|
[NCBI]
|
9.32048e-05
|
|
|
IH
|
[NCBI]
|
9.24372e-05
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
9.24372e-05
|
|
|
BMND3
|
[NCBI]
|
9.24372e-05
|
|
|
PHP
|
[NCBI]
|
9.24372e-05
|
|
|
inclusion body myositis
|
[NCBI]
|
9.24372e-05
|
|
|
renal cell carcinoma, papillary, 3
|
[NCBI]
|
9.24372e-05
|
|
|
MSSE
|
[NCBI]
|
9.24372e-05
|
|
|
MYMY1
|
[NCBI]
|
9.24372e-05
|
|
|
MAOB
|
[NCBI]
|
9.16874e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
9.06856e-05
|
|
|
AGT
|
[NCBI]
|
8.79368e-05
|
|
|
ATXN8OS
|
[NCBI]
|
8.77373e-05
|
|
|
MPO
|
[NCBI]
|
8.74613e-05
|
|
|
haw river syndrome
|
[NCBI]
|
8.73293e-05
|
|
|
PPROM
|
[NCBI]
|
8.73293e-05
|
|
|
cafe-au-lait spots, multiple
|
[NCBI]
|
8.73293e-05
|
|
|
osteoarthritis with mild chondrodysplasia
|
[NCBI]
|
8.73293e-05
|
|
|
abdominal body fat distribution
|
[NCBI]
|
8.73293e-05
|
|
|
CMD3A
|
[NCBI]
|
8.73293e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
8.6994e-05
|
|
|
CFTR
|
[NCBI]
|
8.66699e-05
|
|
|
BDNF
|
[NCBI]
|
8.66145e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
8.55473e-05
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
8.55473e-05
|
|
|
SCA8
|
[NCBI]
|
8.55473e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
8.55473e-05
|
|
|
ORM1
|
[NCBI]
|
8.46625e-05
|
|
|
ACP1
|
[NCBI]
|
8.46397e-05
|
|
|
PTHLH
|
[NCBI]
|
8.45405e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
8.44626e-05
|
|
|
C3
|
[NCBI]
|
8.4205e-05
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
8.36974e-05
|
|
|
ALDH2
|
[NCBI]
|
8.30272e-05
|
|
|
DRD2
|
[NCBI]
|
8.3016e-05
|
|
|
NAT1
|
[NCBI]
|
8.3016e-05
|
|
|
osteoporosis
|
[NCBI]
|
8.29919e-05
|
|
|
INS
|
[NCBI]
|
8.27496e-05
|
|
|
IL1RN
|
[NCBI]
|
8.22248e-05
|
|
|
EVA
|
[NCBI]
|
8.21876e-05
|
|
|
PRNP
|
[NCBI]
|
8.19115e-05
|
|
|
T
|
[NCBI]
|
8.17732e-05
|
|
|
BL
|
[NCBI]
|
8.12025e-05
|
|
|
NOD2
|
[NCBI]
|
7.9957e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
7.99388e-05
|
|
|
OCA2
|
[NCBI]
|
7.92713e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
7.92713e-05
|
|
|
osteogenic sarcoma
|
[NCBI]
|
7.7722e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
7.7722e-05
|
|
|
GIST
|
[NCBI]
|
7.76471e-05
|
|
|
ORM2
|
[NCBI]
|
7.75556e-05
|
|
|
IRF5
|
[NCBI]
|
7.75556e-05
|
|
|
isoniazid inactivation
|
[NCBI]
|
7.73852e-05
|
|
|
C7
|
[NCBI]
|
7.73633e-05
|
|
|
GNB3
|
[NCBI]
|
7.73633e-05
|
|
|
CD
|
[NCBI]
|
7.68873e-05
|
|
|
oca2 gene
|
[NCBI]
|
7.65019e-05
|
|
|
SPTA1
|
[NCBI]
|
7.63913e-05
|
|
|
MBP
|
[NCBI]
|
7.61465e-05
|
|
|
CTLA4
|
[NCBI]
|
7.56972e-05
|
|
|
DYX2
|
[NCBI]
|
7.54039e-05
|
|
|
LPA
|
[NCBI]
|
7.43598e-05
|
|
|
iminoglycinuria
|
[NCBI]
|
7.41144e-05
|
|
|
neuroticism
|
[NCBI]
|
7.41144e-05
|
|
|
AUTS9
|
[NCBI]
|
7.41144e-05
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
7.41144e-05
|
|
|
IDDM7
|
[NCBI]
|
7.41144e-05
|
|
|
ST3
|
[NCBI]
|
7.41062e-05
|
|
|
BRCA2
|
[NCBI]
|
7.25898e-05
|
|
|
CYP2A6
|
[NCBI]
|
7.181e-05
|
|
|
bladder cancer
|
[NCBI]
|
7.11149e-05
|
|
|
JWS
|
[NCBI]
|
7.10208e-05
|
|
|
melanoma-astrocytoma syndrome
|
[NCBI]
|
7.09509e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
7.09509e-05
|
|
|
DI
|
[NCBI]
|
7.09509e-05
|
|
|
cervical cancer
|
[NCBI]
|
7.09509e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
7.09509e-05
|
|
|
FIDD
|
[NCBI]
|
7.09509e-05
|
|
|
pars planitis
|
[NCBI]
|
7.09509e-05
|
|
|
SPP1
|
[NCBI]
|
7.09265e-05
|
|
|
CYP3A5
|
[NCBI]
|
7.05148e-05
|
|
|
CALCR
|
[NCBI]
|
7.05148e-05
|
|
|
TYMS
|
[NCBI]
|
7.00906e-05
|
|
|
PPARA
|
[NCBI]
|
6.91622e-05
|
|
|
TP53
|
[NCBI]
|
6.81784e-05
|
|
|
ACP5
|
[NCBI]
|
6.8138e-05
|
|
|
ALPP
|
[NCBI]
|
6.7765e-05
|
|
|
CR1
|
[NCBI]
|
6.7765e-05
|
|
|
DRD3
|
[NCBI]
|
6.7765e-05
|
|
|
TFPI
|
[NCBI]
|
6.76651e-05
|
|
|
CLN2
|
[NCBI]
|
6.71446e-05
|
|
|
CBAVD
|
[NCBI]
|
6.71446e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
6.71446e-05
|
|
|
NOS3
|
[NCBI]
|
6.66045e-05
|
|
|
STGD1
|
[NCBI]
|
6.65284e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
6.64582e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
6.61054e-05
|
|
|
NP
|
[NCBI]
|
6.59609e-05
|
|
|
PEE1
|
[NCBI]
|
6.57328e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
6.53868e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
6.51847e-05
|
|
|
APOA4
|
[NCBI]
|
6.47749e-05
|
|
|
RCC1
|
[NCBI]
|
6.39374e-05
|
|
|
FGF7
|
[NCBI]
|
6.39209e-05
|
|
|
RHD
|
[NCBI]
|
6.37969e-05
|
|
|
HEPOD
|
[NCBI]
|
6.3456e-05
|
|
|
IHG
|
[NCBI]
|
6.29859e-05
|
|
|
ELN
|
[NCBI]
|
6.28984e-05
|
|
|
THB
|
[NCBI]
|
6.23339e-05
|
|
|
diabetes mellitus, neonatal, with congenital hypothyroidism
|
[NCBI]
|
6.23339e-05
|
|
|
DFNB24
|
[NCBI]
|
6.23339e-05
|
|
|
hyperparathyroidism, primary, caused by water clear cell hyperplasia
|
[NCBI]
|
6.23339e-05
|
|
|
leukocyte nuclear appendages, hereditary prevalence of
|
[NCBI]
|
6.23339e-05
|
|
|
CDG1J
|
[NCBI]
|
6.23339e-05
|
|
|
aortic aneurysm, familial thoracic 5
|
[NCBI]
|
6.23339e-05
|
|
|
LCCS3
|
[NCBI]
|
6.23339e-05
|
|
|
ACEE
|
[NCBI]
|
6.23339e-05
|
|
|
DFNB30
|
[NCBI]
|
6.23339e-05
|
|
|
DFNB23
|
[NCBI]
|
6.23339e-05
|
|
|
polysubstance abuse, susceptibility to
|
[NCBI]
|
6.23339e-05
|
|
|
patent ductus arteriosus and bicuspid aortic valve with hand anomalies
|
[NCBI]
|
6.23339e-05
|
|
|
ectodermal dysplasia, trichoodontoonychial type
|
[NCBI]
|
6.23339e-05
|
|
|
WR
|
[NCBI]
|
6.23339e-05
|
|
|
phosphatase, acid, of tissues
|
[NCBI]
|
6.23339e-05
|
|
|
HPE9
|
[NCBI]
|
6.23339e-05
|
|
|
ectodermal dysplasia with natal teeth, turnpenny type
|
[NCBI]
|
6.23339e-05
|
|
|
CDG2B
|
[NCBI]
|
6.23339e-05
|
|
|
dopamine beta-hydroxylase, plasma, thermolability of
|
[NCBI]
|
6.23339e-05
|
|
|
methylmalonic aciduria, cblh type
|
[NCBI]
|
6.23339e-05
|
|
|
hemopoietic proliferation
|
[NCBI]
|
6.23339e-05
|
|
|
TAQ1
|
[NCBI]
|
6.23339e-05
|
|
|
tn syndrome
|
[NCBI]
|
6.23339e-05
|
|
|
dermatoglyphics--finger ridge count
|
[NCBI]
|
6.23339e-05
|
|
|
CISS2
|
[NCBI]
|
6.23339e-05
|
|
|
CDH23
|
[NCBI]
|
6.19717e-05
|
|
|
PF4
|
[NCBI]
|
6.16107e-05
|
|
|
SLC17A5
|
[NCBI]
|
6.09518e-05
|
|
|
PCWH
|
[NCBI]
|
5.99935e-05
|
|
|
IDDM12
|
[NCBI]
|
5.99935e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 2 deficiency
|
[NCBI]
|
5.99935e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
5.99935e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
5.99935e-05
|
|
|
lichen planus, familial
|
[NCBI]
|
5.99935e-05
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
5.99935e-05
|
|
|
A2M
|
[NCBI]
|
5.98507e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
5.96783e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
5.94826e-05
|
|
|
CGF1
|
[NCBI]
|
5.92401e-05
|
|
|
GCY
|
[NCBI]
|
5.92401e-05
|
|
|
IBD2
|
[NCBI]
|
5.92401e-05
|
|
|
SCZD6
|
[NCBI]
|
5.92401e-05
|
|
|
FCHL
|
[NCBI]
|
5.84923e-05
|
|
|
SCN8A
|
[NCBI]
|
5.77304e-05
|
|
|
IFNG
|
[NCBI]
|
5.70268e-05
|
|
|
IL4R
|
[NCBI]
|
5.70201e-05
|
|
|
AHSG
|
[NCBI]
|
5.70201e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
5.68053e-05
|
|
|
LAM
|
[NCBI]
|
5.66719e-05
|
|
|
CYP1A1
|
[NCBI]
|
5.61076e-05
|
|
|
PGL1
|
[NCBI]
|
5.60571e-05
|
|
|
IRDN
|
[NCBI]
|
5.5772e-05
|
|
|
PCCB
|
[NCBI]
|
5.5772e-05
|
|
|
RB1
|
[NCBI]
|
5.57271e-05
|
|
|
FMR1
|
[NCBI]
|
5.55083e-05
|
|
|
autoimmune disease
|
[NCBI]
|
5.54458e-05
|
|
|
BMND1
|
[NCBI]
|
5.54458e-05
|
|
|
NM
|
[NCBI]
|
5.54458e-05
|
|
|
FTNS
|
[NCBI]
|
5.54458e-05
|
|
|
FRAP1
|
[NCBI]
|
5.53717e-05
|
|
|
KIR3DL1
|
[NCBI]
|
5.48656e-05
|
|
|
CTGF
|
[NCBI]
|
5.42548e-05
|
|
|
IGF2R
|
[NCBI]
|
5.40853e-05
|
|
|
SCA2
|
[NCBI]
|
5.39677e-05
|
|
|
GALK1
|
[NCBI]
|
5.38883e-05
|
|
|
DHCR7
|
[NCBI]
|
5.38883e-05
|
|
|
MLC
|
[NCBI]
|
5.3795e-05
|
|
|
CLN1
|
[NCBI]
|
5.3795e-05
|
|
|
PSNP1
|
[NCBI]
|
5.3795e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
5.3795e-05
|
|
|
RHCE
|
[NCBI]
|
5.34262e-05
|
|
|
HNMT
|
[NCBI]
|
5.34262e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
5.23875e-05
|
|
|
HLA-C
|
[NCBI]
|
5.22882e-05
|
|
|
ATXN2
|
[NCBI]
|
5.22882e-05
|
|
|
GAL
|
[NCBI]
|
5.22646e-05
|
|
|
HLA-G
|
[NCBI]
|
5.21182e-05
|
|
|
neuroblastoma
|
[NCBI]
|
5.18491e-05
|
|
|
protocadherin-beta gene cluster
|
[NCBI]
|
5.18098e-05
|
|
|
OCA4
|
[NCBI]
|
5.18098e-05
|
|
|
SPG13
|
[NCBI]
|
5.18098e-05
|
|
|
DFNB18
|
[NCBI]
|
5.18098e-05
|
|
|
SCZD9
|
[NCBI]
|
5.13201e-05
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
5.13201e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
5.09683e-05
|
|
|
PLOD1
|
[NCBI]
|
5.04495e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
5.04495e-05
|
|
|
HLA-DRA
|
[NCBI]
|
5.02331e-05
|
|
|
ALDH3A2
|
[NCBI]
|
5.01264e-05
|
|
|
CPI
|
[NCBI]
|
5.00579e-05
|
|
|
GRB10
|
[NCBI]
|
4.99479e-05
|
|
|
DND1
|
[NCBI]
|
4.97808e-05
|
|
|
HYMAI
|
[NCBI]
|
4.97808e-05
|
|
|
IL2
|
[NCBI]
|
4.91585e-05
|
|
|
CAPN10
|
[NCBI]
|
4.88723e-05
|
|
|
obesity
|
[NCBI]
|
4.83215e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
4.83087e-05
|
|
|
MKKS
|
[NCBI]
|
4.80851e-05
|
|
|
MAG
|
[NCBI]
|
4.77144e-05
|
|
|
esophageal cancer
|
[NCBI]
|
4.75861e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
4.75861e-05
|
|
|
DRPLA
|
[NCBI]
|
4.73779e-05
|
|
|
AIS
|
[NCBI]
|
4.70613e-05
|
|
|
AMCN
|
[NCBI]
|
4.70429e-05
|
|
|
HYPX
|
[NCBI]
|
4.70429e-05
|
|
|
stiff skin syndrome
|
[NCBI]
|
4.70429e-05
|
|
|
SRF
|
[NCBI]
|
4.69141e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
4.66446e-05
|
|
|
FMO3
|
[NCBI]
|
4.66067e-05
|
|
|
ESR1
|
[NCBI]
|
4.65279e-05
|
|
|
ELAC2
|
[NCBI]
|
4.5835e-05
|
|
|
CYP2C9
|
[NCBI]
|
4.5835e-05
|
|
|
osteoarthritis
|
[NCBI]
|
4.58019e-05
|
|
|
IGKC
|
[NCBI]
|
4.55169e-05
|
|
|
PDS
|
[NCBI]
|
4.53809e-05
|
|
|
HMS
|
[NCBI]
|
4.53335e-05
|
|
|
body mass index
|
[NCBI]
|
4.53335e-05
|
|
|
CDG1C
|
[NCBI]
|
4.53335e-05
|
|
|
GBS
|
[NCBI]
|
4.53335e-05
|
|
|
WT5
|
[NCBI]
|
4.53335e-05
|
|
|
XDH
|
[NCBI]
|
4.52287e-05
|
|
|
IGKV
|
[NCBI]
|
4.50051e-05
|
|
|
CYP2E
|
[NCBI]
|
4.50051e-05
|
|
|
OSM
|
[NCBI]
|
4.49672e-05
|
|
|
PGP
|
[NCBI]
|
4.46081e-05
|
|
|
COL1A2
|
[NCBI]
|
4.43795e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
4.41869e-05
|
|
|
USH2A
|
[NCBI]
|
4.40095e-05
|
|
|
MFS
|
[NCBI]
|
4.39466e-05
|
|
|
COL3A1
|
[NCBI]
|
4.37746e-05
|
|
|
APOA1
|
[NCBI]
|
4.36664e-05
|
|
|
PXE
|
[NCBI]
|
4.36271e-05
|
|
|
ACADS
|
[NCBI]
|
4.34477e-05
|
|
|
SLC26A4
|
[NCBI]
|
4.34477e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
4.34354e-05
|
|
|
ADH2
|
[NCBI]
|
4.33206e-05
|
|
|
A1BG
|
[NCBI]
|
4.332e-05
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
4.332e-05
|
|
|
GCK
|
[NCBI]
|
4.27014e-05
|
|
|
PWS
|
[NCBI]
|
4.26288e-05
|
|
|
MUC1
|
[NCBI]
|
4.25918e-05
|
|
|
INSIG2
|
[NCBI]
|
4.23254e-05
|
|
|
PEX1
|
[NCBI]
|
4.23254e-05
|
|
|
TAS1R3
|
[NCBI]
|
4.23254e-05
|
|
|
homocystinuria
|
[NCBI]
|
4.21583e-05
|
|
|
CF
|
[NCBI]
|
4.20291e-05
|
|
|
CCDC28B
|
[NCBI]
|
4.19898e-05
|
|
|
C15ORF2
|
[NCBI]
|
4.19898e-05
|
|
|
TAS2R38
|
[NCBI]
|
4.19898e-05
|
|
|
C4B
|
[NCBI]
|
4.15122e-05
|
|
|
CFB
|
[NCBI]
|
4.13539e-05
|
|
|
IGHG1
|
[NCBI]
|
4.13539e-05
|
|
|
acromegaly
|
[NCBI]
|
4.10774e-05
|
|
|
HPC1
|
[NCBI]
|
4.10774e-05
|
|
|
PCDH15
|
[NCBI]
|
4.07253e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
4.05901e-05
|
|
|
CJD
|
[NCBI]
|
4.05426e-05
|
|
|
PIL
|
[NCBI]
|
4.00194e-05
|
|
|
IDD
|
[NCBI]
|
4.00194e-05
|
|
|
MCKD2
|
[NCBI]
|
4.00194e-05
|
|
|
AITD3
|
[NCBI]
|
4.00194e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
4.00194e-05
|
|
|
ODG2
|
[NCBI]
|
4.00194e-05
|
|
|
IVL
|
[NCBI]
|
3.99569e-05
|
|
|
MCM6
|
[NCBI]
|
3.99569e-05
|
|
|
FMN
|
[NCBI]
|
3.99569e-05
|
|
|
FUT3
|
[NCBI]
|
3.99569e-05
|
|
|
LPL
|
[NCBI]
|
3.96913e-05
|
|
|
SHFM1
|
[NCBI]
|
3.96887e-05
|
|
|
DGS
|
[NCBI]
|
3.95622e-05
|
|
|
NCSTN
|
[NCBI]
|
3.92385e-05
|
|
|
PGD
|
[NCBI]
|
3.92385e-05
|
|
|
SLS
|
[NCBI]
|
3.90368e-05
|
|
|
DIA3
|
[NCBI]
|
3.87744e-05
|
|
|
TS
|
[NCBI]
|
3.87021e-05
|
|
|
DBA
|
[NCBI]
|
3.84335e-05
|
|
|
VHL
|
[NCBI]
|
3.84215e-05
|
|
|
HSAN3
|
[NCBI]
|
3.8318e-05
|
|
|
MNS
|
[NCBI]
|
3.82209e-05
|
|
|
IL10
|
[NCBI]
|
3.81254e-05
|
|
|
SULT1A1
|
[NCBI]
|
3.78377e-05
|
|
|
DCC
|
[NCBI]
|
3.76938e-05
|
|
|
ALPL
|
[NCBI]
|
3.76712e-05
|
|
|
CETP
|
[NCBI]
|
3.76712e-05
|
|
|
pygmy
|
[NCBI]
|
3.69846e-05
|
|
|
IBD5
|
[NCBI]
|
3.69846e-05
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
3.69846e-05
|
|
|
OTSC1
|
[NCBI]
|
3.69846e-05
|
|
|
acroosteolysis with osteoporosis and changes in skull and mandible
|
[NCBI]
|
3.69846e-05
|
|
|
ENPP1
|
[NCBI]
|
3.6674e-05
|
|
|
RECQL3
|
[NCBI]
|
3.6674e-05
|
|
|
MTP
|
[NCBI]
|
3.59228e-05
|
|
|
FCGR2A
|
[NCBI]
|
3.59228e-05
|
|
|
SAA1
|
[NCBI]
|
3.57142e-05
|
|
|
HIDS
|
[NCBI]
|
3.55875e-05
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
3.55491e-05
|
|
|
iron overload in africa
|
[NCBI]
|
3.55491e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
3.55491e-05
|
|
|
OCA3
|
[NCBI]
|
3.55491e-05
|
|
|
SBS
|
[NCBI]
|
3.55491e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
3.55491e-05
|
|
|
metaphyseal dysplasia without hypotrichosis
|
[NCBI]
|
3.54728e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa synthase 2, mitochondrial, deficiency of
|
[NCBI]
|
3.54728e-05
|
|
|
thanatophoric dysplasia, glasgow variant
|
[NCBI]
|
3.54728e-05
|
|
|
SAL-I
|
[NCBI]
|
3.54728e-05
|
|
|
cardiomyopathy, dilated, with quadriceps myopathy
|
[NCBI]
|
3.54728e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
3.54728e-05
|
|
|
favism, susceptibility to
|
[NCBI]
|
3.54728e-05
|
|
|
glycogen storage disease of heart, lethal congenital
|
[NCBI]
|
3.54728e-05
|
|
|
methylmalonyl-coa epimerase deficiency
|
[NCBI]
|
3.54728e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
3.54728e-05
|
|
|
ear pits, posterior helical
|
[NCBI]
|
3.54728e-05
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
3.54728e-05
|
|
|
SCRA
|
[NCBI]
|
3.54728e-05
|
|
|
AKV
|
[NCBI]
|
3.54728e-05
|
|
|
ichthyosis, cyclic, with epidermolytic hyperkeratosis
|
[NCBI]
|
3.54728e-05
|
|
|
SHEP4
|
[NCBI]
|
3.54728e-05
|
|
|
blepharospasm, benign essential
|
[NCBI]
|
3.54728e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
3.54728e-05
|
|
|
LGMD2G
|
[NCBI]
|
3.54728e-05
|
|
|
CMH8
|
[NCBI]
|
3.54728e-05
|
|
|
fanconi anemia, complementation group n
|
[NCBI]
|
3.54728e-05
|
|
|
glycinuria with or without oxalate urolithiasis
|
[NCBI]
|
3.54728e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
3.54728e-05
|
|
|
CDG1H
|
[NCBI]
|
3.54728e-05
|
|
|
LFS2
|
[NCBI]
|
3.54728e-05
|
|
|
ALGS2
|
[NCBI]
|
3.54728e-05
|
|
|
baculum, congenital absence of
|
[NCBI]
|
3.54728e-05
|
|
|
muscular dystrophy, scapulohumeral
|
[NCBI]
|
3.54728e-05
|
|
|
HMN7B
|
[NCBI]
|
3.54728e-05
|
|
|
AACT
|
[NCBI]
|
3.52755e-05
|
|
|
CA1
|
[NCBI]
|
3.52755e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
3.52541e-05
|
|
|
KRAS
|
[NCBI]
|
3.5055e-05
|
|
|
HRAS
|
[NCBI]
|
3.5055e-05
|
|
|
TCF7L2
|
[NCBI]
|
3.48558e-05
|
|
|
GLB1
|
[NCBI]
|
3.47897e-05
|
|
|
PD
|
[NCBI]
|
3.45125e-05
|
|
|
BCKDHA
|
[NCBI]
|
3.41785e-05
|
|
|
PRH1
|
[NCBI]
|
3.41785e-05
|
|
|
P2RX7
|
[NCBI]
|
3.41785e-05
|
|
|
BTD
|
[NCBI]
|
3.41785e-05
|
|
|
CDSN
|
[NCBI]
|
3.40944e-05
|
|
|
gastric cancer
|
[NCBI]
|
3.33594e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
3.31522e-05
|
|
|
SCA10
|
[NCBI]
|
3.31522e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
3.31522e-05
|
|
|
PMC
|
[NCBI]
|
3.31522e-05
|
|
|
PAI1
|
[NCBI]
|
3.30379e-05
|
|
|
PLG
|
[NCBI]
|
3.28171e-05
|
|
|
DTNBP1
|
[NCBI]
|
3.25789e-05
|
|
|
LEPR
|
[NCBI]
|
3.2503e-05
|
|
|
CCHCR1
|
[NCBI]
|
3.23842e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
3.2207e-05
|
|
|
POMC
|
[NCBI]
|
3.2181e-05
|
|
|
GLO1
|
[NCBI]
|
3.19056e-05
|
|
|
behcet syndrome
|
[NCBI]
|
3.18989e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
3.17201e-05
|
|
|
CLN8
|
[NCBI]
|
3.17201e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
3.17201e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
3.17201e-05
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
3.17201e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
3.17201e-05
|
|
|
GPT
|
[NCBI]
|
3.15011e-05
|
|
|
NIDDM
|
[NCBI]
|
3.13693e-05
|
|
|
SELE
|
[NCBI]
|
3.11035e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
3.11035e-05
|
|
|
COL5A1
|
[NCBI]
|
3.11035e-05
|
|
|
SCA17
|
[NCBI]
|
3.08939e-05
|
|
|
GSTM1
|
[NCBI]
|
3.08887e-05
|
|
|
ERDA1
|
[NCBI]
|
3.08063e-05
|
|
|
deleted in endometrial carcinoma
|
[NCBI]
|
3.08063e-05
|
|
|
SACP
|
[NCBI]
|
3.08063e-05
|
|
|
IPW
|
[NCBI]
|
3.08063e-05
|
|
|
FXN
|
[NCBI]
|
3.07503e-05
|
|
|
ADM
|
[NCBI]
|
3.03618e-05
|
|
|
TYR
|
[NCBI]
|
3.03337e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
3.02246e-05
|
|
|
PKD1
|
[NCBI]
|
2.99988e-05
|
|
|
PITPN
|
[NCBI]
|
2.99666e-05
|
|
|
complement component c1r deficiency
|
[NCBI]
|
2.99666e-05
|
|
|
MUT
|
[NCBI]
|
2.99179e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
2.96087e-05
|
|
|
MEN2A
|
[NCBI]
|
2.91147e-05
|
|
|
COL17A1
|
[NCBI]
|
2.899e-05
|
|
|
ACADM
|
[NCBI]
|
2.8834e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
2.87949e-05
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
2.86748e-05
|
|
|
IL6R
|
[NCBI]
|
2.84634e-05
|
|
|
PTS
|
[NCBI]
|
2.84634e-05
|
|
|
USH1C
|
[NCBI]
|
2.84634e-05
|
|
|
RP11
|
[NCBI]
|
2.83952e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
2.83952e-05
|
|
|
HNPCC2
|
[NCBI]
|
2.83952e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
2.83952e-05
|
|
|
XPV
|
[NCBI]
|
2.83952e-05
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
2.83952e-05
|
|
|
OCD1
|
[NCBI]
|
2.83952e-05
|
|
|
THRB
|
[NCBI]
|
2.8356e-05
|
|
|
HTN3
|
[NCBI]
|
2.78829e-05
|
|
|
SLC4A1
|
[NCBI]
|
2.78667e-05
|
|
|
SMN1
|
[NCBI]
|
2.75085e-05
|
|
|
SLOS
|
[NCBI]
|
2.73636e-05
|
|
|
SPR
|
[NCBI]
|
2.72742e-05
|
|
|
PGM3
|
[NCBI]
|
2.72742e-05
|
|
|
PTPN22
|
[NCBI]
|
2.72742e-05
|
|
|
XRCC9
|
[NCBI]
|
2.72742e-05
|
|
|
PRODH
|
[NCBI]
|
2.72504e-05
|
|
|
CST3
|
[NCBI]
|
2.72504e-05
|
|
|
CSNB1A
|
[NCBI]
|
2.68398e-05
|
|
|
USH2A
|
[NCBI]
|
2.68398e-05
|
|
|
MEN1
|
[NCBI]
|
2.66782e-05
|
|
|
CHS
|
[NCBI]
|
2.66247e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
2.65379e-05
|
|
|
IGF1R
|
[NCBI]
|
2.64335e-05
|
|
|
CAPN3
|
[NCBI]
|
2.64335e-05
|
|
|
IL1A
|
[NCBI]
|
2.64335e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
2.64335e-05
|
|
|
MEFV
|
[NCBI]
|
2.64335e-05
|
|
|
SMAD4
|
[NCBI]
|
2.64335e-05
|
|
|
FBN1
|
[NCBI]
|
2.6429e-05
|
|
|
AT
|
[NCBI]
|
2.63245e-05
|
|
|
PHOX2B
|
[NCBI]
|
2.61596e-05
|
|
|
AMY1A
|
[NCBI]
|
2.61596e-05
|
|
|
DBT
|
[NCBI]
|
2.61596e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
2.61596e-05
|
|
|
PKD2
|
[NCBI]
|
2.61451e-05
|
|
|
PEPC
|
[NCBI]
|
2.6056e-05
|
|
|
IGHM
|
[NCBI]
|
2.6056e-05
|
|
|
RPA1
|
[NCBI]
|
2.6056e-05
|
|
|
HK2
|
[NCBI]
|
2.6056e-05
|
|
|
WS1
|
[NCBI]
|
2.5943e-05
|
|
|
DFNB67
|
[NCBI]
|
2.59024e-05
|
|
|
crisponi syndrome
|
[NCBI]
|
2.59024e-05
|
|
|
DFNB21
|
[NCBI]
|
2.59024e-05
|
|
|
mixed lymphocyte culture locus ii
|
[NCBI]
|
2.59024e-05
|
|
|
DFNB31
|
[NCBI]
|
2.59024e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
2.59024e-05
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
2.59024e-05
|
|
|
ehlers-danlos-like syndrome due to tenascin-x deficiency
|
[NCBI]
|
2.59024e-05
|
|
|
NEK1
|
[NCBI]
|
2.59024e-05
|
|
|
DFNA36
|
[NCBI]
|
2.59024e-05
|
|
|
combined saposin deficiency
|
[NCBI]
|
2.59024e-05
|
|
|
LCA10
|
[NCBI]
|
2.59024e-05
|
|
|
FEB8
|
[NCBI]
|
2.59024e-05
|
|
|
OPTB4
|
[NCBI]
|
2.59024e-05
|
|
|
spherocytosis, autosomal recessive
|
[NCBI]
|
2.59024e-05
|
|
|
macular dystrophy, concentric annular
|
[NCBI]
|
2.59024e-05
|
|
|
tuberous sclerosis 4
|
[NCBI]
|
2.59024e-05
|
|
|
FHM3
|
[NCBI]
|
2.59024e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
2.59024e-05
|
|
|
S CHOICE OF
|
[NCBI]
|
2.59024e-05
|
|
|
chondrosarcoma
|
[NCBI]
|
2.59024e-05
|
|
|
nevus, epidermal, epidermolytic hyperkeratotic type
|
[NCBI]
|
2.59024e-05
|
|
|
LVNCX
|
[NCBI]
|
2.59024e-05
|
|
|
mass syndrome
|
[NCBI]
|
2.59024e-05
|
|
|
otofaciocervical syndrome
|
[NCBI]
|
2.59024e-05
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
2.59024e-05
|
|
|
preaxial deficiency, postaxial polydactyly, and hypospadias
|
[NCBI]
|
2.59024e-05
|
|
|
micromelic bone dysplasia with cloverleaf skull
|
[NCBI]
|
2.59024e-05
|
|
|
HANAC
|
[NCBI]
|
2.59024e-05
|
|
|
irak4 deficiency
|
[NCBI]
|
2.59024e-05
|
|
|
SMC
|
[NCBI]
|
2.59024e-05
|
|
|
SHEP5
|
[NCBI]
|
2.59024e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
2.59024e-05
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
2.59024e-05
|
|
|
SLEB2
|
[NCBI]
|
2.59024e-05
|
|
|
BOS3
|
[NCBI]
|
2.59024e-05
|
|
|
SLC6A14
|
[NCBI]
|
2.58488e-05
|
|
|
RRAD
|
[NCBI]
|
2.58488e-05
|
|
|
PRB4
|
[NCBI]
|
2.58488e-05
|
|
|
minor histocompatibility antigen ha-2
|
[NCBI]
|
2.58488e-05
|
|
|
FAT
|
[NCBI]
|
2.58488e-05
|
|
|
HPS3
|
[NCBI]
|
2.58488e-05
|
|
|
TRMI1
|
[NCBI]
|
2.58488e-05
|
|
|
GABRB1
|
[NCBI]
|
2.58488e-05
|
|
|
NF2
|
[NCBI]
|
2.56273e-05
|
|
|
ITGB3
|
[NCBI]
|
2.56273e-05
|
|
|
OCA1A
|
[NCBI]
|
2.55518e-05
|
|
|
THC1
|
[NCBI]
|
2.54771e-05
|
|
|
CMT4A
|
[NCBI]
|
2.54771e-05
|
|
|
MTC
|
[NCBI]
|
2.54771e-05
|
|
|
CLN5
|
[NCBI]
|
2.54771e-05
|
|
|
CDA
|
[NCBI]
|
2.54771e-05
|
|
|
MCDC1
|
[NCBI]
|
2.54771e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
2.50155e-05
|
|
|
ADHD
|
[NCBI]
|
2.49494e-05
|
|
|
NS1
|
[NCBI]
|
2.48094e-05
|
|
|
GIP
|
[NCBI]
|
2.4706e-05
|
|
|
UGT1A1
|
[NCBI]
|
2.46255e-05
|
|
|
COL7A1
|
[NCBI]
|
2.46198e-05
|
|
|
MLC1
|
[NCBI]
|
2.44331e-05
|
|
|
ADH3
|
[NCBI]
|
2.44331e-05
|
|
|
JARID1C
|
[NCBI]
|
2.44331e-05
|
|
|
MYF5
|
[NCBI]
|
2.44331e-05
|
|
|
PEPD
|
[NCBI]
|
2.41681e-05
|
|
|
WAS
|
[NCBI]
|
2.40443e-05
|
|
|
SHBG
|
[NCBI]
|
2.38589e-05
|
|
|
LMNA
|
[NCBI]
|
2.3603e-05
|
|
|
EV
|
[NCBI]
|
2.357e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
2.33106e-05
|
|
|
MHA
|
[NCBI]
|
2.33106e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
2.33106e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
2.33106e-05
|
|
|
SDHD
|
[NCBI]
|
2.31908e-05
|
|
|
LAMB3
|
[NCBI]
|
2.31908e-05
|
|
|
SMS
|
[NCBI]
|
2.3022e-05
|
|
|
RMRP
|
[NCBI]
|
2.29764e-05
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
2.28944e-05
|
|
|
EDM1
|
[NCBI]
|
2.28944e-05
|
|
|
pick disease of brain
|
[NCBI]
|
2.28944e-05
|
|
|
OPD1
|
[NCBI]
|
2.28944e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
2.28944e-05
|
|
|
DSMA1
|
[NCBI]
|
2.28944e-05
|
|
|
adult syndrome
|
[NCBI]
|
2.28944e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
2.28944e-05
|
|
|
GRTH
|
[NCBI]
|
2.28944e-05
|
|
|
septooptic dysplasia
|
[NCBI]
|
2.28944e-05
|
|
|
CCD
|
[NCBI]
|
2.28698e-05
|
|
|
ABCC6
|
[NCBI]
|
2.27943e-05
|
|
|
PRPH2
|
[NCBI]
|
2.27943e-05
|
|
|
VN1R1
|
[NCBI]
|
2.25011e-05
|
|
|
STK19
|
[NCBI]
|
2.25011e-05
|
|
|
LECT1
|
[NCBI]
|
2.25011e-05
|
|
|
NFKBIL1
|
[NCBI]
|
2.25011e-05
|
|
|
BRSK2
|
[NCBI]
|
2.25011e-05
|
|
|
CSMD1
|
[NCBI]
|
2.25011e-05
|
|
|
GANC
|
[NCBI]
|
2.25011e-05
|
|
|
PALB2
|
[NCBI]
|
2.25011e-05
|
|
|
GABRA5
|
[NCBI]
|
2.25011e-05
|
|
|
SP4
|
[NCBI]
|
2.25011e-05
|
|
|
F13A1
|
[NCBI]
|
2.24087e-05
|
|
|
AHR
|
[NCBI]
|
2.23948e-05
|
|
|
FTD
|
[NCBI]
|
2.23573e-05
|
|
|
UROS
|
[NCBI]
|
2.23072e-05
|
|
|
MSX1
|
[NCBI]
|
2.23072e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
2.21437e-05
|
|
|
FANCA
|
[NCBI]
|
2.21437e-05
|
|
|
RASA1
|
[NCBI]
|
2.20199e-05
|
|
|
PAX3
|
[NCBI]
|
2.18665e-05
|
|
|
G6PD
|
[NCBI]
|
2.18305e-05
|
|
|
ST8
|
[NCBI]
|
2.1821e-05
|
|
|
LRP1
|
[NCBI]
|
2.17959e-05
|
|
|
pheochromocytoma
|
[NCBI]
|
2.17151e-05
|
|
|
TPH2
|
[NCBI]
|
2.16574e-05
|
|
|
MEST
|
[NCBI]
|
2.16574e-05
|
|
|
ADH1
|
[NCBI]
|
2.16574e-05
|
|
|
ODC1
|
[NCBI]
|
2.16574e-05
|
|
|
RAI1
|
[NCBI]
|
2.16574e-05
|
|
|
SFTPA1
|
[NCBI]
|
2.16574e-05
|
|
|
TCF4
|
[NCBI]
|
2.16574e-05
|
|
|
FANCD2
|
[NCBI]
|
2.16574e-05
|
|
|
FANCC
|
[NCBI]
|
2.15155e-05
|
|
|
TPI1
|
[NCBI]
|
2.15155e-05
|
|
|
ADRB2
|
[NCBI]
|
2.15155e-05
|
|
|
von willebrand disease
|
[NCBI]
|
2.14742e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
2.1387e-05
|
|
|
TSC2
|
[NCBI]
|
2.10211e-05
|
|
|
GAS11
|
[NCBI]
|
2.09945e-05
|
|
|
TRMI2
|
[NCBI]
|
2.09945e-05
|
|
|
otopetrin 3
|
[NCBI]
|
2.09945e-05
|
|
|
C11ORF21
|
[NCBI]
|
2.09945e-05
|
|
|
EBF3
|
[NCBI]
|
2.09945e-05
|
|
|
otopetrin 1
|
[NCBI]
|
2.09945e-05
|
|
|
otopetrin 2
|
[NCBI]
|
2.09945e-05
|
|
|
PWRN1
|
[NCBI]
|
2.09945e-05
|
|
|
GTPBP3
|
[NCBI]
|
2.09945e-05
|
|
|
fragile site, folic acid-type, rare, fra(10)(q23.3), candidate gene 1
|
[NCBI]
|
2.09945e-05
|
|
|
CYP2A7
|
[NCBI]
|
2.09945e-05
|
|
|
KIR3DP1
|
[NCBI]
|
2.09945e-05
|
|
|
DISP2
|
[NCBI]
|
2.09945e-05
|
|
|
lymphocyte cytosol polypeptide, 100-kd
|
[NCBI]
|
2.09945e-05
|
|
|
TMC2
|
[NCBI]
|
2.09945e-05
|
|
|
SUDD
|
[NCBI]
|
2.09945e-05
|
|
|
FEA
|
[NCBI]
|
2.09945e-05
|
|
|
methylation modifier for class i hla
|
[NCBI]
|
2.09945e-05
|
|
|
CLPTM1
|
[NCBI]
|
2.09945e-05
|
|
|
DISP1
|
[NCBI]
|
2.09945e-05
|
|
|
ST11
|
[NCBI]
|
2.09945e-05
|
|
|
MAEL
|
[NCBI]
|
2.09945e-05
|
|
|
RPL23L
|
[NCBI]
|
2.09945e-05
|
|
|
ovarian cancer-associated gene 2
|
[NCBI]
|
2.09945e-05
|
|
|
PWRN2
|
[NCBI]
|
2.09945e-05
|
|
|
FBP2
|
[NCBI]
|
2.09945e-05
|
|
|
C16ORF3
|
[NCBI]
|
2.09945e-05
|
|
|
zinc finger protein 320
|
[NCBI]
|
2.09945e-05
|
|
|
SCNM1
|
[NCBI]
|
2.09945e-05
|
|
|
HOXA3
|
[NCBI]
|
2.09945e-05
|
|
|
noncoding transcript in t cells
|
[NCBI]
|
2.09945e-05
|
|
|
ribonuclease 1, serum
|
[NCBI]
|
2.09945e-05
|
|
|
twirler mutation, murine, human homolog of
|
[NCBI]
|
2.09945e-05
|
|
|
CHORDC1
|
[NCBI]
|
2.09945e-05
|
|
|
PSMD7
|
[NCBI]
|
2.09945e-05
|
|
|
TSGA14
|
[NCBI]
|
2.09945e-05
|
|
|
TCTE1
|
[NCBI]
|
2.09945e-05
|
|
|
LELP1
|
[NCBI]
|
2.09945e-05
|
|
|
aldo-keto reductase family 7, member a4
|
[NCBI]
|
2.09945e-05
|
|
|
salivary esterase
|
[NCBI]
|
2.09945e-05
|
|
|
MIAT
|
[NCBI]
|
2.09945e-05
|
|
|
PDYN
|
[NCBI]
|
2.09086e-05
|
|
|
KIT
|
[NCBI]
|
2.08973e-05
|
|
|
CDKN1C
|
[NCBI]
|
2.06725e-05
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
2.05928e-05
|
|
|
NFNS
|
[NCBI]
|
2.05928e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
2.05928e-05
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
2.05928e-05
|
|
|
OPD2
|
[NCBI]
|
2.05928e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
2.05928e-05
|
|
|
FUT1
|
[NCBI]
|
2.04547e-05
|
|
|
AGXT
|
[NCBI]
|
2.04547e-05
|
|
|
APOC3
|
[NCBI]
|
2.04547e-05
|
|
|
CD14
|
[NCBI]
|
2.04547e-05
|
|
|
PLA2G7
|
[NCBI]
|
2.04547e-05
|
|
|
POLH
|
[NCBI]
|
2.04547e-05
|
|
|
COL2A1
|
[NCBI]
|
2.04239e-05
|
|
|
PLP1
|
[NCBI]
|
2.04187e-05
|
|
|
SNRPN
|
[NCBI]
|
2.03218e-05
|
|
|
BCNS
|
[NCBI]
|
2.00475e-05
|
|
|
APS1
|
[NCBI]
|
2.00394e-05
|
|
|
FANCI
|
[NCBI]
|
2.00075e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
2.00075e-05
|
|
|
papilloma of choroid plexus
|
[NCBI]
|
2.00075e-05
|
|
|
SCA15
|
[NCBI]
|
2.00075e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
2.00075e-05
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
2.00075e-05
|
|
|
XS
|
[NCBI]
|
2.00075e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
2.00075e-05
|
|
|
RP19
|
[NCBI]
|
2.00075e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
2.00075e-05
|
|
|
rheumatic fever-related antigen
|
[NCBI]
|
2.00075e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
2.00075e-05
|
|
|
ARVD9
|
[NCBI]
|
2.00075e-05
|
|
|
OPTB2
|
[NCBI]
|
2.00075e-05
|
|
|
microcephaly with chemotactic defect and transient hypogammaglobulinemia
|
[NCBI]
|
2.00075e-05
|
|
|
antisense igf2r
|
[NCBI]
|
2.00075e-05
|
|
|
tietz syndrome
|
[NCBI]
|
2.00075e-05
|
|
|
ependymoma, familial
|
[NCBI]
|
2.00075e-05
|
|
|
FHCA
|
[NCBI]
|
2.00075e-05
|
|
|
clubfoot
|
[NCBI]
|
2.00075e-05
|
|
|
varicose veins
|
[NCBI]
|
2.00075e-05
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
2.00075e-05
|
|
|
oncocytoma
|
[NCBI]
|
2.00075e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
2.00075e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
2.00075e-05
|
|
|
USH1F
|
[NCBI]
|
2.00075e-05
|
|
|
LGMD2K
|
[NCBI]
|
2.00075e-05
|
|
|
FRAXF
|
[NCBI]
|
2.00075e-05
|
|
|
endocardial fibroelastosis
|
[NCBI]
|
2.00075e-05
|
|
|
DFNB59
|
[NCBI]
|
2.00075e-05
|
|
|
CLN7
|
[NCBI]
|
2.00075e-05
|
|
|
gracile bone dysplasia
|
[NCBI]
|
2.00075e-05
|
|
|
CSB
|
[NCBI]
|
2.00075e-05
|
|
|
mevalonic aciduria
|
[NCBI]
|
2.00075e-05
|
|
|
ALK
|
[NCBI]
|
1.99899e-05
|
|
|
GDA
|
[NCBI]
|
1.9977e-05
|
|
|
TAS1R1
|
[NCBI]
|
1.9977e-05
|
|
|
ALPPL2
|
[NCBI]
|
1.9977e-05
|
|
|
MGP
|
[NCBI]
|
1.9977e-05
|
|
|
PRB3
|
[NCBI]
|
1.9977e-05
|
|
|
ALG6
|
[NCBI]
|
1.9977e-05
|
|
|
TYRO3
|
[NCBI]
|
1.9977e-05
|
|
|
COL19A1
|
[NCBI]
|
1.9977e-05
|
|
|
GGTA1
|
[NCBI]
|
1.9977e-05
|
|
|
MCCC1
|
[NCBI]
|
1.9977e-05
|
|
|
PTGIS
|
[NCBI]
|
1.9977e-05
|
|
|
GJB4
|
[NCBI]
|
1.9977e-05
|
|
|
HK3
|
[NCBI]
|
1.9977e-05
|
|
|
ANKK1
|
[NCBI]
|
1.9977e-05
|
|
|
SBDS
|
[NCBI]
|
1.9977e-05
|
|
|
F2
|
[NCBI]
|
1.9952e-05
|
|
|
CDK2
|
[NCBI]
|
1.99316e-05
|
|
|
EYA1
|
[NCBI]
|
1.99143e-05
|
|
|
MVK
|
[NCBI]
|
1.99143e-05
|
|
|
CMH
|
[NCBI]
|
1.98078e-05
|
|
|
SHH
|
[NCBI]
|
1.97088e-05
|
|
|
MLH1
|
[NCBI]
|
1.94292e-05
|
|
|
XIST
|
[NCBI]
|
1.94292e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
1.94023e-05
|
|
|
CTNS
|
[NCBI]
|
1.93515e-05
|
|
|
TAP1
|
[NCBI]
|
1.93515e-05
|
|
|
NAGLU
|
[NCBI]
|
1.93515e-05
|
|
|
MMP3
|
[NCBI]
|
1.92048e-05
|
|
|
PRKAR1A
|
[NCBI]
|
1.91916e-05
|
|
|
STAR
|
[NCBI]
|
1.90295e-05
|
|
|
SPDA1
|
[NCBI]
|
1.88182e-05
|
|
|
HEXB
|
[NCBI]
|
1.86728e-05
|
|
|
BHC
|
[NCBI]
|
1.85306e-05
|
|
|
SCZD4
|
[NCBI]
|
1.85306e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
1.85306e-05
|
|
|
PALS
|
[NCBI]
|
1.85306e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
1.85306e-05
|
|
|
PANK2
|
[NCBI]
|
1.83343e-05
|
|
|
SCARB1
|
[NCBI]
|
1.83343e-05
|
|
|
ALOX5
|
[NCBI]
|
1.83343e-05
|
|
|
GABRB3
|
[NCBI]
|
1.83343e-05
|
|
|
MC3R
|
[NCBI]
|
1.83343e-05
|
|
|
ATXN3
|
[NCBI]
|
1.83343e-05
|
|
|
TSHR
|
[NCBI]
|
1.83151e-05
|
|
|
WBS
|
[NCBI]
|
1.82718e-05
|
|
|
SERPINA6
|
[NCBI]
|
1.82048e-05
|
|
|
CYP17A1
|
[NCBI]
|
1.81572e-05
|
|
|
SMA1
|
[NCBI]
|
1.81289e-05
|
|
|
AHO
|
[NCBI]
|
1.81289e-05
|
|
|
CHRNB1
|
[NCBI]
|
1.796e-05
|
|
|
TRPM1
|
[NCBI]
|
1.796e-05
|
|
|
NSDHL
|
[NCBI]
|
1.796e-05
|
|
|
PRB2
|
[NCBI]
|
1.796e-05
|
|
|
MMP8
|
[NCBI]
|
1.796e-05
|
|
|
DLX5
|
[NCBI]
|
1.796e-05
|
|
|
PPP1R3A
|
[NCBI]
|
1.796e-05
|
|
|
FANCB
|
[NCBI]
|
1.796e-05
|
|
|
GAB1
|
[NCBI]
|
1.796e-05
|
|
|
CLN8
|
[NCBI]
|
1.796e-05
|
|
|
TAP2
|
[NCBI]
|
1.796e-05
|
|
|
IL23R
|
[NCBI]
|
1.796e-05
|
|
|
GP1BA
|
[NCBI]
|
1.78423e-05
|
|
|
PROS1
|
[NCBI]
|
1.78423e-05
|
|
|
NOS2A
|
[NCBI]
|
1.78423e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
1.76575e-05
|
|
|
ATM
|
[NCBI]
|
1.76039e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
1.75021e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
1.75021e-05
|
|
|
TAZ
|
[NCBI]
|
1.73922e-05
|
|
|
SOX2
|
[NCBI]
|
1.73922e-05
|
|
|
KCNQ1OT1
|
[NCBI]
|
1.73922e-05
|
|
|
CBR1
|
[NCBI]
|
1.73922e-05
|
|
|
CYP11A1
|
[NCBI]
|
1.73922e-05
|
|
|
VLDLR
|
[NCBI]
|
1.71728e-05
|
|
|
STAT3
|
[NCBI]
|
1.69874e-05
|
|
|
FA
|
[NCBI]
|
1.6942e-05
|
|
|
IDE
|
[NCBI]
|
1.68799e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
1.66743e-05
|
|
|
GCE
|
[NCBI]
|
1.66743e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
1.66743e-05
|
|
|
DLB
|
[NCBI]
|
1.66743e-05
|
|
|
ND
|
[NCBI]
|
1.66635e-05
|
|
|
AK1
|
[NCBI]
|
1.6607e-05
|
|
|
TSIX
|
[NCBI]
|
1.65164e-05
|
|
|
TSHB
|
[NCBI]
|
1.65164e-05
|
|
|
GLDC
|
[NCBI]
|
1.65164e-05
|
|
|
BCHE
|
[NCBI]
|
1.64076e-05
|
|
|
DYT1
|
[NCBI]
|
1.63394e-05
|
|
|
SCIDX1
|
[NCBI]
|
1.63394e-05
|
|
|
DVL2
|
[NCBI]
|
1.62881e-05
|
|
|
BECN1
|
[NCBI]
|
1.62881e-05
|
|
|
COL9A3
|
[NCBI]
|
1.62881e-05
|
|
|
INHBB
|
[NCBI]
|
1.62881e-05
|
|
|
RLN1
|
[NCBI]
|
1.62881e-05
|
|
|
SLC39A4
|
[NCBI]
|
1.62881e-05
|
|
|
FUT6
|
[NCBI]
|
1.62881e-05
|
|
|
ROM1
|
[NCBI]
|
1.62881e-05
|
|
|
PRPF31
|
[NCBI]
|
1.62881e-05
|
|
|
IL11
|
[NCBI]
|
1.62881e-05
|
|
|
KRT4
|
[NCBI]
|
1.62881e-05
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
1.62881e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
1.62658e-05
|
|
|
SDC2
|
[NCBI]
|
1.62494e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
1.6068e-05
|
|
|
KRT5
|
[NCBI]
|
1.60276e-05
|
|
|
COL10A1
|
[NCBI]
|
1.60276e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
1.58581e-05
|
|
|
EDM2
|
[NCBI]
|
1.58581e-05
|
|
|
RP7
|
[NCBI]
|
1.58581e-05
|
|
|
LISX2
|
[NCBI]
|
1.58581e-05
|
|
|
epidermolysis bullosa of hands and feet
|
[NCBI]
|
1.58581e-05
|
|
|
PGL3
|
[NCBI]
|
1.58581e-05
|
|
|
watson syndrome
|
[NCBI]
|
1.58581e-05
|
|
|
DFNB2
|
[NCBI]
|
1.58581e-05
|
|
|
paroxysmal extreme pain disorder
|
[NCBI]
|
1.58581e-05
|
|
|
novelty seeking personality trait
|
[NCBI]
|
1.58581e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
1.58581e-05
|
|
|
enterokinase deficiency
|
[NCBI]
|
1.58581e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
1.58581e-05
|
|
|
insulin-like growth factor i deficiency
|
[NCBI]
|
1.58581e-05
|
|
|
RCDP3
|
[NCBI]
|
1.58581e-05
|
|
|
NAIC
|
[NCBI]
|
1.58581e-05
|
|
|
west nile virus, susceptibility to
|
[NCBI]
|
1.58581e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
1.58581e-05
|
|
|
cd4/cd8 t-cell ratio
|
[NCBI]
|
1.58581e-05
|
|
|
DFNB12
|
[NCBI]
|
1.58581e-05
|
|
|
ED3
|
[NCBI]
|
1.58581e-05
|
|
|
EBDSC
|
[NCBI]
|
1.58581e-05
|
|
|
EDM3
|
[NCBI]
|
1.58581e-05
|
|
|
DFNB6
|
[NCBI]
|
1.58581e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
1.58581e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
1.58581e-05
|
|
|
melorheostosis
|
[NCBI]
|
1.58581e-05
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
1.58581e-05
|
|
|
melanoma-pancreatic cancer syndrome
|
[NCBI]
|
1.58581e-05
|
|
|
thalassemia, beta+, silent allele
|
[NCBI]
|
1.58581e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.57996e-05
|
|
|
CSF1R
|
[NCBI]
|
1.56994e-05
|
|
|
PRKCG
|
[NCBI]
|
1.56994e-05
|
|
|
MUTYH
|
[NCBI]
|
1.56994e-05
|
|
|
IL9
|
[NCBI]
|
1.56994e-05
|
|
|
LCT
|
[NCBI]
|
1.56378e-05
|
|
|
RTT
|
[NCBI]
|
1.55597e-05
|
|
|
MECP2
|
[NCBI]
|
1.54928e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.54776e-05
|
|
|
DHFR
|
[NCBI]
|
1.54688e-05
|
|
|
BLM
|
[NCBI]
|
1.52751e-05
|
|
|
krabbe disease
|
[NCBI]
|
1.5248e-05
|
|
|
alkaptonuria
|
[NCBI]
|
1.49973e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
1.49973e-05
|
|
|
OPTB3
|
[NCBI]
|
1.49973e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
1.49973e-05
|
|
|
NPHS1
|
[NCBI]
|
1.49973e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
1.49973e-05
|
|
|
SCCMS
|
[NCBI]
|
1.49973e-05
|
|
|
SPG2
|
[NCBI]
|
1.49973e-05
|
|
|
NR1I2
|
[NCBI]
|
1.4963e-05
|
|
|
FTH1
|
[NCBI]
|
1.49349e-05
|
|
|
IGHV
|
[NCBI]
|
1.49349e-05
|
|
|
SFTPB
|
[NCBI]
|
1.49349e-05
|
|
|
NRG1
|
[NCBI]
|
1.49283e-05
|
|
|
GCKR
|
[NCBI]
|
1.48668e-05
|
|
|
ST7
|
[NCBI]
|
1.48668e-05
|
|
|
CYP3A7
|
[NCBI]
|
1.48668e-05
|
|
|
NEUROG3
|
[NCBI]
|
1.48668e-05
|
|
|
TBCE
|
[NCBI]
|
1.48668e-05
|
|
|
CRLF1
|
[NCBI]
|
1.48668e-05
|
|
|
CHX10
|
[NCBI]
|
1.48668e-05
|
|
|
CASP10
|
[NCBI]
|
1.48668e-05
|
|
|
BCKDHB
|
[NCBI]
|
1.48668e-05
|
|
|
PRH2
|
[NCBI]
|
1.48668e-05
|
|
|
FGF20
|
[NCBI]
|
1.48668e-05
|
|
|
CYSLTR1
|
[NCBI]
|
1.48668e-05
|
|
|
COL9A2
|
[NCBI]
|
1.48668e-05
|
|
|
PPP2R2B
|
[NCBI]
|
1.48668e-05
|
|
|
GSTZ1
|
[NCBI]
|
1.48668e-05
|
|
|
ACTN3
|
[NCBI]
|
1.48668e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
1.45185e-05
|
|
|
EPHX1
|
[NCBI]
|
1.44238e-05
|
|
|
PNMT
|
[NCBI]
|
1.43842e-05
|
|
|
CTSD
|
[NCBI]
|
1.42178e-05
|
|
|
PEX7
|
[NCBI]
|
1.42178e-05
|
|
|
NME1
|
[NCBI]
|
1.42178e-05
|
|
|
HR
|
[NCBI]
|
1.42178e-05
|
|
|
CPT2
|
[NCBI]
|
1.42178e-05
|
|
|
cystinuria
|
[NCBI]
|
1.4011e-05
|
|
|
CTCF
|
[NCBI]
|
1.39298e-05
|
|
|
PLTP
|
[NCBI]
|
1.38894e-05
|
|
|
TCOF
|
[NCBI]
|
1.3739e-05
|
|
|
RDT
|
[NCBI]
|
1.3739e-05
|
|
|
GSTT1
|
[NCBI]
|
1.36359e-05
|
|
|
MORF4
|
[NCBI]
|
1.36359e-05
|
|
|
EPHX2
|
[NCBI]
|
1.36359e-05
|
|
|
SULT1A3
|
[NCBI]
|
1.36359e-05
|
|
|
SCNN1G
|
[NCBI]
|
1.36359e-05
|
|
|
GBE1
|
[NCBI]
|
1.36359e-05
|
|
|
SLC22A18
|
[NCBI]
|
1.36359e-05
|
|
|
APOA5
|
[NCBI]
|
1.36359e-05
|
|
|
ITIH1
|
[NCBI]
|
1.36359e-05
|
|
|
CDH13
|
[NCBI]
|
1.36359e-05
|
|
|
PABPN1
|
[NCBI]
|
1.36359e-05
|
|
|
CHEK1
|
[NCBI]
|
1.36359e-05
|
|
|
PCD
|
[NCBI]
|
1.35934e-05
|
|
|
DBH
|
[NCBI]
|
1.35434e-05
|
|
|
IFNAR1
|
[NCBI]
|
1.35434e-05
|
|
|
SELP
|
[NCBI]
|
1.35434e-05
|
|
|
AMPD1
|
[NCBI]
|
1.35434e-05
|
|
|
RP
|
[NCBI]
|
1.35394e-05
|
|
|
CNTF
|
[NCBI]
|
1.34551e-05
|
|
|
CYP3A4
|
[NCBI]
|
1.34542e-05
|
|
|
KCNH2
|
[NCBI]
|
1.33396e-05
|
|
|
PLK1
|
[NCBI]
|
1.31856e-05
|
|
|
HOS
|
[NCBI]
|
1.3171e-05
|
|
|
SLC6A4
|
[NCBI]
|
1.31117e-05
|
|
|
CMM
|
[NCBI]
|
1.30769e-05
|
|
|
LGMD2A
|
[NCBI]
|
1.2983e-05
|
|
|
PARK2
|
[NCBI]
|
1.2983e-05
|
|
|
GLIS3
|
[NCBI]
|
1.2924e-05
|
|
|
CYP2A13
|
[NCBI]
|
1.2924e-05
|
|
|
SETDB2
|
[NCBI]
|
1.2924e-05
|
|
|
RCL1
|
[NCBI]
|
1.2924e-05
|
|
|
breast cancer-related regulator of tp53
|
[NCBI]
|
1.2924e-05
|
|
|
hook, drosophila, homolog of, 2
|
[NCBI]
|
1.2924e-05
|
|
|
LRE2
|
[NCBI]
|
1.2924e-05
|
|
|
ASMT
|
[NCBI]
|
1.2924e-05
|
|
|
PPEF2
|
[NCBI]
|
1.2924e-05
|
|
|
mei1, mouse, homolog of
|
[NCBI]
|
1.2924e-05
|
|
|
KRTAP1-5
|
[NCBI]
|
1.2924e-05
|
|
|
CSMD3
|
[NCBI]
|
1.2924e-05
|
|
|
ALKBH2
|
[NCBI]
|
1.2924e-05
|
|
|
TTC8
|
[NCBI]
|
1.2924e-05
|
|
|
CUTC
|
[NCBI]
|
1.2924e-05
|
|
|
GPR33
|
[NCBI]
|
1.2924e-05
|
|
|
minisatellite 33.6
|
[NCBI]
|
1.2924e-05
|
|
|
EMR1
|
[NCBI]
|
1.2924e-05
|
|
|
JAZF1
|
[NCBI]
|
1.2924e-05
|
|
|
TAF1A
|
[NCBI]
|
1.2924e-05
|
|
|
minisatellite 33.15
|
[NCBI]
|
1.2924e-05
|
|
|
IGHG2
|
[NCBI]
|
1.2924e-05
|
|
|
DIA2
|
[NCBI]
|
1.2924e-05
|
|
|
COBL
|
[NCBI]
|
1.2924e-05
|
|
|
ASMT
|
[NCBI]
|
1.2924e-05
|
|
|
PGA3
|
[NCBI]
|
1.2924e-05
|
|
|
ZC3H12D
|
[NCBI]
|
1.2924e-05
|
|
|
DVL1L1
|
[NCBI]
|
1.2924e-05
|
|
|
PRKAG3
|
[NCBI]
|
1.2924e-05
|
|
|
KIF1C
|
[NCBI]
|
1.2924e-05
|
|
|
KRTAP1-1
|
[NCBI]
|
1.2924e-05
|
|
|
BRWD2
|
[NCBI]
|
1.2924e-05
|
|
|
lipin 3
|
[NCBI]
|
1.2924e-05
|
|
|
MAGEB5
|
[NCBI]
|
1.2924e-05
|
|
|
yeast factor
|
[NCBI]
|
1.2924e-05
|
|
|
COX7B2
|
[NCBI]
|
1.2924e-05
|
|
|
AKR7A3
|
[NCBI]
|
1.2924e-05
|
|
|
OVOL1
|
[NCBI]
|
1.2924e-05
|
|
|
LPHH1
|
[NCBI]
|
1.2924e-05
|
|
|
KRTAP1-3
|
[NCBI]
|
1.2924e-05
|
|
|
ZNF214
|
[NCBI]
|
1.2924e-05
|
|
|
CBR3
|
[NCBI]
|
1.2924e-05
|
|
|
HMX1
|
[NCBI]
|
1.2924e-05
|
|
|
HYLS1
|
[NCBI]
|
1.2924e-05
|
|
|
MYO3A
|
[NCBI]
|
1.2924e-05
|
|
|
SULT1A2
|
[NCBI]
|
1.2924e-05
|
|
|
KCTD11
|
[NCBI]
|
1.2924e-05
|
|
|
cobl-like protein 1: cobll1
|
[NCBI]
|
1.2924e-05
|
|
|
SLC12A8
|
[NCBI]
|
1.2924e-05
|
|
|
lunapark
|
[NCBI]
|
1.2924e-05
|
|
|
IGF2AS
|
[NCBI]
|
1.2924e-05
|
|
|
CDC14B
|
[NCBI]
|
1.2924e-05
|
|
|
TAF1C
|
[NCBI]
|
1.2924e-05
|
|
|
TUSC2
|
[NCBI]
|
1.2924e-05
|
|
|
DUSP8
|
[NCBI]
|
1.2924e-05
|
|
|
EEF1E1
|
[NCBI]
|
1.2924e-05
|
|
|
KIAA0020
|
[NCBI]
|
1.2924e-05
|
|
|
KRTAP1-4
|
[NCBI]
|
1.2924e-05
|
|
|
ZNF215
|
[NCBI]
|
1.2924e-05
|
|
|
selenoprotein, 15-kd
|
[NCBI]
|
1.2924e-05
|
|
|
MAGEB6
|
[NCBI]
|
1.2924e-05
|
|
|
TTLL6
|
[NCBI]
|
1.2924e-05
|
|
|
TAF1B
|
[NCBI]
|
1.2924e-05
|
|
|
DUSP12
|
[NCBI]
|
1.2924e-05
|
|
|
DIRC1
|
[NCBI]
|
1.2924e-05
|
|
|
HLA8
|
[NCBI]
|
1.2924e-05
|
|
|
MAGEC3
|
[NCBI]
|
1.2924e-05
|
|
|
GFPT2
|
[NCBI]
|
1.2924e-05
|
|
|
H3F3A
|
[NCBI]
|
1.29078e-05
|
|
|
WFS1
|
[NCBI]
|
1.29078e-05
|
|
|
PARK2
|
[NCBI]
|
1.28806e-05
|
|
|
NF2
|
[NCBI]
|
1.28565e-05
|
|
|
IAPP
|
[NCBI]
|
1.27929e-05
|
|
|
STHAG1
|
[NCBI]
|
1.27368e-05
|
|
|
nonarteritic anterior ischemic optic neuropathy, susceptibility to
|
[NCBI]
|
1.27368e-05
|
|
|
DFNB7
|
[NCBI]
|
1.27368e-05
|
|
|
ADCC
|
[NCBI]
|
1.27368e-05
|
|
|
DFNB10
|
[NCBI]
|
1.27368e-05
|
|
|
OCA1B
|
[NCBI]
|
1.27368e-05
|
|
|
CRS2
|
[NCBI]
|
1.27368e-05
|
|
|
HDL1
|
[NCBI]
|
1.27368e-05
|
|
|
PRTH
|
[NCBI]
|
1.27368e-05
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
1.27368e-05
|
|
|
serpentine fibula-polycystic kidney syndrome
|
[NCBI]
|
1.27368e-05
|
|
|
PMF
|
[NCBI]
|
1.27368e-05
|
|
|
DFNB8
|
[NCBI]
|
1.27368e-05
|
|
|
uniparental disomy, paternal, chromosome 14
|
[NCBI]
|
1.27368e-05
|
|
|
UL
|
[NCBI]
|
1.27368e-05
|
|
|
hyperalphalipoproteinemia
|
[NCBI]
|
1.27368e-05
|
|
|
ATCAY
|
[NCBI]
|
1.27368e-05
|
|
|
CGL1
|
[NCBI]
|
1.27368e-05
|
|
|
SMDP2
|
[NCBI]
|
1.27368e-05
|
|
|
PBC
|
[NCBI]
|
1.27368e-05
|
|
|
elejalde disease
|
[NCBI]
|
1.27368e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
1.27368e-05
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
1.27368e-05
|
|
|
GRTH
|
[NCBI]
|
1.27368e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
1.27368e-05
|
|
|
HDL2
|
[NCBI]
|
1.27368e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
1.27368e-05
|
|
|
patterned dystrophy of retinal pigment epithelium
|
[NCBI]
|
1.27368e-05
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
1.27368e-05
|
|
|
naxos disease
|
[NCBI]
|
1.27368e-05
|
|
|
thrombophilia
|
[NCBI]
|
1.27368e-05
|
|
|
oguchi disease
|
[NCBI]
|
1.27368e-05
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
1.27368e-05
|
|
|
ragweed sensitivity
|
[NCBI]
|
1.27368e-05
|
|
|
RCDP2
|
[NCBI]
|
1.27368e-05
|
|
|
REN
|
[NCBI]
|
1.26744e-05
|
|
|
PSEN2
|
[NCBI]
|
1.26744e-05
|
|
|
MKS1
|
[NCBI]
|
1.2609e-05
|
|
|
HDC
|
[NCBI]
|
1.25693e-05
|
|
|
GYS1
|
[NCBI]
|
1.25546e-05
|
|
|
PLAGL1
|
[NCBI]
|
1.25546e-05
|
|
|
HOXA1
|
[NCBI]
|
1.25546e-05
|
|
|
TLX1
|
[NCBI]
|
1.25546e-05
|
|
|
HESX1
|
[NCBI]
|
1.25546e-05
|
|
|
CD38
|
[NCBI]
|
1.25546e-05
|
|
|
HOXA13
|
[NCBI]
|
1.25546e-05
|
|
|
ALPI
|
[NCBI]
|
1.25546e-05
|
|
|
RGS4
|
[NCBI]
|
1.25546e-05
|
|
|
ACO2
|
[NCBI]
|
1.25546e-05
|
|
|
BARD1
|
[NCBI]
|
1.25546e-05
|
|
|
MTNR1A
|
[NCBI]
|
1.25546e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.25544e-05
|
|
|
PMM2
|
[NCBI]
|
1.23077e-05
|
|
|
NGFR
|
[NCBI]
|
1.221e-05
|
|
|
STK11
|
[NCBI]
|
1.21285e-05
|
|
|
ATP7B
|
[NCBI]
|
1.21285e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
1.20977e-05
|
|
|
BPES
|
[NCBI]
|
1.20533e-05
|
|
|
PGR
|
[NCBI]
|
1.17791e-05
|
|
|
MYO5A
|
[NCBI]
|
1.174e-05
|
|
|
FGFR4
|
[NCBI]
|
1.174e-05
|
|
|
MYH9
|
[NCBI]
|
1.174e-05
|
|
|
IGF1
|
[NCBI]
|
1.16658e-05
|
|
|
STAT1
|
[NCBI]
|
1.16581e-05
|
|
|
BGLAP
|
[NCBI]
|
1.16581e-05
|
|
|
alopecia areata 1
|
[NCBI]
|
1.1632e-05
|
|
|
DURS1
|
[NCBI]
|
1.1632e-05
|
|
|
twinning, dizygotic
|
[NCBI]
|
1.1632e-05
|
|
|
PAND1
|
[NCBI]
|
1.1632e-05
|
|
|
MYO15A
|
[NCBI]
|
1.15942e-05
|
|
|
SUZ12
|
[NCBI]
|
1.15942e-05
|
|
|
LTK
|
[NCBI]
|
1.15942e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.15942e-05
|
|
|
AMBP
|
[NCBI]
|
1.15942e-05
|
|
|
CDKN2B
|
[NCBI]
|
1.15942e-05
|
|
|
CX3CR1
|
[NCBI]
|
1.15942e-05
|
|
|
ITPA
|
[NCBI]
|
1.15942e-05
|
|
|
loc387715 gene
|
[NCBI]
|
1.15942e-05
|
|
|
SLC6A2
|
[NCBI]
|
1.15942e-05
|
|
|
KIR2DL1
|
[NCBI]
|
1.15942e-05
|
|
|
ZNF9
|
[NCBI]
|
1.15942e-05
|
|
|
MS4A2
|
[NCBI]
|
1.15942e-05
|
|
|
TIMELESS
|
[NCBI]
|
1.15942e-05
|
|
|
PON2
|
[NCBI]
|
1.15942e-05
|
|
|
WT1
|
[NCBI]
|
1.13468e-05
|
|
|
DBI
|
[NCBI]
|
1.12469e-05
|
|
|
NRAS
|
[NCBI]
|
1.12023e-05
|
|
|
HPX
|
[NCBI]
|
1.12023e-05
|
|
|
CACNA1C
|
[NCBI]
|
1.12023e-05
|
|
|
CCND1
|
[NCBI]
|
1.11834e-05
|
|
|
CHM
|
[NCBI]
|
1.09617e-05
|
|
|
ACPP
|
[NCBI]
|
1.09243e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
1.08419e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
1.08419e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
1.08419e-05
|
|
|
KTCN1
|
[NCBI]
|
1.08419e-05
|
|
|
MAP3K5
|
[NCBI]
|
1.08382e-05
|
|
|
F13B
|
[NCBI]
|
1.07334e-05
|
|
|
PRKAG2
|
[NCBI]
|
1.07334e-05
|
|
|
KLK1
|
[NCBI]
|
1.07334e-05
|
|
|
CNTFR
|
[NCBI]
|
1.07334e-05
|
|
|
CLCN7
|
[NCBI]
|
1.07334e-05
|
|
|
ICOS
|
[NCBI]
|
1.07334e-05
|
|
|
GFI1
|
[NCBI]
|
1.07334e-05
|
|
|
CYP19A1
|
[NCBI]
|
1.0733e-05
|
|
|
OPA1
|
[NCBI]
|
1.06921e-05
|
|
|
GUSB
|
[NCBI]
|
1.06412e-05
|
|
|
ARPKD
|
[NCBI]
|
1.06326e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
1.06326e-05
|
|
|
POLG
|
[NCBI]
|
1.0567e-05
|
|
|
PEDF
|
[NCBI]
|
1.03224e-05
|
|
|
RP9
|
[NCBI]
|
1.02949e-05
|
|
|
complement component 5 deficiency
|
[NCBI]
|
1.02949e-05
|
|
|
CLN6
|
[NCBI]
|
1.02949e-05
|
|
|
hypospadias, autosomal
|
[NCBI]
|
1.02949e-05
|
|
|
KNO
|
[NCBI]
|
1.02949e-05
|
|
|
vater association
|
[NCBI]
|
1.02949e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
1.02949e-05
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
1.02949e-05
|
|
|
TD2
|
[NCBI]
|
1.02949e-05
|
|
|
F5F8D
|
[NCBI]
|
1.02949e-05
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
1.02949e-05
|
|
|
CSNB1B
|
[NCBI]
|
1.02949e-05
|
|
|
twinning, monozygotic
|
[NCBI]
|
1.02949e-05
|
|
|
myasthenic syndrome, congenital, fast-channel
|
[NCBI]
|
1.02949e-05
|
|
|
ectodermal dysplasia, anhidrotic
|
[NCBI]
|
1.02949e-05
|
|
|
SPMM
|
[NCBI]
|
1.02949e-05
|
|
|
IDDM5
|
[NCBI]
|
1.02949e-05
|
|
|
EAD
|
[NCBI]
|
1.02949e-05
|
|
|
endometrial cancer
|
[NCBI]
|
1.02949e-05
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
1.02949e-05
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
1.02949e-05
|
|
|
ARMD7
|
[NCBI]
|
1.02949e-05
|
|
|
AKR1B1
|
[NCBI]
|
1.0283e-05
|
|
|
SMA3
|
[NCBI]
|
1.02493e-05
|
|
|
CLN3
|
[NCBI]
|
1.02493e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
1.02493e-05
|
|
|
TCRA
|
[NCBI]
|
1.0209e-05
|
|
|
CHRNE
|
[NCBI]
|
1.02074e-05
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
1.02074e-05
|
|
|
DYT1
|
[NCBI]
|
1.02074e-05
|
|
|
KL
|
[NCBI]
|
1.02074e-05
|
|
|
EIF4E
|
[NCBI]
|
1.01497e-05
|
|
|
PSACH
|
[NCBI]
|
1.01426e-05
|
|
|
GPR49
|
[NCBI]
|
9.98816e-06
|
|
|
HS1BP3
|
[NCBI]
|
9.98816e-06
|
|
|
leucine-rich repeat-containing g protein-coupled receptor 7
|
[NCBI]
|
9.98816e-06
|
|
|
ATP2B4
|
[NCBI]
|
9.98816e-06
|
|
|
DLX6
|
[NCBI]
|
9.98816e-06
|
|
|
DMGDH
|
[NCBI]
|
9.98816e-06
|
|
|
CDH18
|
[NCBI]
|
9.98816e-06
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
9.98816e-06
|
|
|
ALKBH3
|
[NCBI]
|
9.98816e-06
|
|
|
HOXD1
|
[NCBI]
|
9.98816e-06
|
|
|
HOXA11
|
[NCBI]
|
9.98816e-06
|
|
|
NAB2
|
[NCBI]
|
9.98816e-06
|
|
|
E2F5
|
[NCBI]
|
9.98816e-06
|
|
|
ITGA8
|
[NCBI]
|
9.98816e-06
|
|
|
CDH4
|
[NCBI]
|
9.98816e-06
|
|
|
selective lim-binding factor, rat, homolog of
|
[NCBI]
|
9.98816e-06
|
|
|
MN1
|
[NCBI]
|
9.98816e-06
|
|
|
LHFPL5
|
[NCBI]
|
9.98816e-06
|
|
|
DNAI1
|
[NCBI]
|
9.98816e-06
|
|
|
AGTPBP1
|
[NCBI]
|
9.98816e-06
|
|
|
TSSC4
|
[NCBI]
|
9.98816e-06
|
|
|
ARID4B
|
[NCBI]
|
9.98816e-06
|
|
|
WSB1
|
[NCBI]
|
9.98816e-06
|
|
|
SMARCAL1
|
[NCBI]
|
9.98816e-06
|
|
|
HOXB1
|
[NCBI]
|
9.98816e-06
|
|
|
SYN3
|
[NCBI]
|
9.98816e-06
|
|
|
PEX10
|
[NCBI]
|
9.98816e-06
|
|
|
TEX14
|
[NCBI]
|
9.98816e-06
|
|
|
CHL1
|
[NCBI]
|
9.98816e-06
|
|
|
PCSK4
|
[NCBI]
|
9.98816e-06
|
|
|
SUCLA2
|
[NCBI]
|
9.98816e-06
|
|
|
INPP4A
|
[NCBI]
|
9.98816e-06
|
|
|
FUT5
|
[NCBI]
|
9.98816e-06
|
|
|
USP14
|
[NCBI]
|
9.98816e-06
|
|
|
DYM
|
[NCBI]
|
9.98816e-06
|
|
|
AKR7A2
|
[NCBI]
|
9.98816e-06
|
|
|
DBNL
|
[NCBI]
|
9.98816e-06
|
|
|
BCL11B
|
[NCBI]
|
9.98816e-06
|
|
|
DIRAS3
|
[NCBI]
|
9.98816e-06
|
|
|
PTGES2
|
[NCBI]
|
9.98816e-06
|
|
|
PAFAH1B3
|
[NCBI]
|
9.98816e-06
|
|
|
DPH1
|
[NCBI]
|
9.98816e-06
|
|
|
PRRX2
|
[NCBI]
|
9.98816e-06
|
|
|
IGLP1
|
[NCBI]
|
9.98816e-06
|
|
|
PPEF1
|
[NCBI]
|
9.98816e-06
|
|
|
SLC24A5
|
[NCBI]
|
9.98816e-06
|
|
|
parathyroid hormone-responsive b1 gene
|
[NCBI]
|
9.98816e-06
|
|
|
CLCF1
|
[NCBI]
|
9.98816e-06
|
|
|
STK36
|
[NCBI]
|
9.98816e-06
|
|
|
fifth ewing sarcoma variant
|
[NCBI]
|
9.98816e-06
|
|
|
RASGRF1
|
[NCBI]
|
9.98816e-06
|
|
|
SLC8A3
|
[NCBI]
|
9.98816e-06
|
|
|
CAPN5
|
[NCBI]
|
9.98816e-06
|
|
|
NXPH3
|
[NCBI]
|
9.98816e-06
|
|
|
POMT2
|
[NCBI]
|
9.98816e-06
|
|
|
IGHG4
|
[NCBI]
|
9.98816e-06
|
|
|
BARX2
|
[NCBI]
|
9.98816e-06
|
|
|
PWCR1
|
[NCBI]
|
9.98816e-06
|
|
|
PKDREJ
|
[NCBI]
|
9.98816e-06
|
|
|
MUC3B
|
[NCBI]
|
9.98816e-06
|
|
|
CDH17
|
[NCBI]
|
9.98816e-06
|
|
|
RNASE1
|
[NCBI]
|
9.98816e-06
|
|
|
RAPGEF1
|
[NCBI]
|
9.98816e-06
|
|
|
FOXH1
|
[NCBI]
|
9.98816e-06
|
|
|
RGS7
|
[NCBI]
|
9.98816e-06
|
|
|
HSF2
|
[NCBI]
|
9.98816e-06
|
|
|
MGRN1
|
[NCBI]
|
9.98816e-06
|
|
|
COX17
|
[NCBI]
|
9.98816e-06
|
|
|
CYP2G1
|
[NCBI]
|
9.98816e-06
|
|
|
ED1
|
[NCBI]
|
9.95733e-06
|
|
|
SFTPC
|
[NCBI]
|
9.95608e-06
|
|
|
ITGA2
|
[NCBI]
|
9.95608e-06
|
|
|
RASSF1
|
[NCBI]
|
9.95608e-06
|
|
|
IKBKAP
|
[NCBI]
|
9.95608e-06
|
|
|
MAT1A
|
[NCBI]
|
9.95608e-06
|
|
|
ABCB4
|
[NCBI]
|
9.95608e-06
|
|
|
NCF2
|
[NCBI]
|
9.95608e-06
|
|
|
MSR1
|
[NCBI]
|
9.95608e-06
|
|
|
OLR1
|
[NCBI]
|
9.95608e-06
|
|
|
PEPA
|
[NCBI]
|
9.95608e-06
|
|
|
EN2
|
[NCBI]
|
9.95608e-06
|
|
|
BLMH
|
[NCBI]
|
9.95608e-06
|
|
|
COL9A1
|
[NCBI]
|
9.95608e-06
|
|
|
HGD
|
[NCBI]
|
9.95608e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
9.95608e-06
|
|
|
TGFB1
|
[NCBI]
|
9.8689e-06
|
|
|
ATRX
|
[NCBI]
|
9.86272e-06
|
|
|
SLPI
|
[NCBI]
|
9.76148e-06
|
|
|
TCRB
|
[NCBI]
|
9.74638e-06
|
|
|
SLC25A4
|
[NCBI]
|
9.74638e-06
|
|
|
SMPD1
|
[NCBI]
|
9.74638e-06
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
9.69747e-06
|
|
|
pfeiffer syndrome
|
[NCBI]
|
9.69747e-06
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
9.69747e-06
|
|
|
FMF
|
[NCBI]
|
9.59844e-06
|
|
|
ZS
|
[NCBI]
|
9.53253e-06
|
|
|
ERBB2
|
[NCBI]
|
9.52771e-06
|
|
|
L1CAM
|
[NCBI]
|
9.52771e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
9.52771e-06
|
|
|
DMPK
|
[NCBI]
|
9.52771e-06
|
|
|
TSC1
|
[NCBI]
|
9.52771e-06
|
|
|
VWS
|
[NCBI]
|
9.31296e-06
|
|
|
hurler syndrome
|
[NCBI]
|
9.31296e-06
|
|
|
XPC
|
[NCBI]
|
9.30743e-06
|
|
|
IHH
|
[NCBI]
|
9.28057e-06
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
9.24979e-06
|
|
|
AHCY
|
[NCBI]
|
9.24979e-06
|
|
|
SMOH
|
[NCBI]
|
9.24979e-06
|
|
|
LU
|
[NCBI]
|
9.24979e-06
|
|
|
NDN
|
[NCBI]
|
9.24979e-06
|
|
|
JUP
|
[NCBI]
|
9.24979e-06
|
|
|
OGG1
|
[NCBI]
|
9.24979e-06
|
|
|
HSPD1
|
[NCBI]
|
9.24979e-06
|
|
|
NEFH
|
[NCBI]
|
9.24979e-06
|
|
|
CASR
|
[NCBI]
|
9.1073e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
9.02569e-06
|
|
|
JMML
|
[NCBI]
|
8.92008e-06
|
|
|
NPC1
|
[NCBI]
|
8.88906e-06
|
|
|
RBP4
|
[NCBI]
|
8.88906e-06
|
|
|
KCNJ11
|
[NCBI]
|
8.88906e-06
|
|
|
IRS2
|
[NCBI]
|
8.88906e-06
|
|
|
AMC
|
[NCBI]
|
8.86502e-06
|
|
|
AN2
|
[NCBI]
|
8.86502e-06
|
|
|
CNC1
|
[NCBI]
|
8.65364e-06
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
8.65364e-06
|
|
|
TBX21
|
[NCBI]
|
8.60469e-06
|
|
|
ALOX5AP
|
[NCBI]
|
8.60469e-06
|
|
|
GALE
|
[NCBI]
|
8.60469e-06
|
|
|
PKHD1
|
[NCBI]
|
8.60469e-06
|
|
|
SIX5
|
[NCBI]
|
8.60469e-06
|
|
|
POMT1
|
[NCBI]
|
8.60469e-06
|
|
|
LDHC
|
[NCBI]
|
8.60469e-06
|
|
|
ME2
|
[NCBI]
|
8.60469e-06
|
|
|
SGSH
|
[NCBI]
|
8.60469e-06
|
|
|
FOXP2
|
[NCBI]
|
8.60469e-06
|
|
|
TP73
|
[NCBI]
|
8.60469e-06
|
|
|
PTN
|
[NCBI]
|
8.57517e-06
|
|
|
GCH1
|
[NCBI]
|
8.48994e-06
|
|
|
HHT
|
[NCBI]
|
8.36055e-06
|
|
|
down syndrome
|
[NCBI]
|
8.36055e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
8.36055e-06
|
|
|
takayasu arteritis
|
[NCBI]
|
8.33579e-06
|
|
|
PHA2
|
[NCBI]
|
8.33579e-06
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
8.33579e-06
|
|
|
PARK7
|
[NCBI]
|
8.33579e-06
|
|
|
protocadherin-gamma gene cluster
|
[NCBI]
|
8.33579e-06
|
|
|
GS1
|
[NCBI]
|
8.33579e-06
|
|
|
vitiligo
|
[NCBI]
|
8.33579e-06
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
8.33579e-06
|
|
|
EPD
|
[NCBI]
|
8.33579e-06
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
8.33579e-06
|
|
|
EVR2
|
[NCBI]
|
8.33579e-06
|
|
|
OPLL
|
[NCBI]
|
8.33579e-06
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
8.33579e-06
|
|
|
FANCB
|
[NCBI]
|
8.33579e-06
|
|
|
EBS-MP
|
[NCBI]
|
8.33579e-06
|
|
|
IBM3
|
[NCBI]
|
8.33579e-06
|
|
|
VMCM
|
[NCBI]
|
8.33579e-06
|
|
|
AMDM
|
[NCBI]
|
8.33579e-06
|
|
|
PARK4
|
[NCBI]
|
8.33579e-06
|
|
|
desmoid disease, hereditary
|
[NCBI]
|
8.33579e-06
|
|
|
H6PD
|
[NCBI]
|
8.32309e-06
|
|
|
DSG3
|
[NCBI]
|
8.29133e-06
|
|
|
TTR
|
[NCBI]
|
8.27872e-06
|
|
|
CRYZ
|
[NCBI]
|
8.14371e-06
|
|
|
TLE3
|
[NCBI]
|
8.14371e-06
|
|
|
RNASEH1
|
[NCBI]
|
8.14371e-06
|
|
|
DNMBP
|
[NCBI]
|
8.14371e-06
|
|
|
RGS5
|
[NCBI]
|
8.14371e-06
|
|
|
pejvakin
|
[NCBI]
|
8.14371e-06
|
|
|
PCSK5
|
[NCBI]
|
8.14371e-06
|
|
|
MYBBP1A
|
[NCBI]
|
8.14371e-06
|
|
|
ITGA9
|
[NCBI]
|
8.14371e-06
|
|
|
IGHG3
|
[NCBI]
|
8.14371e-06
|
|
|
BBS2
|
[NCBI]
|
8.14371e-06
|
|
|
SLC10A1
|
[NCBI]
|
8.14371e-06
|
|
|
SLC5A3
|
[NCBI]
|
8.14371e-06
|
|
|
CELSR3
|
[NCBI]
|
8.14371e-06
|
|
|
NUDT1
|
[NCBI]
|
8.14371e-06
|
|
|
double parked, drosophila, homolog of
|
[NCBI]
|
8.14371e-06
|
|
|
GCS1
|
[NCBI]
|
8.14371e-06
|
|
|
AP3D1
|
[NCBI]
|
8.14371e-06
|
|
|
RPS4Y
|
[NCBI]
|
8.14371e-06
|
|
|
IFNA17
|
[NCBI]
|
8.14371e-06
|
|
|
VIPR2
|
[NCBI]
|
8.14371e-06
|
|
|
CYP46A1
|
[NCBI]
|
8.14371e-06
|
|
|
LILRA3
|
[NCBI]
|
8.14371e-06
|
|
|
MIRN1-2
|
[NCBI]
|
8.14371e-06
|
|
|
CLK2
|
[NCBI]
|
8.14371e-06
|
|
|
CPEB1
|
[NCBI]
|
8.14371e-06
|
|
|
PSMA6
|
[NCBI]
|
8.14371e-06
|
|
|
HOXB8
|
[NCBI]
|
8.14371e-06
|
|
|
PSMB8
|
[NCBI]
|
8.14371e-06
|
|
|
L3MBTL
|
[NCBI]
|
8.14371e-06
|
|
|
MND1
|
[NCBI]
|
8.14371e-06
|
|
|
PHF11
|
[NCBI]
|
8.14371e-06
|
|
|
FGL2
|
[NCBI]
|
8.14371e-06
|
|
|
POU6F2
|
[NCBI]
|
8.14371e-06
|
|
|
PHKG1
|
[NCBI]
|
8.14371e-06
|
|
|
BST1
|
[NCBI]
|
8.14371e-06
|
|
|
GAPDHS
|
[NCBI]
|
8.14371e-06
|
|
|
MCCC2
|
[NCBI]
|
8.14371e-06
|
|
|
SOX18
|
[NCBI]
|
8.14371e-06
|
|
|
NEDD4L
|
[NCBI]
|
8.14371e-06
|
|
|
PFN2
|
[NCBI]
|
8.14371e-06
|
|
|
JRK
|
[NCBI]
|
8.14371e-06
|
|
|
ACOT8
|
[NCBI]
|
8.14371e-06
|
|
|
PEX26
|
[NCBI]
|
8.14371e-06
|
|
|
SSTR4
|
[NCBI]
|
8.14371e-06
|
|
|
FAM123B
|
[NCBI]
|
8.14371e-06
|
|
|
TOB1
|
[NCBI]
|
8.14371e-06
|
|
|
HOXD8
|
[NCBI]
|
8.14371e-06
|
|
|
IPP
|
[NCBI]
|
8.14371e-06
|
|
|
PIK3CB
|
[NCBI]
|
8.14371e-06
|
|
|
CDC14A
|
[NCBI]
|
8.14371e-06
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
8.14371e-06
|
|
|
PLEKHG4
|
[NCBI]
|
8.14371e-06
|
|
|
ACTN2
|
[NCBI]
|
8.14371e-06
|
|
|
WIF1
|
[NCBI]
|
8.14371e-06
|
|
|
CD109
|
[NCBI]
|
8.14371e-06
|
|
|
WWC1
|
[NCBI]
|
8.14371e-06
|
|
|
CDH12
|
[NCBI]
|
8.14371e-06
|
|
|
RASSF5
|
[NCBI]
|
8.14371e-06
|
|
|
MEP1A
|
[NCBI]
|
8.14371e-06
|
|
|
SMYD3
|
[NCBI]
|
8.14371e-06
|
|
|
CACNA2D2
|
[NCBI]
|
8.14371e-06
|
|
|
DPP6
|
[NCBI]
|
8.14371e-06
|
|
|
VAV2
|
[NCBI]
|
8.14371e-06
|
|
|
IGHA1
|
[NCBI]
|
8.14371e-06
|
|
|
LSP1
|
[NCBI]
|
8.14371e-06
|
|
|
C1GALT1C1
|
[NCBI]
|
8.14371e-06
|
|
|
ORC2L
|
[NCBI]
|
8.14371e-06
|
|
|
MKRN1
|
[NCBI]
|
8.14371e-06
|
|
|
JMJD1A
|
[NCBI]
|
8.14371e-06
|
|
|
MYOM2
|
[NCBI]
|
8.14371e-06
|
|
|
CANX
|
[NCBI]
|
8.14371e-06
|
|
|
PCM1
|
[NCBI]
|
8.14371e-06
|
|
|
PAXIP1
|
[NCBI]
|
8.14371e-06
|
|
|
TAF10
|
[NCBI]
|
8.14371e-06
|
|
|
OTOR
|
[NCBI]
|
8.14371e-06
|
|
|
CH25H
|
[NCBI]
|
8.14371e-06
|
|
|
SYBL1
|
[NCBI]
|
8.14371e-06
|
|
|
CHRM2
|
[NCBI]
|
8.14371e-06
|
|
|
alkaline phosphatase, intestinal, fetal form
|
[NCBI]
|
8.14371e-06
|
|
|
GPR34
|
[NCBI]
|
8.14371e-06
|
|
|
alg8, s. cerevisiae, homolog of
|
[NCBI]
|
8.14371e-06
|
|
|
PTPRJ
|
[NCBI]
|
8.14371e-06
|
|
|
MUS81
|
[NCBI]
|
8.14371e-06
|
|
|
SRR
|
[NCBI]
|
8.14371e-06
|
|
|
MAB21L1
|
[NCBI]
|
8.14371e-06
|
|
|
STRBP
|
[NCBI]
|
8.14371e-06
|
|
|
FRG1
|
[NCBI]
|
8.14371e-06
|
|
|
CYP26A1
|
[NCBI]
|
8.14371e-06
|
|
|
DCXR
|
[NCBI]
|
8.14371e-06
|
|
|
GAN
|
[NCBI]
|
8.14371e-06
|
|
|
MN
|
[NCBI]
|
8.10885e-06
|
|
|
CGD
|
[NCBI]
|
8.10765e-06
|
|
|
FSHR
|
[NCBI]
|
8.08687e-06
|
|
|
LPO
|
[NCBI]
|
8.05737e-06
|
|
|
AMY2A
|
[NCBI]
|
8.01282e-06
|
|
|
CYP1A2
|
[NCBI]
|
8.01282e-06
|
|
|
FLG
|
[NCBI]
|
8.01282e-06
|
|
|
SLC26A2
|
[NCBI]
|
8.01282e-06
|
|
|
LEF1
|
[NCBI]
|
8.01282e-06
|
|
|
CDH2
|
[NCBI]
|
8.01282e-06
|
|
|
CYBA
|
[NCBI]
|
8.01282e-06
|
|
|
NCF1
|
[NCBI]
|
8.01282e-06
|
|
|
COL18A1
|
[NCBI]
|
8.01282e-06
|
|
|
APAF1
|
[NCBI]
|
8.01282e-06
|
|
|
IRF6
|
[NCBI]
|
8.01282e-06
|
|
|
NPHS1
|
[NCBI]
|
8.01282e-06
|
|
|
PLA2G2A
|
[NCBI]
|
8.01282e-06
|
|
|
RAPSN
|
[NCBI]
|
8.01282e-06
|
|
|
ATP1A2
|
[NCBI]
|
8.01282e-06
|
|
|
BEST1
|
[NCBI]
|
8.01282e-06
|
|
|
SLC19A1
|
[NCBI]
|
8.01282e-06
|
|
|
SCN5A
|
[NCBI]
|
8.0061e-06
|
|
|
MRX1
|
[NCBI]
|
7.97955e-06
|
|
|
HHF1
|
[NCBI]
|
7.97269e-06
|
|
|
BTHS
|
[NCBI]
|
7.97269e-06
|
|
|
CP
|
[NCBI]
|
7.89723e-06
|
|
|
DNMT3B
|
[NCBI]
|
7.7447e-06
|
|
|
CFI
|
[NCBI]
|
7.7447e-06
|
|
|
diastrophic dysplasia
|
[NCBI]
|
7.701e-06
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
7.701e-06
|
|
|
ARMD1
|
[NCBI]
|
7.55366e-06
|
|
|
CMPK1
|
[NCBI]
|
7.46771e-06
|
|
|
SLC45A2
|
[NCBI]
|
7.46771e-06
|
|
|
KEL
|
[NCBI]
|
7.46771e-06
|
|
|
CAST
|
[NCBI]
|
7.46771e-06
|
|
|
RNASEL
|
[NCBI]
|
7.46771e-06
|
|
|
CALM1
|
[NCBI]
|
7.46771e-06
|
|
|
SLC22A8
|
[NCBI]
|
7.46771e-06
|
|
|
PAK2
|
[NCBI]
|
7.46771e-06
|
|
|
MYOD1
|
[NCBI]
|
7.46771e-06
|
|
|
THY1
|
[NCBI]
|
7.46771e-06
|
|
|
RAD51
|
[NCBI]
|
7.46771e-06
|
|
|
PEG3
|
[NCBI]
|
7.46771e-06
|
|
|
FGB
|
[NCBI]
|
7.46771e-06
|
|
|
IKBKG
|
[NCBI]
|
7.3965e-06
|
|
|
CMT1B
|
[NCBI]
|
7.37756e-06
|
|
|
NPS
|
[NCBI]
|
7.37756e-06
|
|
|
CSA
|
[NCBI]
|
7.37756e-06
|
|
|
SMEI
|
[NCBI]
|
7.30276e-06
|
|
|
HBG1
|
[NCBI]
|
7.19714e-06
|
|
|
GH1
|
[NCBI]
|
7.03438e-06
|
|
|
HMBS
|
[NCBI]
|
7.00964e-06
|
|
|
UCHL1
|
[NCBI]
|
6.96398e-06
|
|
|
CBP
|
[NCBI]
|
6.96398e-06
|
|
|
BHMT
|
[NCBI]
|
6.96398e-06
|
|
|
TGFBR1
|
[NCBI]
|
6.96398e-06
|
|
|
HBZ
|
[NCBI]
|
6.96398e-06
|
|
|
JK
|
[NCBI]
|
6.96398e-06
|
|
|
SURF1
|
[NCBI]
|
6.96398e-06
|
|
|
C5
|
[NCBI]
|
6.96398e-06
|
|
|
GLRA1
|
[NCBI]
|
6.96398e-06
|
|
|
TAL1
|
[NCBI]
|
6.96398e-06
|
|
|
IFNA1
|
[NCBI]
|
6.91624e-06
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
6.89979e-06
|
|
|
LWD
|
[NCBI]
|
6.89979e-06
|
|
|
alcohol dependence
|
[NCBI]
|
6.83142e-06
|
|
|
TREH
|
[NCBI]
|
6.81762e-06
|
|
|
TSPAN32
|
[NCBI]
|
6.81762e-06
|
|
|
PRSS7
|
[NCBI]
|
6.81762e-06
|
|
|
SART1
|
[NCBI]
|
6.81762e-06
|
|
|
TCP10
|
[NCBI]
|
6.81762e-06
|
|
|
BEX1
|
[NCBI]
|
6.81762e-06
|
|
|
INTS6
|
[NCBI]
|
6.81762e-06
|
|
|
GPR44
|
[NCBI]
|
6.81762e-06
|
|
|
MAGEE1
|
[NCBI]
|
6.81762e-06
|
|
|
ZDHHC8
|
[NCBI]
|
6.81762e-06
|
|
|
SKIV2L
|
[NCBI]
|
6.81762e-06
|
|
|
FANCF
|
[NCBI]
|
6.81762e-06
|
|
|
AARS
|
[NCBI]
|
6.81762e-06
|
|
|
GLMN
|
[NCBI]
|
6.81762e-06
|
|
|
IKZF3
|
[NCBI]
|
6.81762e-06
|
|
|
hook, drosophila, homolog of, 1
|
[NCBI]
|
6.81762e-06
|
|
|
GCM2
|
[NCBI]
|
6.81762e-06
|
|
|
DRAP1
|
[NCBI]
|
6.81762e-06
|
|
|
g30 gene
|
[NCBI]
|
6.81762e-06
|
|
|
TFCP2
|
[NCBI]
|
6.81762e-06
|
|
|
EHF
|
[NCBI]
|
6.81762e-06
|
|
|
NTSR1
|
[NCBI]
|
6.81762e-06
|
|
|
lipin 1
|
[NCBI]
|
6.81762e-06
|
|
|
PHF8
|
[NCBI]
|
6.81762e-06
|
|
|
ACLY
|
[NCBI]
|
6.81762e-06
|
|
|
MTUS1
|
[NCBI]
|
6.81762e-06
|
|
|
saitohin
|
[NCBI]
|
6.81762e-06
|
|
|
MAN2A1
|
[NCBI]
|
6.81762e-06
|
|
|
GPR74
|
[NCBI]
|
6.81762e-06
|
|
|
thyrotropin-releasing hormone deficiency
|
[NCBI]
|
6.81762e-06
|
|
|
CDKAL1
|
[NCBI]
|
6.81762e-06
|
|
|
MTX1
|
[NCBI]
|
6.81762e-06
|
|
|
rapamycin-insensitive companion of mtor
|
[NCBI]
|
6.81762e-06
|
|
|
CSNK1E
|
[NCBI]
|
6.81762e-06
|
|
|
VPS35
|
[NCBI]
|
6.81762e-06
|
|
|
GLRB
|
[NCBI]
|
6.81762e-06
|
|
|
MX1
|
[NCBI]
|
6.81762e-06
|
|
|
TAS1R2
|
[NCBI]
|
6.81762e-06
|
|
|
ATXN10
|
[NCBI]
|
6.81762e-06
|
|
|
CD79B
|
[NCBI]
|
6.81762e-06
|
|
|
IRAK3
|
[NCBI]
|
6.81762e-06
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
6.81762e-06
|
|
|
PPP1R9A
|
[NCBI]
|
6.81762e-06
|
|
|
SSTR3
|
[NCBI]
|
6.81762e-06
|
|
|
NYX
|
[NCBI]
|
6.81762e-06
|
|
|
CXCR6
|
[NCBI]
|
6.81762e-06
|
|
|
OSTM1
|
[NCBI]
|
6.81762e-06
|
|
|
NEO1
|
[NCBI]
|
6.81762e-06
|
|
|
YWHAQ
|
[NCBI]
|
6.81762e-06
|
|
|
SLC25A32
|
[NCBI]
|
6.81762e-06
|
|
|
SORCS1
|
[NCBI]
|
6.81762e-06
|
|
|
GPD1
|
[NCBI]
|
6.81762e-06
|
|
|
PRKAR1B
|
[NCBI]
|
6.81762e-06
|
|
|
NCR3
|
[NCBI]
|
6.81762e-06
|
|
|
MSC
|
[NCBI]
|
6.81762e-06
|
|
|
RAD54L
|
[NCBI]
|
6.81762e-06
|
|
|
DPAGT1
|
[NCBI]
|
6.81762e-06
|
|
|
SLC25A12
|
[NCBI]
|
6.81762e-06
|
|
|
SSPN
|
[NCBI]
|
6.81762e-06
|
|
|
FOXI1
|
[NCBI]
|
6.81762e-06
|
|
|
CDH6
|
[NCBI]
|
6.81762e-06
|
|
|
TOP3B
|
[NCBI]
|
6.81762e-06
|
|
|
LAP3
|
[NCBI]
|
6.81762e-06
|
|
|
OSBPL5
|
[NCBI]
|
6.81762e-06
|
|
|
PACRG
|
[NCBI]
|
6.81762e-06
|
|
|
AMHR2
|
[NCBI]
|
6.81762e-06
|
|
|
ABCD3
|
[NCBI]
|
6.81762e-06
|
|
|
DMTF1
|
[NCBI]
|
6.81762e-06
|
|
|
KNSL2
|
[NCBI]
|
6.81762e-06
|
|
|
PIP5K1B
|
[NCBI]
|
6.81762e-06
|
|
|
PLA2G6
|
[NCBI]
|
6.81762e-06
|
|
|
FBP1
|
[NCBI]
|
6.81762e-06
|
|
|
SEL1L
|
[NCBI]
|
6.81762e-06
|
|
|
FGFR3
|
[NCBI]
|
6.81383e-06
|
|
|
MDM2
|
[NCBI]
|
6.74435e-06
|
|
|
MYO7A
|
[NCBI]
|
6.74435e-06
|
|
|
GATA1
|
[NCBI]
|
6.74435e-06
|
|
|
cutis laxa, autosomal dominant
|
[NCBI]
|
6.73774e-06
|
|
|
GS2
|
[NCBI]
|
6.73774e-06
|
|
|
EDM4
|
[NCBI]
|
6.73774e-06
|
|
|
DMC
|
[NCBI]
|
6.73774e-06
|
|
|
NIDDM1
|
[NCBI]
|
6.73774e-06
|
|
|
ehlers-danlos syndrome, type vii, autosomal dominant
|
[NCBI]
|
6.73774e-06
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
6.73774e-06
|
|
|
OPTA2
|
[NCBI]
|
6.73774e-06
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
6.73774e-06
|
|
|
INAD1
|
[NCBI]
|
6.73774e-06
|
|
|
DFNA3
|
[NCBI]
|
6.73774e-06
|
|
|
FTC
|
[NCBI]
|
6.73774e-06
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
6.73774e-06
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
6.73774e-06
|
|
|
complement factor i deficiency
|
[NCBI]
|
6.73774e-06
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
6.73774e-06
|
|
|
mucolipidosis iii, complementation group c
|
[NCBI]
|
6.73774e-06
|
|
|
DDD
|
[NCBI]
|
6.73774e-06
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
6.73774e-06
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
6.73774e-06
|
|
|
CALCRL
|
[NCBI]
|
6.66754e-06
|
|
|
PMD
|
[NCBI]
|
6.58232e-06
|
|
|
ACTC1
|
[NCBI]
|
6.49716e-06
|
|
|
SGCE
|
[NCBI]
|
6.49716e-06
|
|
|
FRAXE
|
[NCBI]
|
6.49716e-06
|
|
|
FOXL2
|
[NCBI]
|
6.49716e-06
|
|
|
ADRB3
|
[NCBI]
|
6.49716e-06
|
|
|
KCNE1
|
[NCBI]
|
6.49716e-06
|
|
|
SLC2A2
|
[NCBI]
|
6.46895e-06
|
|
|
APOC2
|
[NCBI]
|
6.43879e-06
|
|
|
FOXO1A
|
[NCBI]
|
6.43879e-06
|
|
|
JAK1
|
[NCBI]
|
6.43879e-06
|
|
|
SCS
|
[NCBI]
|
6.43172e-06
|
|
|
PIGR
|
[NCBI]
|
6.42077e-06
|
|
|
MTR
|
[NCBI]
|
6.38896e-06
|
|
|
MCP
|
[NCBI]
|
6.32896e-06
|
|
|
TERT
|
[NCBI]
|
6.22539e-06
|
|
|
factor v deficiency
|
[NCBI]
|
6.1987e-06
|
|
|
RECQL2
|
[NCBI]
|
6.14596e-06
|
|
|
wolman disease
|
[NCBI]
|
6.14596e-06
|
|
|
OPTN
|
[NCBI]
|
6.14596e-06
|
|
|
C9
|
[NCBI]
|
6.06343e-06
|
|
|
DMBT1
|
[NCBI]
|
6.06343e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
6.06343e-06
|
|
|
NEU1
|
[NCBI]
|
6.06343e-06
|
|
|
PHB
|
[NCBI]
|
6.06343e-06
|
|
|
NEB
|
[NCBI]
|
6.06343e-06
|
|
|
GAD2
|
[NCBI]
|
6.06343e-06
|
|
|
LCP1
|
[NCBI]
|
6.06343e-06
|
|
|
CFNS
|
[NCBI]
|
6.03782e-06
|
|
|
PDB
|
[NCBI]
|
6.03782e-06
|
|
|
PBD
|
[NCBI]
|
6.03782e-06
|
|
|
MRXHF1
|
[NCBI]
|
6.03782e-06
|
|
|
CDH1
|
[NCBI]
|
6.0161e-06
|
|
|
ASL
|
[NCBI]
|
6.0161e-06
|
|
|
KCNQ1
|
[NCBI]
|
6.0161e-06
|
|
|
LAD
|
[NCBI]
|
5.97379e-06
|
|
|
IL6
|
[NCBI]
|
5.92016e-06
|
|
|
PKLR
|
[NCBI]
|
5.86519e-06
|
|
|
MYC
|
[NCBI]
|
5.83152e-06
|
|
|
SRY
|
[NCBI]
|
5.81269e-06
|
|
|
NSF
|
[NCBI]
|
5.81269e-06
|
|
|
SCD
|
[NCBI]
|
5.81269e-06
|
|
|
FGR
|
[NCBI]
|
5.79682e-06
|
|
|
KIR2DL3
|
[NCBI]
|
5.79682e-06
|
|
|
CDC2L2
|
[NCBI]
|
5.79682e-06
|
|
|
DYNLL1
|
[NCBI]
|
5.79682e-06
|
|
|
SLC22A12
|
[NCBI]
|
5.79682e-06
|
|
|
PLOD3
|
[NCBI]
|
5.79682e-06
|
|
|
LMO1
|
[NCBI]
|
5.79682e-06
|
|
|
MYL3
|
[NCBI]
|
5.79682e-06
|
|
|
CHRNB4
|
[NCBI]
|
5.79682e-06
|
|
|
TUBAL1
|
[NCBI]
|
5.79682e-06
|
|
|
ZBP1
|
[NCBI]
|
5.79682e-06
|
|
|
PLEKHC1
|
[NCBI]
|
5.79682e-06
|
|
|
GABRA2
|
[NCBI]
|
5.79682e-06
|
|
|
COPA
|
[NCBI]
|
5.79682e-06
|
|
|
PON3
|
[NCBI]
|
5.79682e-06
|
|
|
RNF139
|
[NCBI]
|
5.79682e-06
|
|
|
IGHA2
|
[NCBI]
|
5.79682e-06
|
|
|
NPY5R
|
[NCBI]
|
5.79682e-06
|
|
|
CES2
|
[NCBI]
|
5.79682e-06
|
|
|
ARNT2
|
[NCBI]
|
5.79682e-06
|
|
|
SLC22A3
|
[NCBI]
|
5.79682e-06
|
|
|
PER3
|
[NCBI]
|
5.79682e-06
|
|
|
DLX3
|
[NCBI]
|
5.79682e-06
|
|
|
CD24
|
[NCBI]
|
5.79682e-06
|
|
|
RBBP9
|
[NCBI]
|
5.79682e-06
|
|
|
ATP1B1
|
[NCBI]
|
5.79682e-06
|
|
|
PLA2G1B
|
[NCBI]
|
5.79682e-06
|
|
|
GNA13
|
[NCBI]
|
5.79682e-06
|
|
|
NAB1
|
[NCBI]
|
5.79682e-06
|
|
|
KTN1
|
[NCBI]
|
5.79682e-06
|
|
|
MLH3
|
[NCBI]
|
5.79682e-06
|
|
|
RDX
|
[NCBI]
|
5.79682e-06
|
|
|
E2F2
|
[NCBI]
|
5.79682e-06
|
|
|
GRK1
|
[NCBI]
|
5.79682e-06
|
|
|
CSN10
|
[NCBI]
|
5.79682e-06
|
|
|
GABRA4
|
[NCBI]
|
5.79682e-06
|
|
|
NIPA1
|
[NCBI]
|
5.79682e-06
|
|
|
KCNE2
|
[NCBI]
|
5.79682e-06
|
|
|
CAMTA1
|
[NCBI]
|
5.79682e-06
|
|
|
CASQ1
|
[NCBI]
|
5.79682e-06
|
|
|
LW
|
[NCBI]
|
5.79682e-06
|
|
|
LALBA
|
[NCBI]
|
5.79682e-06
|
|
|
ADRA1A
|
[NCBI]
|
5.79682e-06
|
|
|
DLG5
|
[NCBI]
|
5.79682e-06
|
|
|
GPRK2L
|
[NCBI]
|
5.79682e-06
|
|
|
CHST6
|
[NCBI]
|
5.79682e-06
|
|
|
GRM6
|
[NCBI]
|
5.79682e-06
|
|
|
ARID4A
|
[NCBI]
|
5.79682e-06
|
|
|
TEAD1
|
[NCBI]
|
5.79682e-06
|
|
|
BTNL2
|
[NCBI]
|
5.79682e-06
|
|
|
NLGN4
|
[NCBI]
|
5.79682e-06
|
|
|
FTSJ1
|
[NCBI]
|
5.79682e-06
|
|
|
HSD17B3
|
[NCBI]
|
5.79682e-06
|
|
|
BLK
|
[NCBI]
|
5.79682e-06
|
|
|
MYCL1
|
[NCBI]
|
5.79682e-06
|
|
|
UBE2B
|
[NCBI]
|
5.79682e-06
|
|
|
FANCM
|
[NCBI]
|
5.79682e-06
|
|
|
PTPRE
|
[NCBI]
|
5.79682e-06
|
|
|
HMCN1
|
[NCBI]
|
5.79682e-06
|
|
|
NDST2
|
[NCBI]
|
5.79682e-06
|
|
|
FUCA2
|
[NCBI]
|
5.79682e-06
|
|
|
GCSH
|
[NCBI]
|
5.79682e-06
|
|
|
HSPA1L
|
[NCBI]
|
5.79682e-06
|
|
|
DACH1
|
[NCBI]
|
5.79682e-06
|
|
|
KLF7
|
[NCBI]
|
5.79682e-06
|
|
|
CSDE1
|
[NCBI]
|
5.79682e-06
|
|
|
KIR2DL2
|
[NCBI]
|
5.79682e-06
|
|
|
COX4I1
|
[NCBI]
|
5.79682e-06
|
|
|
ARL6
|
[NCBI]
|
5.79682e-06
|
|
|
MIC2Y
|
[NCBI]
|
5.79682e-06
|
|
|
GLI2
|
[NCBI]
|
5.79682e-06
|
|
|
MSH5
|
[NCBI]
|
5.79682e-06
|
|
|
g72 gene
|
[NCBI]
|
5.79682e-06
|
|
|
BBS1
|
[NCBI]
|
5.79682e-06
|
|
|
TRPM5
|
[NCBI]
|
5.79682e-06
|
|
|
FDXR
|
[NCBI]
|
5.79682e-06
|
|
|
PHF9
|
[NCBI]
|
5.79682e-06
|
|
|
LEP
|
[NCBI]
|
5.79306e-06
|
|
|
CHRNA1
|
[NCBI]
|
5.65956e-06
|
|
|
TNXB
|
[NCBI]
|
5.65956e-06
|
|
|
CLN3
|
[NCBI]
|
5.65956e-06
|
|
|
EPHB2
|
[NCBI]
|
5.65956e-06
|
|
|
ASS
|
[NCBI]
|
5.65439e-06
|
|
|
SMN2
|
[NCBI]
|
5.59588e-06
|
|
|
fucosidosis
|
[NCBI]
|
5.59588e-06
|
|
|
IL4
|
[NCBI]
|
5.57321e-06
|
|
|
RTS
|
[NCBI]
|
5.52645e-06
|
|
|
JPS
|
[NCBI]
|
5.52645e-06
|
|
|
WRN
|
[NCBI]
|
5.42347e-06
|
|
|
XPG
|
[NCBI]
|
5.41992e-06
|
|
|
schwannomatosis
|
[NCBI]
|
5.41992e-06
|
|
|
GBD1
|
[NCBI]
|
5.41992e-06
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
5.41992e-06
|
|
|
HCHWAD
|
[NCBI]
|
5.41992e-06
|
|
|
alzheimer disease 4
|
[NCBI]
|
5.41992e-06
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
5.41992e-06
|
|
|
liddle syndrome
|
[NCBI]
|
5.41992e-06
|
|
|
PCS
|
[NCBI]
|
5.41992e-06
|
|
|
argininemia
|
[NCBI]
|
5.41992e-06
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
5.41992e-06
|
|
|
CTLN2
|
[NCBI]
|
5.41992e-06
|
|
|
CZP1
|
[NCBI]
|
5.41992e-06
|
|
|
DFNB9
|
[NCBI]
|
5.41992e-06
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
5.41992e-06
|
|
|
USH1D
|
[NCBI]
|
5.41992e-06
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
5.41992e-06
|
|
|
SXI1
|
[NCBI]
|
5.41992e-06
|
|
|
PBT
|
[NCBI]
|
5.41992e-06
|
|
|
DFNA2
|
[NCBI]
|
5.41992e-06
|
|
|
FMD
|
[NCBI]
|
5.41992e-06
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
5.33747e-06
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
5.31397e-06
|
|
|
DDC
|
[NCBI]
|
5.30881e-06
|
|
|
GHSR
|
[NCBI]
|
5.28277e-06
|
|
|
HOXD13
|
[NCBI]
|
5.28277e-06
|
|
|
ASIP
|
[NCBI]
|
5.28277e-06
|
|
|
MYB
|
[NCBI]
|
5.28277e-06
|
|
|
ATP2A2
|
[NCBI]
|
5.28277e-06
|
|
|
PAX5
|
[NCBI]
|
5.28277e-06
|
|
|
EBF
|
[NCBI]
|
5.28277e-06
|
|
|
LRE1
|
[NCBI]
|
5.28277e-06
|
|
|
CYP27B1
|
[NCBI]
|
5.28277e-06
|
|
|
EBP
|
[NCBI]
|
5.28277e-06
|
|
|
SST
|
[NCBI]
|
5.21803e-06
|
|
|
CHH
|
[NCBI]
|
5.14102e-06
|
|
|
HBA1
|
[NCBI]
|
5.12753e-06
|
|
|
CPE
|
[NCBI]
|
5.10114e-06
|
|
|
VHL
|
[NCBI]
|
5.09615e-06
|
|
|
SMAX1
|
[NCBI]
|
5.09388e-06
|
|
|
TCRG
|
[NCBI]
|
5.08944e-06
|
|
|
TFR2
|
[NCBI]
|
5.08944e-06
|
|
|
FGFR2
|
[NCBI]
|
5.07021e-06
|
|
|
ABL
|
[NCBI]
|
5.00978e-06
|
|
|
CNGA2
|
[NCBI]
|
4.97777e-06
|
|
|
CAPN1
|
[NCBI]
|
4.97777e-06
|
|
|
LIPG
|
[NCBI]
|
4.97777e-06
|
|
|
TPP2
|
[NCBI]
|
4.97777e-06
|
|
|
SNAI1
|
[NCBI]
|
4.97777e-06
|
|
|
NHS
|
[NCBI]
|
4.97777e-06
|
|
|
RYK
|
[NCBI]
|
4.97777e-06
|
|
|
PMX1
|
[NCBI]
|
4.97777e-06
|
|
|
SP110
|
[NCBI]
|
4.97777e-06
|
|
|
CLN2
|
[NCBI]
|
4.97777e-06
|
|
|
TAS2R10
|
[NCBI]
|
4.97777e-06
|
|
|
NPR3
|
[NCBI]
|
4.97777e-06
|
|
|
MUC3A
|
[NCBI]
|
4.97777e-06
|
|
|
CRYBA4
|
[NCBI]
|
4.97777e-06
|
|
|
TTID
|
[NCBI]
|
4.97777e-06
|
|
|
TRMU
|
[NCBI]
|
4.97777e-06
|
|
|
LHX8
|
[NCBI]
|
4.97777e-06
|
|
|
AKAP13
|
[NCBI]
|
4.97777e-06
|
|
|
ACTN4
|
[NCBI]
|
4.97777e-06
|
|
|
DPYSL2
|
[NCBI]
|
4.97777e-06
|
|
|
SLC30A8
|
[NCBI]
|
4.97777e-06
|
|
|
DYX1C1
|
[NCBI]
|
4.97777e-06
|
|
|
LAG5
|
[NCBI]
|
4.97777e-06
|
|
|
ATP2B1
|
[NCBI]
|
4.97777e-06
|
|
|
GNA11
|
[NCBI]
|
4.97777e-06
|
|
|
PCK1
|
[NCBI]
|
4.97777e-06
|
|
|
KIR2DL4
|
[NCBI]
|
4.97777e-06
|
|
|
P2RY12
|
[NCBI]
|
4.97777e-06
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
4.97777e-06
|
|
|
FTO
|
[NCBI]
|
4.97777e-06
|
|
|
XCE
|
[NCBI]
|
4.97777e-06
|
|
|
ALDH4A1
|
[NCBI]
|
4.97777e-06
|
|
|
LIPE
|
[NCBI]
|
4.97777e-06
|
|
|
RNF2
|
[NCBI]
|
4.97777e-06
|
|
|
LCP2
|
[NCBI]
|
4.97777e-06
|
|
|
NHLH1
|
[NCBI]
|
4.97777e-06
|
|
|
MPP1
|
[NCBI]
|
4.97777e-06
|
|
|
SLC4A2
|
[NCBI]
|
4.97777e-06
|
|
|
ROBO2
|
[NCBI]
|
4.97777e-06
|
|
|
MGEA5
|
[NCBI]
|
4.97777e-06
|
|
|
AMELY
|
[NCBI]
|
4.97777e-06
|
|
|
IGF2BP2
|
[NCBI]
|
4.97777e-06
|
|
|
WHRN
|
[NCBI]
|
4.97777e-06
|
|
|
NPY1R
|
[NCBI]
|
4.97777e-06
|
|
|
MYH2
|
[NCBI]
|
4.97777e-06
|
|
|
WNT2
|
[NCBI]
|
4.97777e-06
|
|
|
PNOC
|
[NCBI]
|
4.97777e-06
|
|
|
SIL
|
[NCBI]
|
4.97777e-06
|
|
|
GLP1R
|
[NCBI]
|
4.97777e-06
|
|
|
GCLC
|
[NCBI]
|
4.97777e-06
|
|
|
NHLRC1
|
[NCBI]
|
4.97777e-06
|
|
|
SUMO4
|
[NCBI]
|
4.97777e-06
|
|
|
HMGCS2
|
[NCBI]
|
4.97777e-06
|
|
|
KCNA5
|
[NCBI]
|
4.97777e-06
|
|
|
ATP2C1
|
[NCBI]
|
4.97777e-06
|
|
|
HAGH
|
[NCBI]
|
4.97777e-06
|
|
|
IL1RAPL1
|
[NCBI]
|
4.97777e-06
|
|
|
negative elongation factor polypeptide b
|
[NCBI]
|
4.97777e-06
|
|
|
DNMT3L
|
[NCBI]
|
4.97777e-06
|
|
|
FOXJ1
|
[NCBI]
|
4.97777e-06
|
|
|
LTC4S
|
[NCBI]
|
4.93064e-06
|
|
|
MRE11A
|
[NCBI]
|
4.93064e-06
|
|
|
PLAT
|
[NCBI]
|
4.93064e-06
|
|
|
CYP1B1
|
[NCBI]
|
4.93064e-06
|
|
|
DMD
|
[NCBI]
|
4.92606e-06
|
|
|
BTK
|
[NCBI]
|
4.82942e-06
|
|
|
CD36
|
[NCBI]
|
4.8099e-06
|
|
|
PSEN1
|
[NCBI]
|
4.73331e-06
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
4.67592e-06
|
|
|
RSTS
|
[NCBI]
|
4.66566e-06
|
|
|
HBFQTL1
|
[NCBI]
|
4.6544e-06
|
|
|
RCDP1
|
[NCBI]
|
4.6544e-06
|
|
|
DFNB1
|
[NCBI]
|
4.6544e-06
|
|
|
FHM1
|
[NCBI]
|
4.6544e-06
|
|
|
HSR
|
[NCBI]
|
4.60106e-06
|
|
|
LDHA
|
[NCBI]
|
4.60106e-06
|
|
|
CRYAA
|
[NCBI]
|
4.60106e-06
|
|
|
CYP11B1
|
[NCBI]
|
4.60106e-06
|
|
|
OSBP
|
[NCBI]
|
4.60106e-06
|
|
|
ABCC8
|
[NCBI]
|
4.5686e-06
|
|
|
ALGS1
|
[NCBI]
|
4.52411e-06
|
|
|
LBP
|
[NCBI]
|
4.41174e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
4.41174e-06
|
|
|
SOD1
|
[NCBI]
|
4.33615e-06
|
|
|
galactokinase deficiency
|
[NCBI]
|
4.32597e-06
|
|
|
LGMD1A
|
[NCBI]
|
4.32597e-06
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
4.32597e-06
|
|
|
DGI1
|
[NCBI]
|
4.32597e-06
|
|
|
CDL1
|
[NCBI]
|
4.32597e-06
|
|
|
Ii
|
[NCBI]
|
4.32597e-06
|
|
|
PHA1
|
[NCBI]
|
4.32597e-06
|
|
|
CMT2A2
|
[NCBI]
|
4.32597e-06
|
|
|
DFNA12
|
[NCBI]
|
4.32597e-06
|
|
|
BDC
|
[NCBI]
|
4.32597e-06
|
|
|
SPG6
|
[NCBI]
|
4.32597e-06
|
|
|
BOS1
|
[NCBI]
|
4.32597e-06
|
|
|
GVM
|
[NCBI]
|
4.32597e-06
|
|
|
SCZD2
|
[NCBI]
|
4.32597e-06
|
|
|
HTX1
|
[NCBI]
|
4.32597e-06
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
4.32597e-06
|
|
|
RPL4
|
[NCBI]
|
4.30209e-06
|
|
|
HADHB
|
[NCBI]
|
4.30209e-06
|
|
|
TP53BP2
|
[NCBI]
|
4.30209e-06
|
|
|
LPIN2
|
[NCBI]
|
4.30209e-06
|
|
|
SMAD1
|
[NCBI]
|
4.30209e-06
|
|
|
ADAM15
|
[NCBI]
|
4.30209e-06
|
|
|
PROX1
|
[NCBI]
|
4.30209e-06
|
|
|
CAMK2G
|
[NCBI]
|
4.30209e-06
|
|
|
SRD5A1
|
[NCBI]
|
4.30209e-06
|
|
|
ODF1
|
[NCBI]
|
4.30209e-06
|
|
|
USH3A
|
[NCBI]
|
4.30209e-06
|
|
|
PFKP
|
[NCBI]
|
4.30209e-06
|
|
|
PIP5K1C
|
[NCBI]
|
4.30209e-06
|
|
|
S100B
|
[NCBI]
|
4.30209e-06
|
|
|
PICALM
|
[NCBI]
|
4.30209e-06
|
|
|
TMPRSS3
|
[NCBI]
|
4.30209e-06
|
|
|
NNT
|
[NCBI]
|
4.30209e-06
|
|
|
GLRA2
|
[NCBI]
|
4.30209e-06
|
|
|
PAK1
|
[NCBI]
|
4.30209e-06
|
|
|
TM4SF2
|
[NCBI]
|
4.30209e-06
|
|
|
MOCS2
|
[NCBI]
|
4.30209e-06
|
|
|
TAC1
|
[NCBI]
|
4.30209e-06
|
|
|
MAP2K4
|
[NCBI]
|
4.30209e-06
|
|
|
APBB1
|
[NCBI]
|
4.30209e-06
|
|
|
ACP2
|
[NCBI]
|
4.30209e-06
|
|
|
RAB3A
|
[NCBI]
|
4.30209e-06
|
|
|
EVPL
|
[NCBI]
|
4.30209e-06
|
|
|
CYP4A11
|
[NCBI]
|
4.30209e-06
|
|
|
TNP1
|
[NCBI]
|
4.30209e-06
|
|
|
PDXK
|
[NCBI]
|
4.30209e-06
|
|
|
POU3F1
|
[NCBI]
|
4.30209e-06
|
|
|
NFE2L1
|
[NCBI]
|
4.30209e-06
|
|
|
SLC9A1
|
[NCBI]
|
4.30209e-06
|
|
|
CLCN4
|
[NCBI]
|
4.30209e-06
|
|
|
E2F4
|
[NCBI]
|
4.30209e-06
|
|
|
AVPR1A
|
[NCBI]
|
4.30209e-06
|
|
|
PPP1R2
|
[NCBI]
|
4.30209e-06
|
|
|
PCBD1
|
[NCBI]
|
4.30209e-06
|
|
|
ISL1
|
[NCBI]
|
4.30209e-06
|
|
|
EDG3
|
[NCBI]
|
4.30209e-06
|
|
|
IFNGR2
|
[NCBI]
|
4.30209e-06
|
|
|
CUL2
|
[NCBI]
|
4.30209e-06
|
|
|
BMP5
|
[NCBI]
|
4.30209e-06
|
|
|
BCYRN1
|
[NCBI]
|
4.30209e-06
|
|
|
CCL4L1
|
[NCBI]
|
4.30209e-06
|
|
|
TMC1
|
[NCBI]
|
4.30209e-06
|
|
|
RPL7A
|
[NCBI]
|
4.30209e-06
|
|
|
EDG5
|
[NCBI]
|
4.30209e-06
|
|
|
MICB
|
[NCBI]
|
4.30209e-06
|
|
|
BAT1
|
[NCBI]
|
4.30209e-06
|
|
|
SLC7A7
|
[NCBI]
|
4.30209e-06
|
|
|
SLC25A13
|
[NCBI]
|
4.30209e-06
|
|
|
ME1
|
[NCBI]
|
4.30209e-06
|
|
|
FANCE
|
[NCBI]
|
4.30209e-06
|
|
|
SLC10A2
|
[NCBI]
|
4.30209e-06
|
|
|
ATOH1
|
[NCBI]
|
4.30209e-06
|
|
|
TPO
|
[NCBI]
|
4.29684e-06
|
|
|
SRD5A2
|
[NCBI]
|
4.2922e-06
|
|
|
GSK3B
|
[NCBI]
|
4.2922e-06
|
|
|
SLC3A1
|
[NCBI]
|
4.2922e-06
|
|
|
LRP5
|
[NCBI]
|
4.2922e-06
|
|
|
AMH
|
[NCBI]
|
4.26707e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
4.26457e-06
|
|
|
POAG
|
[NCBI]
|
4.25332e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
4.23693e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
4.19194e-06
|
|
|
CDK4
|
[NCBI]
|
4.12285e-06
|
|
|
HPRT1
|
[NCBI]
|
4.06662e-06
|
|
|
LDHB
|
[NCBI]
|
4.00242e-06
|
|
|
PMS2
|
[NCBI]
|
4.00242e-06
|
|
|
pta deficiency
|
[NCBI]
|
4.00242e-06
|
|
|
LYZ
|
[NCBI]
|
4.00242e-06
|
|
|
PAX2
|
[NCBI]
|
4.00242e-06
|
|
|
GALC
|
[NCBI]
|
4.00242e-06
|
|
|
BMP15
|
[NCBI]
|
4.00242e-06
|
|
|
factor x deficiency
|
[NCBI]
|
3.98918e-06
|
|
|
NMB
|
[NCBI]
|
3.96588e-06
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
3.89637e-06
|
|
|
lipomatosis, multiple
|
[NCBI]
|
3.89637e-06
|
|
|
HBFQTL2
|
[NCBI]
|
3.89637e-06
|
|
|
TRPS2
|
[NCBI]
|
3.85384e-06
|
|
|
menkes disease
|
[NCBI]
|
3.84117e-06
|
|
|
MAS1
|
[NCBI]
|
3.73362e-06
|
|
|
AZGP1
|
[NCBI]
|
3.73362e-06
|
|
|
PEPB
|
[NCBI]
|
3.73362e-06
|
|
|
MCL1
|
[NCBI]
|
3.73362e-06
|
|
|
NOTCH2
|
[NCBI]
|
3.73362e-06
|
|
|
BDKRB2
|
[NCBI]
|
3.73362e-06
|
|
|
SNAI2
|
[NCBI]
|
3.73362e-06
|
|
|
NUMBL
|
[NCBI]
|
3.73362e-06
|
|
|
EDNRA
|
[NCBI]
|
3.73362e-06
|
|
|
DDB2
|
[NCBI]
|
3.73362e-06
|
|
|
NME2
|
[NCBI]
|
3.73362e-06
|
|
|
PKP2
|
[NCBI]
|
3.73362e-06
|
|
|
SSTR1
|
[NCBI]
|
3.73362e-06
|
|
|
ST8SIA2
|
[NCBI]
|
3.73362e-06
|
|
|
ARHGEF6
|
[NCBI]
|
3.73362e-06
|
|
|
BTG2
|
[NCBI]
|
3.73362e-06
|
|
|
NOTCH4
|
[NCBI]
|
3.73362e-06
|
|
|
MYLK
|
[NCBI]
|
3.73362e-06
|
|
|
CHRND
|
[NCBI]
|
3.73362e-06
|
|
|
PTF1A
|
[NCBI]
|
3.73362e-06
|
|
|
PEX5
|
[NCBI]
|
3.73362e-06
|
|
|
DAXX
|
[NCBI]
|
3.73362e-06
|
|
|
IRF2
|
[NCBI]
|
3.73362e-06
|
|
|
ICMT
|
[NCBI]
|
3.73362e-06
|
|
|
CCKBR
|
[NCBI]
|
3.73362e-06
|
|
|
GP1BB
|
[NCBI]
|
3.73362e-06
|
|
|
OPHN1
|
[NCBI]
|
3.73362e-06
|
|
|
GRIK1
|
[NCBI]
|
3.73362e-06
|
|
|
CDC2L1
|
[NCBI]
|
3.73362e-06
|
|
|
SCGB3A2
|
[NCBI]
|
3.73362e-06
|
|
|
MAF
|
[NCBI]
|
3.73362e-06
|
|
|
HTR2C
|
[NCBI]
|
3.73362e-06
|
|
|
HRH1
|
[NCBI]
|
3.73362e-06
|
|
|
LIG1
|
[NCBI]
|
3.73362e-06
|
|
|
MTRR
|
[NCBI]
|
3.73362e-06
|
|
|
UNC119
|
[NCBI]
|
3.73362e-06
|
|
|
HOXD3
|
[NCBI]
|
3.73362e-06
|
|
|
SFRS1
|
[NCBI]
|
3.73362e-06
|
|
|
CASQ2
|
[NCBI]
|
3.73362e-06
|
|
|
FCAR
|
[NCBI]
|
3.73362e-06
|
|
|
DNASE1
|
[NCBI]
|
3.73362e-06
|
|
|
TFAP2C
|
[NCBI]
|
3.73362e-06
|
|
|
CHM
|
[NCBI]
|
3.73029e-06
|
|
|
PTPN1
|
[NCBI]
|
3.73029e-06
|
|
|
CD4
|
[NCBI]
|
3.73029e-06
|
|
|
APP
|
[NCBI]
|
3.71967e-06
|
|
|
PNPLA6
|
[NCBI]
|
3.71309e-06
|
|
|
ABCB1
|
[NCBI]
|
3.69263e-06
|
|
|
FFI
|
[NCBI]
|
3.64904e-06
|
|
|
CD
|
[NCBI]
|
3.64904e-06
|
|
|
AKT1
|
[NCBI]
|
3.6071e-06
|
|
|
AANAT
|
[NCBI]
|
3.6071e-06
|
|
|
NTRK1
|
[NCBI]
|
3.6071e-06
|
|
|
MSTN
|
[NCBI]
|
3.6071e-06
|
|
|
MAPT
|
[NCBI]
|
3.60436e-06
|
|
|
JAK2
|
[NCBI]
|
3.57967e-06
|
|
|
DNMT1
|
[NCBI]
|
3.56879e-06
|
|
|
CMT1A
|
[NCBI]
|
3.53967e-06
|
|
|
AICDA
|
[NCBI]
|
3.47451e-06
|
|
|
GAS
|
[NCBI]
|
3.47451e-06
|
|
|
TNNT2
|
[NCBI]
|
3.47451e-06
|
|
|
PROP1
|
[NCBI]
|
3.47451e-06
|
|
|
PTCH1
|
[NCBI]
|
3.47451e-06
|
|
|
GPX1
|
[NCBI]
|
3.47451e-06
|
|
|
ITGA2B
|
[NCBI]
|
3.47451e-06
|
|
|
GLC1A
|
[NCBI]
|
3.4679e-06
|
|
|
CTNS
|
[NCBI]
|
3.4679e-06
|
|
|
factor vii deficiency
|
[NCBI]
|
3.42716e-06
|
|
|
CACNA1A
|
[NCBI]
|
3.42716e-06
|
|
|
RP2
|
[NCBI]
|
3.42716e-06
|
|
|
TBG
|
[NCBI]
|
3.42716e-06
|
|
|
ABCG2
|
[NCBI]
|
3.41544e-06
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
3.415e-06
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
3.415e-06
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
3.415e-06
|
|
|
medulloblastoma
|
[NCBI]
|
3.415e-06
|
|
|
DFNA6
|
[NCBI]
|
3.415e-06
|
|
|
SACS
|
[NCBI]
|
3.415e-06
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
3.415e-06
|
|
|
sarcoidosis
|
[NCBI]
|
3.415e-06
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
3.415e-06
|
|
|
IHPS1
|
[NCBI]
|
3.415e-06
|
|
|
LIS1
|
[NCBI]
|
3.415e-06
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
3.415e-06
|
|
|
ADA
|
[NCBI]
|
3.34571e-06
|
|
|
ALB
|
[NCBI]
|
3.34172e-06
|
|
|
MITF
|
[NCBI]
|
3.28221e-06
|
|
|
HS
|
[NCBI]
|
3.25421e-06
|
|
|
BRRS
|
[NCBI]
|
3.25246e-06
|
|
|
TYK2
|
[NCBI]
|
3.24836e-06
|
|
|
RP1
|
[NCBI]
|
3.24836e-06
|
|
|
AGC1
|
[NCBI]
|
3.24836e-06
|
|
|
FZD4
|
[NCBI]
|
3.24836e-06
|
|
|
ELOVL4
|
[NCBI]
|
3.24836e-06
|
|
|
GUCA1A
|
[NCBI]
|
3.24836e-06
|
|
|
SCN1B
|
[NCBI]
|
3.24836e-06
|
|
|
SETX
|
[NCBI]
|
3.24836e-06
|
|
|
EDAR
|
[NCBI]
|
3.24836e-06
|
|
|
MT2A
|
[NCBI]
|
3.24836e-06
|
|
|
BBS4
|
[NCBI]
|
3.24836e-06
|
|
|
SCO2
|
[NCBI]
|
3.24836e-06
|
|
|
DSCAM
|
[NCBI]
|
3.24836e-06
|
|
|
CR2
|
[NCBI]
|
3.24836e-06
|
|
|
HBE1
|
[NCBI]
|
3.24836e-06
|
|
|
SLC19A2
|
[NCBI]
|
3.24836e-06
|
|
|
HTRA1
|
[NCBI]
|
3.24836e-06
|
|
|
BMP6
|
[NCBI]
|
3.24836e-06
|
|
|
ICSBP1
|
[NCBI]
|
3.24836e-06
|
|
|
DSG4
|
[NCBI]
|
3.24836e-06
|
|
|
AMT
|
[NCBI]
|
3.24836e-06
|
|
|
GCNT2
|
[NCBI]
|
3.24836e-06
|
|
|
CD3E
|
[NCBI]
|
3.24836e-06
|
|
|
IL9R
|
[NCBI]
|
3.24836e-06
|
|
|
HAVCR1
|
[NCBI]
|
3.24836e-06
|
|
|
PHYH
|
[NCBI]
|
3.24836e-06
|
|
|
A4GALT
|
[NCBI]
|
3.24836e-06
|
|
|
IRAK4
|
[NCBI]
|
3.24836e-06
|
|
|
RPS4X
|
[NCBI]
|
3.24836e-06
|
|
|
FGF5
|
[NCBI]
|
3.24836e-06
|
|
|
CD19
|
[NCBI]
|
3.24836e-06
|
|
|
FOXN1
|
[NCBI]
|
3.24836e-06
|
|
|
TUB
|
[NCBI]
|
3.24836e-06
|
|
|
ASPN
|
[NCBI]
|
3.24836e-06
|
|
|
HAL
|
[NCBI]
|
3.24836e-06
|
|
|
CNGB3
|
[NCBI]
|
3.24836e-06
|
|
|
CTSG
|
[NCBI]
|
3.24836e-06
|
|
|
MBD4
|
[NCBI]
|
3.24836e-06
|
|
|
TTC10
|
[NCBI]
|
3.24836e-06
|
|
|
MAP3K1
|
[NCBI]
|
3.24836e-06
|
|
|
ANKH
|
[NCBI]
|
3.24836e-06
|
|
|
GRID2
|
[NCBI]
|
3.24836e-06
|
|
|
TACSTD2
|
[NCBI]
|
3.24836e-06
|
|
|
GH2
|
[NCBI]
|
3.24836e-06
|
|
|
NCAM1
|
[NCBI]
|
3.24836e-06
|
|
|
NANOG
|
[NCBI]
|
3.24836e-06
|
|
|
LMAN1
|
[NCBI]
|
3.24836e-06
|
|
|
SPTB
|
[NCBI]
|
3.23394e-06
|
|
|
ARSB
|
[NCBI]
|
3.23394e-06
|
|
|
THRA
|
[NCBI]
|
3.23394e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
3.23394e-06
|
|
|
ARX
|
[NCBI]
|
3.23394e-06
|
|
|
IP
|
[NCBI]
|
3.1059e-06
|
|
|
ATS
|
[NCBI]
|
3.09623e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
3.09623e-06
|
|
|
PARP1
|
[NCBI]
|
3.08891e-06
|
|
|
RYR1
|
[NCBI]
|
3.08891e-06
|
|
|
MODY
|
[NCBI]
|
3.04567e-06
|
|
|
NRCLP1
|
[NCBI]
|
3.01535e-06
|
|
|
STL1
|
[NCBI]
|
3.01535e-06
|
|
|
homocysteinemia
|
[NCBI]
|
3.01535e-06
|
|
|
FGF8
|
[NCBI]
|
3.00904e-06
|
|
|
GSTP1
|
[NCBI]
|
3.00754e-06
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
2.98069e-06
|
|
|
IGAN1
|
[NCBI]
|
2.98069e-06
|
|
|
HBA2
|
[NCBI]
|
2.98e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
2.96547e-06
|
|
|
HNPP
|
[NCBI]
|
2.88595e-06
|
|
|
SLC1A5
|
[NCBI]
|
2.82958e-06
|
|
|
FOXF1
|
[NCBI]
|
2.82958e-06
|
|
|
NXF1
|
[NCBI]
|
2.82958e-06
|
|
|
DEFB4
|
[NCBI]
|
2.82958e-06
|
|
|
NODAL
|
[NCBI]
|
2.82958e-06
|
|
|
FACL4
|
[NCBI]
|
2.82958e-06
|
|
|
TYROBP
|
[NCBI]
|
2.82958e-06
|
|
|
GMPR
|
[NCBI]
|
2.82958e-06
|
|
|
NPPB
|
[NCBI]
|
2.82958e-06
|
|
|
DAP3
|
[NCBI]
|
2.82958e-06
|
|
|
SGCG
|
[NCBI]
|
2.82958e-06
|
|
|
PRKAA2
|
[NCBI]
|
2.82958e-06
|
|
|
SGCB
|
[NCBI]
|
2.82958e-06
|
|
|
PRB1
|
[NCBI]
|
2.82958e-06
|
|
|
NAGS
|
[NCBI]
|
2.82958e-06
|
|
|
SORD
|
[NCBI]
|
2.82958e-06
|
|
|
PRM1
|
[NCBI]
|
2.82958e-06
|
|
|
CSPG2
|
[NCBI]
|
2.82958e-06
|
|
|
FGF18
|
[NCBI]
|
2.82958e-06
|
|
|
CTSE
|
[NCBI]
|
2.82958e-06
|
|
|
PLA2G4A
|
[NCBI]
|
2.82958e-06
|
|
|
PPP2R4
|
[NCBI]
|
2.82958e-06
|
|
|
ATP2B2
|
[NCBI]
|
2.82958e-06
|
|
|
PRND
|
[NCBI]
|
2.82958e-06
|
|
|
SMAD7
|
[NCBI]
|
2.82958e-06
|
|
|
CCL4
|
[NCBI]
|
2.82958e-06
|
|
|
SEMA3B
|
[NCBI]
|
2.82958e-06
|
|
|
AAAS
|
[NCBI]
|
2.82958e-06
|
|
|
SLC22A2
|
[NCBI]
|
2.82958e-06
|
|
|
INSIG1
|
[NCBI]
|
2.82958e-06
|
|
|
LAMC1
|
[NCBI]
|
2.82958e-06
|
|
|
PDCD2
|
[NCBI]
|
2.82958e-06
|
|
|
MXI1
|
[NCBI]
|
2.82958e-06
|
|
|
SGKL
|
[NCBI]
|
2.82958e-06
|
|
|
HTR1B
|
[NCBI]
|
2.82958e-06
|
|
|
BUB1B
|
[NCBI]
|
2.82958e-06
|
|
|
LAMB1
|
[NCBI]
|
2.82958e-06
|
|
|
GAS6
|
[NCBI]
|
2.82958e-06
|
|
|
POMGNT1
|
[NCBI]
|
2.82958e-06
|
|
|
ADH5
|
[NCBI]
|
2.79439e-06
|
|
|
COL4A5
|
[NCBI]
|
2.79439e-06
|
|
|
CSTB
|
[NCBI]
|
2.79439e-06
|
|
|
TGFBR2
|
[NCBI]
|
2.79439e-06
|
|
|
NCOA3
|
[NCBI]
|
2.79439e-06
|
|
|
ATXN1
|
[NCBI]
|
2.79439e-06
|
|
|
MSH6
|
[NCBI]
|
2.79439e-06
|
|
|
CYP11B2
|
[NCBI]
|
2.79439e-06
|
|
|
DPYD
|
[NCBI]
|
2.79439e-06
|
|
|
GCDH
|
[NCBI]
|
2.79439e-06
|
|
|
LHCGR
|
[NCBI]
|
2.77481e-06
|
|
|
FIH
|
[NCBI]
|
2.73961e-06
|
|
|
OPA1
|
[NCBI]
|
2.73961e-06
|
|
|
kartagener syndrome
|
[NCBI]
|
2.73961e-06
|
|
|
SNCA
|
[NCBI]
|
2.71053e-06
|
|
|
GJB1
|
[NCBI]
|
2.69415e-06
|
|
|
CDGG1
|
[NCBI]
|
2.65641e-06
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
2.65641e-06
|
|
|
CMT2A1
|
[NCBI]
|
2.65641e-06
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
2.65641e-06
|
|
|
OPPG
|
[NCBI]
|
2.65641e-06
|
|
|
ED2
|
[NCBI]
|
2.65641e-06
|
|
|
USH3
|
[NCBI]
|
2.65641e-06
|
|
|
MCDS
|
[NCBI]
|
2.65641e-06
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
2.65641e-06
|
|
|
WS2A
|
[NCBI]
|
2.65641e-06
|
|
|
AEZ
|
[NCBI]
|
2.65641e-06
|
|
|
MSH2
|
[NCBI]
|
2.62735e-06
|
|
|
OTC
|
[NCBI]
|
2.62735e-06
|
|
|
ERCC2
|
[NCBI]
|
2.59363e-06
|
|
|
GLI3
|
[NCBI]
|
2.59363e-06
|
|
|
CRY1
|
[NCBI]
|
2.59363e-06
|
|
|
DCN
|
[NCBI]
|
2.59363e-06
|
|
|
BCPM
|
[NCBI]
|
2.56925e-06
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
2.56925e-06
|
|
|
MYOC
|
[NCBI]
|
2.56521e-06
|
|
|
MHS1
|
[NCBI]
|
2.54612e-06
|
|
|
OCP
|
[NCBI]
|
2.54612e-06
|
|
|
UCN
|
[NCBI]
|
2.5348e-06
|
|
|
NR0B2
|
[NCBI]
|
2.50948e-06
|
|
|
VCP
|
[NCBI]
|
2.50948e-06
|
|
|
HPS
|
[NCBI]
|
2.49004e-06
|
|
|
CRHR2
|
[NCBI]
|
2.46514e-06
|
|
|
ERCC8
|
[NCBI]
|
2.46514e-06
|
|
|
ARG1
|
[NCBI]
|
2.46514e-06
|
|
|
NUMB
|
[NCBI]
|
2.46514e-06
|
|
|
CKM
|
[NCBI]
|
2.46514e-06
|
|
|
GABBR2
|
[NCBI]
|
2.46514e-06
|
|
|
MCPH1
|
[NCBI]
|
2.46514e-06
|
|
|
GOT2
|
[NCBI]
|
2.46514e-06
|
|
|
NNAT
|
[NCBI]
|
2.46514e-06
|
|
|
SOAT1
|
[NCBI]
|
2.46514e-06
|
|
|
CYP7A1
|
[NCBI]
|
2.46514e-06
|
|
|
CXORF5
|
[NCBI]
|
2.46514e-06
|
|
|
MSH3
|
[NCBI]
|
2.46514e-06
|
|
|
NLRP3
|
[NCBI]
|
2.46514e-06
|
|
|
POU3F4
|
[NCBI]
|
2.46514e-06
|
|
|
MATN1
|
[NCBI]
|
2.46514e-06
|
|
|
FLCN
|
[NCBI]
|
2.46514e-06
|
|
|
ECGF1
|
[NCBI]
|
2.46514e-06
|
|
|
DGAT1
|
[NCBI]
|
2.46514e-06
|
|
|
PEA15
|
[NCBI]
|
2.46514e-06
|
|
|
TRIM24
|
[NCBI]
|
2.46514e-06
|
|
|
PCBP2
|
[NCBI]
|
2.46514e-06
|
|
|
RYR3
|
[NCBI]
|
2.46514e-06
|
|
|
KCNQ4
|
[NCBI]
|
2.46514e-06
|
|
|
MERTK
|
[NCBI]
|
2.46514e-06
|
|
|
DMD
|
[NCBI]
|
2.46268e-06
|
|
|
PRKCM
|
[NCBI]
|
2.45633e-06
|
|
|
TD1
|
[NCBI]
|
2.43174e-06
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
2.42726e-06
|
|
|
F2R
|
[NCBI]
|
2.41268e-06
|
|
|
PENK
|
[NCBI]
|
2.41268e-06
|
|
|
IL8
|
[NCBI]
|
2.40452e-06
|
|
|
IL12B
|
[NCBI]
|
2.40452e-06
|
|
|
CLL
|
[NCBI]
|
2.39891e-06
|
|
|
sandhoff disease
|
[NCBI]
|
2.39891e-06
|
|
|
SJS1
|
[NCBI]
|
2.39891e-06
|
|
|
FCAS
|
[NCBI]
|
2.39891e-06
|
|
|
CADASIL
|
[NCBI]
|
2.39891e-06
|
|
|
STAT6
|
[NCBI]
|
2.36568e-06
|
|
|
TLR3
|
[NCBI]
|
2.31698e-06
|
|
|
CLCN1
|
[NCBI]
|
2.22635e-06
|
|
|
SOX10
|
[NCBI]
|
2.22635e-06
|
|
|
POU1F1
|
[NCBI]
|
2.22635e-06
|
|
|
ABCD1
|
[NCBI]
|
2.22241e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
2.15155e-06
|
|
|
MATN3
|
[NCBI]
|
2.14594e-06
|
|
|
ASCL1
|
[NCBI]
|
2.14594e-06
|
|
|
IDH1
|
[NCBI]
|
2.14594e-06
|
|
|
ANXA2
|
[NCBI]
|
2.14594e-06
|
|
|
WWOX
|
[NCBI]
|
2.14594e-06
|
|
|
COL6A2
|
[NCBI]
|
2.14594e-06
|
|
|
GNAQ
|
[NCBI]
|
2.14594e-06
|
|
|
CRYGC
|
[NCBI]
|
2.14594e-06
|
|
|
MIRNLET7A1
|
[NCBI]
|
2.14594e-06
|
|
|
CDC25A
|
[NCBI]
|
2.14594e-06
|
|
|
ADD1
|
[NCBI]
|
2.14594e-06
|
|
|
RPGRIP1
|
[NCBI]
|
2.14594e-06
|
|
|
ATP2A1
|
[NCBI]
|
2.14594e-06
|
|
|
FKTN
|
[NCBI]
|
2.14594e-06
|
|
|
SEPT9
|
[NCBI]
|
2.14594e-06
|
|
|
KRT8
|
[NCBI]
|
2.14594e-06
|
|
|
G22P1
|
[NCBI]
|
2.14594e-06
|
|
|
CTNNA1
|
[NCBI]
|
2.14594e-06
|
|
|
PAPSS2
|
[NCBI]
|
2.14594e-06
|
|
|
SIX3
|
[NCBI]
|
2.14594e-06
|
|
|
ZAP70
|
[NCBI]
|
2.14594e-06
|
|
|
KRT15
|
[NCBI]
|
2.14594e-06
|
|
|
PRDX5
|
[NCBI]
|
2.14594e-06
|
|
|
PKM2
|
[NCBI]
|
2.14594e-06
|
|
|
EMX2
|
[NCBI]
|
2.14594e-06
|
|
|
HHEX
|
[NCBI]
|
2.14594e-06
|
|
|
MEG3
|
[NCBI]
|
2.14594e-06
|
|
|
SOX3
|
[NCBI]
|
2.14594e-06
|
|
|
myoclonic dystonia
|
[NCBI]
|
2.07507e-06
|
|
|
SPG4
|
[NCBI]
|
2.07507e-06
|
|
|
PPOX
|
[NCBI]
|
2.05848e-06
|
|
|
ERCC5
|
[NCBI]
|
2.05848e-06
|
|
|
NBS1
|
[NCBI]
|
2.05848e-06
|
|
|
SPG4
|
[NCBI]
|
2.05848e-06
|
|
|
GSN
|
[NCBI]
|
2.05848e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
2.05848e-06
|
|
|
RARA
|
[NCBI]
|
2.05848e-06
|
|
|
NR5A1
|
[NCBI]
|
2.0368e-06
|
|
|
CTNNB1
|
[NCBI]
|
2.0368e-06
|
|
|
CORDX1
|
[NCBI]
|
2.02666e-06
|
|
|
LPG
|
[NCBI]
|
2.02666e-06
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
2.02666e-06
|
|
|
USH1C
|
[NCBI]
|
2.02666e-06
|
|
|
FRA16A
|
[NCBI]
|
2.02666e-06
|
|
|
LGMD1B
|
[NCBI]
|
2.02666e-06
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
2.02666e-06
|
|
|
hypoascorbemia
|
[NCBI]
|
2.02666e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
2.02666e-06
|
|
|
BHD
|
[NCBI]
|
2.02666e-06
|
|
|
JLNS1
|
[NCBI]
|
2.02666e-06
|
|
|
PNDM
|
[NCBI]
|
2.02666e-06
|
|
|
PPS
|
[NCBI]
|
2.02666e-06
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
2.02666e-06
|
|
|
HSCR2
|
[NCBI]
|
2.02666e-06
|
|
|
ACH
|
[NCBI]
|
2.02368e-06
|
|
|
PMP22
|
[NCBI]
|
2.00937e-06
|
|
|
PTEN
|
[NCBI]
|
1.95477e-06
|
|
|
CCL17
|
[NCBI]
|
1.94582e-06
|
|
|
SDS
|
[NCBI]
|
1.91093e-06
|
|
|
TYRP1
|
[NCBI]
|
1.90034e-06
|
|
|
OA1
|
[NCBI]
|
1.90034e-06
|
|
|
DAZL
|
[NCBI]
|
1.86499e-06
|
|
|
MCOLN1
|
[NCBI]
|
1.86499e-06
|
|
|
CD82
|
[NCBI]
|
1.86499e-06
|
|
|
FEN1
|
[NCBI]
|
1.86499e-06
|
|
|
C5R1
|
[NCBI]
|
1.86499e-06
|
|
|
PXMP3
|
[NCBI]
|
1.86499e-06
|
|
|
ATP1A1
|
[NCBI]
|
1.86499e-06
|
|
|
SDHC
|
[NCBI]
|
1.86499e-06
|
|
|
TFF2
|
[NCBI]
|
1.86499e-06
|
|
|
prekallikrein deficiency
|
[NCBI]
|
1.86499e-06
|
|
|
ACAT1
|
[NCBI]
|
1.86499e-06
|
|
|
EIF2B5
|
[NCBI]
|
1.86499e-06
|
|
|
CEP290
|
[NCBI]
|
1.86499e-06
|
|
|
CCS
|
[NCBI]
|
1.86499e-06
|
|
|
GSK3A
|
[NCBI]
|
1.86499e-06
|
|
|
MYF6
|
[NCBI]
|
1.86499e-06
|
|
|
NCL
|
[NCBI]
|
1.86499e-06
|
|
|
NQO1
|
[NCBI]
|
1.86499e-06
|
|
|
DRD1
|
[NCBI]
|
1.86499e-06
|
|
|
CBP2
|
[NCBI]
|
1.86499e-06
|
|
|
ZP3
|
[NCBI]
|
1.86499e-06
|
|
|
PDE4D
|
[NCBI]
|
1.86499e-06
|
|
|
HDAC1
|
[NCBI]
|
1.85961e-06
|
|
|
UCP3
|
[NCBI]
|
1.85904e-06
|
|
|
LIPC
|
[NCBI]
|
1.85612e-06
|
|
|
GHR
|
[NCBI]
|
1.8288e-06
|
|
|
costello syndrome
|
[NCBI]
|
1.76911e-06
|
|
|
SPG3A
|
[NCBI]
|
1.76911e-06
|
|
|
glycogen storage disease vii
|
[NCBI]
|
1.76911e-06
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
1.76911e-06
|
|
|
JAK3
|
[NCBI]
|
1.76772e-06
|
|
|
FOXP3
|
[NCBI]
|
1.76772e-06
|
|
|
RPS6KA3
|
[NCBI]
|
1.7514e-06
|
|
|
AURKA
|
[NCBI]
|
1.61683e-06
|
|
|
SLC22A1
|
[NCBI]
|
1.61683e-06
|
|
|
MAP1A
|
[NCBI]
|
1.61683e-06
|
|
|
PCSK9
|
[NCBI]
|
1.61683e-06
|
|
|
TBXA2R
|
[NCBI]
|
1.61683e-06
|
|
|
FSHB
|
[NCBI]
|
1.61683e-06
|
|
|
GGH
|
[NCBI]
|
1.61683e-06
|
|
|
SPAM1
|
[NCBI]
|
1.61683e-06
|
|
|
SLCO2A1
|
[NCBI]
|
1.61683e-06
|
|
|
ADAR
|
[NCBI]
|
1.61683e-06
|
|
|
PRX
|
[NCBI]
|
1.61683e-06
|
|
|
MT1A
|
[NCBI]
|
1.61683e-06
|
|
|
TECTA
|
[NCBI]
|
1.61683e-06
|
|
|
RNR1
|
[NCBI]
|
1.61683e-06
|
|
|
HTATIP
|
[NCBI]
|
1.61683e-06
|
|
|
DCTN1
|
[NCBI]
|
1.61683e-06
|
|
|
ACO1
|
[NCBI]
|
1.61683e-06
|
|
|
KRT10
|
[NCBI]
|
1.61683e-06
|
|
|
SORBS1
|
[NCBI]
|
1.61683e-06
|
|
|
CRYGD
|
[NCBI]
|
1.61683e-06
|
|
|
SMARCB1
|
[NCBI]
|
1.61683e-06
|
|
|
YY1
|
[NCBI]
|
1.61683e-06
|
|
|
ETS2
|
[NCBI]
|
1.61683e-06
|
|
|
ESR2
|
[NCBI]
|
1.61115e-06
|
|
|
RAG1
|
[NCBI]
|
1.61115e-06
|
|
|
ATP7A
|
[NCBI]
|
1.61115e-06
|
|
|
GRB2
|
[NCBI]
|
1.59501e-06
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
1.51077e-06
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
1.50732e-06
|
|
|
gilbert syndrome
|
[NCBI]
|
1.50732e-06
|
|
|
GAN1
|
[NCBI]
|
1.50732e-06
|
|
|
aging
|
[NCBI]
|
1.50732e-06
|
|
|
propionic acidemia
|
[NCBI]
|
1.50732e-06
|
|
|
LMS
|
[NCBI]
|
1.50732e-06
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
1.50732e-06
|
|
|
HPE3
|
[NCBI]
|
1.50732e-06
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
1.50732e-06
|
|
|
muckle-wells syndrome
|
[NCBI]
|
1.50732e-06
|
|
|
CHNG1
|
[NCBI]
|
1.50732e-06
|
|
|
danon disease
|
[NCBI]
|
1.50732e-06
|
|
|
HMS1
|
[NCBI]
|
1.50732e-06
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
1.50732e-06
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.48754e-06
|
|
|
HCH
|
[NCBI]
|
1.48754e-06
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
1.48214e-06
|
|
|
DJS
|
[NCBI]
|
1.48214e-06
|
|
|
GRIA2
|
[NCBI]
|
1.47916e-06
|
|
|
JAG1
|
[NCBI]
|
1.47916e-06
|
|
|
CHEK2
|
[NCBI]
|
1.47916e-06
|
|
|
PTPRC
|
[NCBI]
|
1.47916e-06
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
1.46168e-06
|
|
|
SCZD3
|
[NCBI]
|
1.46168e-06
|
|
|
AQP4
|
[NCBI]
|
1.42802e-06
|
|
|
SOD2
|
[NCBI]
|
1.39818e-06
|
|
|
IGFBP3
|
[NCBI]
|
1.39707e-06
|
|
|
DRD5
|
[NCBI]
|
1.39707e-06
|
|
|
AP3B1
|
[NCBI]
|
1.39707e-06
|
|
|
MMP7
|
[NCBI]
|
1.39707e-06
|
|
|
GDAP1
|
[NCBI]
|
1.39707e-06
|
|
|
PDCD1
|
[NCBI]
|
1.39707e-06
|
|
|
GGCX
|
[NCBI]
|
1.39707e-06
|
|
|
ECE1
|
[NCBI]
|
1.39707e-06
|
|
|
APOA2
|
[NCBI]
|
1.39707e-06
|
|
|
PLAU
|
[NCBI]
|
1.39707e-06
|
|
|
SSTR5
|
[NCBI]
|
1.39707e-06
|
|
|
RPS3
|
[NCBI]
|
1.39707e-06
|
|
|
oncogene dj1
|
[NCBI]
|
1.39707e-06
|
|
|
JARID1D
|
[NCBI]
|
1.39707e-06
|
|
|
CNP
|
[NCBI]
|
1.39707e-06
|
|
|
ATRN
|
[NCBI]
|
1.39707e-06
|
|
|
LIG4
|
[NCBI]
|
1.39707e-06
|
|
|
IGLC1
|
[NCBI]
|
1.39707e-06
|
|
|
ENAM
|
[NCBI]
|
1.39707e-06
|
|
|
MHC2TA
|
[NCBI]
|
1.39707e-06
|
|
|
INVS
|
[NCBI]
|
1.39707e-06
|
|
|
NTF3
|
[NCBI]
|
1.39707e-06
|
|
|
POU5F1
|
[NCBI]
|
1.39707e-06
|
|
|
MOS
|
[NCBI]
|
1.39707e-06
|
|
|
PGK2
|
[NCBI]
|
1.39707e-06
|
|
|
COCH
|
[NCBI]
|
1.39707e-06
|
|
|
MGMT
|
[NCBI]
|
1.39707e-06
|
|
|
C4BPA
|
[NCBI]
|
1.39707e-06
|
|
|
GAMT
|
[NCBI]
|
1.35499e-06
|
|
|
EDNRB
|
[NCBI]
|
1.35499e-06
|
|
|
ATF3
|
[NCBI]
|
1.34679e-06
|
|
|
ENPEP
|
[NCBI]
|
1.34679e-06
|
|
|
CBX5
|
[NCBI]
|
1.31497e-06
|
|
|
GCCR
|
[NCBI]
|
1.25868e-06
|
|
|
UMOD
|
[NCBI]
|
1.23827e-06
|
|
|
LCAT
|
[NCBI]
|
1.22225e-06
|
|
|
FPLD2
|
[NCBI]
|
1.21539e-06
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
1.21129e-06
|
|
|
NPC1
|
[NCBI]
|
1.21129e-06
|
|
|
CDPX2
|
[NCBI]
|
1.20388e-06
|
|
|
BMPR1A
|
[NCBI]
|
1.20215e-06
|
|
|
JARID2
|
[NCBI]
|
1.20215e-06
|
|
|
PRKCA
|
[NCBI]
|
1.20215e-06
|
|
|
MAZ
|
[NCBI]
|
1.20215e-06
|
|
|
LHX3
|
[NCBI]
|
1.20215e-06
|
|
|
PCSK1
|
[NCBI]
|
1.20215e-06
|
|
|
ATF1
|
[NCBI]
|
1.20215e-06
|
|
|
PLIN
|
[NCBI]
|
1.20215e-06
|
|
|
ADRB1
|
[NCBI]
|
1.20215e-06
|
|
|
THBD
|
[NCBI]
|
1.20215e-06
|
|
|
IKZF1
|
[NCBI]
|
1.20215e-06
|
|
|
CNR1
|
[NCBI]
|
1.20215e-06
|
|
|
LYST
|
[NCBI]
|
1.20215e-06
|
|
|
CD99
|
[NCBI]
|
1.20215e-06
|
|
|
RCC1
|
[NCBI]
|
1.20215e-06
|
|
|
CPS1
|
[NCBI]
|
1.20215e-06
|
|
|
SCN9A
|
[NCBI]
|
1.20215e-06
|
|
|
GPR24
|
[NCBI]
|
1.20215e-06
|
|
|
FCGR3A
|
[NCBI]
|
1.20215e-06
|
|
|
PRLR
|
[NCBI]
|
1.20046e-06
|
|
|
BCR
|
[NCBI]
|
1.16643e-06
|
|
|
wilson disease
|
[NCBI]
|
1.1401e-06
|
|
|
SIRT1
|
[NCBI]
|
1.12864e-06
|
|
|
CCL2
|
[NCBI]
|
1.09174e-06
|
|
|
pitt syndrome
|
[NCBI]
|
1.08361e-06
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
1.08361e-06
|
|
|
PFIC1
|
[NCBI]
|
1.08361e-06
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
1.08361e-06
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
1.08361e-06
|
|
|
PPAC
|
[NCBI]
|
1.08361e-06
|
|
|
HSAN2
|
[NCBI]
|
1.08361e-06
|
|
|
PARK6
|
[NCBI]
|
1.08361e-06
|
|
|
NBIA1
|
[NCBI]
|
1.08361e-06
|
|
|
AFD1
|
[NCBI]
|
1.08361e-06
|
|
|
IVA
|
[NCBI]
|
1.08361e-06
|
|
|
PARG
|
[NCBI]
|
1.03814e-06
|
|
|
CRX
|
[NCBI]
|
1.02914e-06
|
|
|
SMAD3
|
[NCBI]
|
1.02914e-06
|
|
|
orotic aciduria i
|
[NCBI]
|
1.02914e-06
|
|
|
ATXN7
|
[NCBI]
|
1.02914e-06
|
|
|
MEF2A
|
[NCBI]
|
1.02914e-06
|
|
|
MIF
|
[NCBI]
|
1.02914e-06
|
|
|
WNT1
|
[NCBI]
|
1.02914e-06
|
|
|
GCG
|
[NCBI]
|
1.02914e-06
|
|
|
GJA4
|
[NCBI]
|
1.02914e-06
|
|
|
GABRG2
|
[NCBI]
|
1.02914e-06
|
|
|
CCR2
|
[NCBI]
|
1.02914e-06
|
|
|
CBFA2T1
|
[NCBI]
|
1.02914e-06
|
|
|
ROR2
|
[NCBI]
|
1.02914e-06
|
|
|
SCNN1A
|
[NCBI]
|
1.02914e-06
|
|
|
SCNN1B
|
[NCBI]
|
1.02914e-06
|
|
|
DNMT3A
|
[NCBI]
|
1.02914e-06
|
|
|
DKC
|
[NCBI]
|
9.70213e-07
|
|
|
RP3
|
[NCBI]
|
9.70213e-07
|
|
|
LSA
|
[NCBI]
|
9.70213e-07
|
|
|
MYH7
|
[NCBI]
|
9.65328e-07
|
|
|
GCPS
|
[NCBI]
|
9.5495e-07
|
|
|
MEB
|
[NCBI]
|
9.5495e-07
|
|
|
MDLS
|
[NCBI]
|
9.5495e-07
|
|
|
WFS1
|
[NCBI]
|
9.5495e-07
|
|
|
AIRE
|
[NCBI]
|
9.42163e-07
|
|
|
SOCS1
|
[NCBI]
|
9.29319e-07
|
|
|
SCN4A
|
[NCBI]
|
9.29319e-07
|
|
|
ADIPOQ
|
[NCBI]
|
9.29319e-07
|
|
|
BRAF
|
[NCBI]
|
9.29319e-07
|
|
|
OPRM1
|
[NCBI]
|
9.12553e-07
|
|
|
ITGB2
|
[NCBI]
|
8.94383e-07
|
|
|
ABL1
|
[NCBI]
|
8.94383e-07
|
|
|
PROCR
|
[NCBI]
|
8.94383e-07
|
|
|
PFKM
|
[NCBI]
|
8.75614e-07
|
|
|
EXT2
|
[NCBI]
|
8.75614e-07
|
|
|
G6PC2
|
[NCBI]
|
8.75614e-07
|
|
|
CDK7
|
[NCBI]
|
8.75614e-07
|
|
|
GDI1
|
[NCBI]
|
8.75614e-07
|
|
|
TRHR
|
[NCBI]
|
8.75614e-07
|
|
|
F2RL1
|
[NCBI]
|
8.75614e-07
|
|
|
ACADVL
|
[NCBI]
|
8.75614e-07
|
|
|
ADSL
|
[NCBI]
|
8.75614e-07
|
|
|
ITGB4
|
[NCBI]
|
8.75614e-07
|
|
|
VCAM1
|
[NCBI]
|
8.75614e-07
|
|
|
SPG7
|
[NCBI]
|
8.75614e-07
|
|
|
SQSTM1
|
[NCBI]
|
8.75614e-07
|
|
|
Ge
|
[NCBI]
|
8.75614e-07
|
|
|
TCF3
|
[NCBI]
|
8.75614e-07
|
|
|
WAS
|
[NCBI]
|
8.72952e-07
|
|
|
MC4R
|
[NCBI]
|
8.68823e-07
|
|
|
PJS
|
[NCBI]
|
8.6353e-07
|
|
|
SLC6A3
|
[NCBI]
|
8.62533e-07
|
|
|
ENG
|
[NCBI]
|
8.3903e-07
|
|
|
SOX9
|
[NCBI]
|
8.3903e-07
|
|
|
LQT1
|
[NCBI]
|
8.30589e-07
|
|
|
FLNA
|
[NCBI]
|
8.25371e-07
|
|
|
UNG
|
[NCBI]
|
8.25371e-07
|
|
|
temporal arteritis
|
[NCBI]
|
8.22754e-07
|
|
|
COMP
|
[NCBI]
|
8.21541e-07
|
|
|
ALPS
|
[NCBI]
|
7.94625e-07
|
|
|
RP1
|
[NCBI]
|
7.48085e-07
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
7.48085e-07
|
|
|
apert syndrome
|
[NCBI]
|
7.48085e-07
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
7.48085e-07
|
|
|
MKKS
|
[NCBI]
|
7.43577e-07
|
|
|
DYT3
|
[NCBI]
|
7.43577e-07
|
|
|
RSMD1
|
[NCBI]
|
7.43577e-07
|
|
|
longevity
|
[NCBI]
|
7.43577e-07
|
|
|
blood group, p system
|
[NCBI]
|
7.43577e-07
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
7.43577e-07
|
|
|
SPCH1
|
[NCBI]
|
7.43577e-07
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
7.43577e-07
|
|
|
TMAU
|
[NCBI]
|
7.43577e-07
|
|
|
PHA
|
[NCBI]
|
7.43577e-07
|
|
|
CORD2
|
[NCBI]
|
7.43577e-07
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
7.43577e-07
|
|
|
FXTAS
|
[NCBI]
|
7.43577e-07
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
7.43577e-07
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
7.43577e-07
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
7.43577e-07
|
|
|
MVA
|
[NCBI]
|
7.43577e-07
|
|
|
NR4A2
|
[NCBI]
|
7.39505e-07
|
|
|
G6PT1
|
[NCBI]
|
7.39505e-07
|
|
|
RETN
|
[NCBI]
|
7.39505e-07
|
|
|
KCNJ2
|
[NCBI]
|
7.39505e-07
|
|
|
FGF3
|
[NCBI]
|
7.39505e-07
|
|
|
FLT4
|
[NCBI]
|
7.39505e-07
|
|
|
KRIT1
|
[NCBI]
|
7.39505e-07
|
|
|
HMOX1
|
[NCBI]
|
7.39505e-07
|
|
|
HADHA
|
[NCBI]
|
7.39505e-07
|
|
|
GUCY2D
|
[NCBI]
|
7.39505e-07
|
|
|
TKT
|
[NCBI]
|
7.39505e-07
|
|
|
LFS1
|
[NCBI]
|
7.38777e-07
|
|
|
CDG1A
|
[NCBI]
|
7.38777e-07
|
|
|
FGFR1
|
[NCBI]
|
7.26335e-07
|
|
|
HBB
|
[NCBI]
|
7.25127e-07
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
7.12822e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
7.02052e-07
|
|
|
TLR4
|
[NCBI]
|
7.01182e-07
|
|
|
DAO
|
[NCBI]
|
6.93435e-07
|
|
|
PVR
|
[NCBI]
|
6.93435e-07
|
|
|
FGA
|
[NCBI]
|
6.76508e-07
|
|
|
PAX6
|
[NCBI]
|
6.76508e-07
|
|
|
RELN
|
[NCBI]
|
6.75842e-07
|
|
|
MTAP
|
[NCBI]
|
6.30667e-07
|
|
|
CA2
|
[NCBI]
|
6.19074e-07
|
|
|
TMOD
|
[NCBI]
|
6.19074e-07
|
|
|
CACNA1S
|
[NCBI]
|
6.19074e-07
|
|
|
HSD11B1
|
[NCBI]
|
6.19074e-07
|
|
|
WNK1
|
[NCBI]
|
6.19074e-07
|
|
|
HAP1
|
[NCBI]
|
6.19074e-07
|
|
|
ERCC6
|
[NCBI]
|
6.19074e-07
|
|
|
CTSC
|
[NCBI]
|
6.02453e-07
|
|
|
CPB2
|
[NCBI]
|
5.719e-07
|
|
|
MLL
|
[NCBI]
|
5.70143e-07
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
5.53572e-07
|
|
|
HYPP
|
[NCBI]
|
5.53572e-07
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
5.5066e-07
|
|
|
PHS
|
[NCBI]
|
5.5066e-07
|
|
|
POF1
|
[NCBI]
|
5.5066e-07
|
|
|
AIMAH
|
[NCBI]
|
5.5066e-07
|
|
|
HBG2
|
[NCBI]
|
5.34233e-07
|
|
|
ADAM17
|
[NCBI]
|
5.34233e-07
|
|
|
XK
|
[NCBI]
|
5.12825e-07
|
|
|
DICER1
|
[NCBI]
|
5.12825e-07
|
|
|
RXRA
|
[NCBI]
|
5.12825e-07
|
|
|
DCX
|
[NCBI]
|
5.12825e-07
|
|
|
TDG
|
[NCBI]
|
5.12825e-07
|
|
|
EIF5A
|
[NCBI]
|
5.12825e-07
|
|
|
CLCN5
|
[NCBI]
|
5.12825e-07
|
|
|
GJB6
|
[NCBI]
|
5.12825e-07
|
|
|
SLC2A1
|
[NCBI]
|
5.12825e-07
|
|
|
SSTR2
|
[NCBI]
|
5.12825e-07
|
|
|
NTN1
|
[NCBI]
|
5.12825e-07
|
|
|
VUR1
|
[NCBI]
|
5.04123e-07
|
|
|
glycogen storage disease iv
|
[NCBI]
|
4.77346e-07
|
|
|
FBS
|
[NCBI]
|
4.77346e-07
|
|
|
EA2
|
[NCBI]
|
4.77346e-07
|
|
|
FHM2
|
[NCBI]
|
4.77346e-07
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
4.77346e-07
|
|
|
EAOH
|
[NCBI]
|
4.77346e-07
|
|
|
GABEB
|
[NCBI]
|
4.77346e-07
|
|
|
HCRT
|
[NCBI]
|
4.70972e-07
|
|
|
SLC11A2
|
[NCBI]
|
4.63614e-07
|
|
|
ABCA1
|
[NCBI]
|
4.56194e-07
|
|
|
TNFRSF6
|
[NCBI]
|
4.56194e-07
|
|
|
DCT
|
[NCBI]
|
4.56194e-07
|
|
|
CVID
|
[NCBI]
|
4.27512e-07
|
|
|
SLC5A5
|
[NCBI]
|
4.19469e-07
|
|
|
MC2R
|
[NCBI]
|
4.19469e-07
|
|
|
PIK3CA
|
[NCBI]
|
4.19469e-07
|
|
|
FOXC2
|
[NCBI]
|
4.19469e-07
|
|
|
F12
|
[NCBI]
|
4.19469e-07
|
|
|
OR1D2
|
[NCBI]
|
4.19469e-07
|
|
|
OPMD
|
[NCBI]
|
4.13339e-07
|
|
|
MTATP6
|
[NCBI]
|
4.02965e-07
|
|
|
melanoma, uveal
|
[NCBI]
|
3.9768e-07
|
|
|
APC
|
[NCBI]
|
3.92056e-07
|
|
|
OPTB1
|
[NCBI]
|
3.79765e-07
|
|
|
UCP2
|
[NCBI]
|
3.6471e-07
|
|
|
CLS
|
[NCBI]
|
3.55523e-07
|
|
|
DAZ
|
[NCBI]
|
3.52374e-07
|
|
|
RUNX1
|
[NCBI]
|
3.52374e-07
|
|
|
ZNF145
|
[NCBI]
|
3.52374e-07
|
|
|
UBE3A
|
[NCBI]
|
3.37883e-07
|
|
|
CTSB
|
[NCBI]
|
3.37883e-07
|
|
|
CLTC
|
[NCBI]
|
3.37883e-07
|
|
|
DLD
|
[NCBI]
|
3.37883e-07
|
|
|
CASP8
|
[NCBI]
|
3.37883e-07
|
|
|
NKX2-1
|
[NCBI]
|
3.37883e-07
|
|
|
NR3C2
|
[NCBI]
|
3.37883e-07
|
|
|
GJB3
|
[NCBI]
|
3.37883e-07
|
|
|
LCK
|
[NCBI]
|
3.37883e-07
|
|
|
RPE65
|
[NCBI]
|
3.37883e-07
|
|
|
FH
|
[NCBI]
|
3.09039e-07
|
|
|
PSAP
|
[NCBI]
|
3.09039e-07
|
|
|
HRPT1
|
[NCBI]
|
2.76709e-07
|
|
|
HNA
|
[NCBI]
|
2.76709e-07
|
|
|
VWM
|
[NCBI]
|
2.76709e-07
|
|
|
ACLS
|
[NCBI]
|
2.76709e-07
|
|
|
brugada syndrome 1
|
[NCBI]
|
2.76709e-07
|
|
|
bethlem myopathy
|
[NCBI]
|
2.76709e-07
|
|
|
MTS
|
[NCBI]
|
2.69579e-07
|
|
|
TGFBI
|
[NCBI]
|
2.67086e-07
|
|
|
IRF1
|
[NCBI]
|
2.67086e-07
|
|
|
MTND3
|
[NCBI]
|
2.67086e-07
|
|
|
PINK1
|
[NCBI]
|
2.67086e-07
|
|
|
LHB
|
[NCBI]
|
2.67086e-07
|
|
|
MFN2
|
[NCBI]
|
2.67086e-07
|
|
|
COL4A1
|
[NCBI]
|
2.67086e-07
|
|
|
EDA
|
[NCBI]
|
2.67086e-07
|
|
|
DDIT3
|
[NCBI]
|
2.67086e-07
|
|
|
TLR2
|
[NCBI]
|
2.64269e-07
|
|
|
B2M
|
[NCBI]
|
2.63762e-07
|
|
|
DSTN
|
[NCBI]
|
2.59575e-07
|
|
|
AMACR
|
[NCBI]
|
2.59575e-07
|
|
|
MTCYB
|
[NCBI]
|
2.59575e-07
|
|
|
ARNT
|
[NCBI]
|
2.53692e-07
|
|
|
HRG
|
[NCBI]
|
2.53692e-07
|
|
|
CCM
|
[NCBI]
|
2.52046e-07
|
|
|
FCMD
|
[NCBI]
|
2.52046e-07
|
|
|
HHF2
|
[NCBI]
|
2.52046e-07
|
|
|
AGER
|
[NCBI]
|
2.39588e-07
|
|
|
SMA2
|
[NCBI]
|
2.37443e-07
|
|
|
lung cancer
|
[NCBI]
|
2.37443e-07
|
|
|
HNFJ
|
[NCBI]
|
2.37443e-07
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
2.37443e-07
|
|
|
LCA1
|
[NCBI]
|
2.37443e-07
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
2.37443e-07
|
|
|
FOLH1
|
[NCBI]
|
2.1762e-07
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
2.1762e-07
|
|
|
HGPS
|
[NCBI]
|
2.09446e-07
|
|
|
SVAS
|
[NCBI]
|
2.09446e-07
|
|
|
MMP1
|
[NCBI]
|
2.06213e-07
|
|
|
RPS19
|
[NCBI]
|
2.06213e-07
|
|
|
GZMB
|
[NCBI]
|
2.06213e-07
|
|
|
KLF6
|
[NCBI]
|
2.06213e-07
|
|
|
HK1
|
[NCBI]
|
2.06213e-07
|
|
|
CLOCK
|
[NCBI]
|
2.06213e-07
|
|
|
TGM1
|
[NCBI]
|
2.06213e-07
|
|
|
DFFA
|
[NCBI]
|
2.06213e-07
|
|
|
PDHA1
|
[NCBI]
|
1.7881e-07
|
|
|
MST1
|
[NCBI]
|
1.7881e-07
|
|
|
CSF2
|
[NCBI]
|
1.7881e-07
|
|
|
HIF1A
|
[NCBI]
|
1.7881e-07
|
|
|
BMD
|
[NCBI]
|
1.67861e-07
|
|
|
BMP2
|
[NCBI]
|
1.65651e-07
|
|
|
GRA
|
[NCBI]
|
1.65281e-07
|
|
|
EXT1
|
[NCBI]
|
1.54501e-07
|
|
|
IL2RG
|
[NCBI]
|
1.54501e-07
|
|
|
SCN1A
|
[NCBI]
|
1.54501e-07
|
|
|
ETS1
|
[NCBI]
|
1.54501e-07
|
|
|
RBP3
|
[NCBI]
|
1.54501e-07
|
|
|
lynch syndrome i
|
[NCBI]
|
1.43944e-07
|
|
|
GNMT
|
[NCBI]
|
1.43297e-07
|
|
|
EDN1
|
[NCBI]
|
1.43297e-07
|
|
|
CUTL1
|
[NCBI]
|
1.43297e-07
|
|
|
MYH11
|
[NCBI]
|
1.43297e-07
|
|
|
stroke, ischemic
|
[NCBI]
|
1.34751e-07
|
|
|
canavan disease
|
[NCBI]
|
1.34751e-07
|
|
|
ORW2
|
[NCBI]
|
1.34751e-07
|
|
|
AAA
|
[NCBI]
|
1.34751e-07
|
|
|
PLOSL
|
[NCBI]
|
1.34751e-07
|
|
|
MEN2B
|
[NCBI]
|
1.34751e-07
|
|
|
SEDC
|
[NCBI]
|
1.25981e-07
|
|
|
PNKD1
|
[NCBI]
|
1.25981e-07
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
1.25981e-07
|
|
|
CPX
|
[NCBI]
|
1.25981e-07
|
|
|
MAS
|
[NCBI]
|
1.23929e-07
|
|
|
HEMB
|
[NCBI]
|
1.20906e-07
|
|
|
PCI
|
[NCBI]
|
1.12851e-07
|
|
|
TSG101
|
[NCBI]
|
1.1127e-07
|
|
|
ATF6
|
[NCBI]
|
1.1127e-07
|
|
|
CDC42
|
[NCBI]
|
1.1127e-07
|
|
|
GJA5
|
[NCBI]
|
1.1127e-07
|
|
|
CRYAB
|
[NCBI]
|
1.1127e-07
|
|
|
CTSK
|
[NCBI]
|
1.1127e-07
|
|
|
PPT1
|
[NCBI]
|
1.1124e-07
|
|
|
SLC1A2
|
[NCBI]
|
1.1124e-07
|
|
|
DSG1
|
[NCBI]
|
1.1124e-07
|
|
|
ATF2
|
[NCBI]
|
1.1124e-07
|
|
|
RPGR
|
[NCBI]
|
9.57979e-08
|
|
|
CEL
|
[NCBI]
|
9.57979e-08
|
|
|
RS1
|
[NCBI]
|
8.28124e-08
|
|
|
PDE6B
|
[NCBI]
|
8.28124e-08
|
|
|
RUNX2
|
[NCBI]
|
8.28124e-08
|
|
|
PEMT
|
[NCBI]
|
8.28124e-08
|
|
|
HDGF
|
[NCBI]
|
8.28124e-08
|
|
|
LPI
|
[NCBI]
|
8.02189e-08
|
|
|
IVD
|
[NCBI]
|
7.59156e-08
|
|
|
CES1
|
[NCBI]
|
7.59156e-08
|
|
|
MYCN
|
[NCBI]
|
7.59156e-08
|
|
|
TIMP3
|
[NCBI]
|
7.59156e-08
|
|
|
IFNGR1
|
[NCBI]
|
7.59156e-08
|
|
|
LRRK2
|
[NCBI]
|
7.52226e-08
|
|
|
HBD
|
[NCBI]
|
7.29619e-08
|
|
|
UCP1
|
[NCBI]
|
7.14016e-08
|
|
|
BAX
|
[NCBI]
|
5.82007e-08
|
|
|
XPA
|
[NCBI]
|
5.82007e-08
|
|
|
ASPA
|
[NCBI]
|
5.82007e-08
|
|
|
GK
|
[NCBI]
|
5.82007e-08
|
|
|
LOX
|
[NCBI]
|
5.77715e-08
|
|
|
MMP9
|
[NCBI]
|
5.34332e-08
|
|
|
WHS
|
[NCBI]
|
5.24595e-08
|
|
|
PG
|
[NCBI]
|
5.03288e-08
|
|
|
HNF1A
|
[NCBI]
|
4.85384e-08
|
|
|
CRMO
|
[NCBI]
|
4.79501e-08
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
4.79501e-08
|
|
|
CMM2
|
[NCBI]
|
4.79501e-08
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
4.79501e-08
|
|
|
glycogen storage disease v
|
[NCBI]
|
4.79501e-08
|
|
|
HOKPP
|
[NCBI]
|
4.79501e-08
|
|
|
glycogen storage disease ib
|
[NCBI]
|
4.79501e-08
|
|
|
LFNG
|
[NCBI]
|
4.78928e-08
|
|
|
IPF1
|
[NCBI]
|
4.78928e-08
|
|
|
PITX2
|
[NCBI]
|
4.78928e-08
|
|
|
C1NH
|
[NCBI]
|
4.78928e-08
|
|
|
TIMP1
|
[NCBI]
|
4.78928e-08
|
|
|
DLG1
|
[NCBI]
|
4.78928e-08
|
|
|
PRSS1
|
[NCBI]
|
4.78928e-08
|
|
|
HMGA2
|
[NCBI]
|
4.78928e-08
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
4.55978e-08
|
|
|
GLC3A
|
[NCBI]
|
4.55978e-08
|
|
|
CGL2
|
[NCBI]
|
4.55978e-08
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
4.55978e-08
|
|
|
EDMD2
|
[NCBI]
|
4.55978e-08
|
|
|
histidinemia
|
[NCBI]
|
4.55978e-08
|
|
|
EBR1
|
[NCBI]
|
4.55978e-08
|
|
|
NHS
|
[NCBI]
|
4.55978e-08
|
|
|
ETM1
|
[NCBI]
|
4.55978e-08
|
|
|
HSAN1
|
[NCBI]
|
4.55978e-08
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
4.55978e-08
|
|
|
VMD
|
[NCBI]
|
3.84554e-08
|
|
|
LI1
|
[NCBI]
|
3.84554e-08
|
|
|
AVPR2
|
[NCBI]
|
3.76056e-08
|
|
|
INHBA
|
[NCBI]
|
3.76056e-08
|
|
|
NDP
|
[NCBI]
|
3.76056e-08
|
|
|
NR6A1
|
[NCBI]
|
3.76056e-08
|
|
|
PDGFB
|
[NCBI]
|
3.76056e-08
|
|
|
BCL6
|
[NCBI]
|
3.76056e-08
|
|
|
TBP
|
[NCBI]
|
3.74232e-08
|
|
|
MPZ
|
[NCBI]
|
3.5814e-08
|
|
|
RHO
|
[NCBI]
|
2.84376e-08
|
|
|
TTN
|
[NCBI]
|
2.67131e-08
|
|
|
DISC1
|
[NCBI]
|
2.67131e-08
|
|
|
ALDH1A2
|
[NCBI]
|
2.67131e-08
|
|
|
DHH
|
[NCBI]
|
2.67131e-08
|
|
|
PLD2
|
[NCBI]
|
2.67131e-08
|
|
|
PBP
|
[NCBI]
|
2.67131e-08
|
|
|
TP73L
|
[NCBI]
|
2.67131e-08
|
|
|
AR
|
[NCBI]
|
2.35862e-08
|
|
|
CXCR4
|
[NCBI]
|
2.12442e-08
|
|
|
GDF5
|
[NCBI]
|
2.12442e-08
|
|
|
FHIT
|
[NCBI]
|
2.12442e-08
|
|
|
GHRL
|
[NCBI]
|
2.12442e-08
|
|
|
GDXY
|
[NCBI]
|
2.12442e-08
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
2.12442e-08
|
|
|
ANG
|
[NCBI]
|
1.87061e-08
|
|
|
ACVRL1
|
[NCBI]
|
1.19348e-08
|
|
|
IL1B
|
[NCBI]
|
1.19348e-08
|
|
|
CD40LG
|
[NCBI]
|
1.19348e-08
|
|
|
IFNB1
|
[NCBI]
|
1.19348e-08
|
|
|
GRIN1
|
[NCBI]
|
1.19348e-08
|
|
|
TWIST1
|
[NCBI]
|
1.19348e-08
|
|
|
APOD
|
[NCBI]
|
1.03221e-08
|
|
|
CDK6
|
[NCBI]
|
9.3517e-09
|
|
|
CBD
|
[NCBI]
|
9.3517e-09
|
|
|
QTRT1
|
[NCBI]
|
9.3517e-09
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
8.43537e-09
|
|
|
DM2
|
[NCBI]
|
8.43537e-09
|
|
|
GTS
|
[NCBI]
|
7.64913e-09
|
|
|
KITLG
|
[NCBI]
|
6.70841e-09
|
|
|
IRS1
|
[NCBI]
|
6.31614e-09
|
|
|
EKV
|
[NCBI]
|
6.26007e-09
|
|
|
glycogen storage disease iii
|
[NCBI]
|
6.26007e-09
|
|
|
DRD
|
[NCBI]
|
6.26007e-09
|
|
|
hodgkin lymphoma
|
[NCBI]
|
6.26007e-09
|
|
|
MADA
|
[NCBI]
|
6.26007e-09
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
4.21639e-09
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
4.21639e-09
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
4.21639e-09
|
|
|
mucolipidosis iv
|
[NCBI]
|
4.21639e-09
|
|
|
PPH1
|
[NCBI]
|
4.21639e-09
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
4.21639e-09
|
|
|
IRF3
|
[NCBI]
|
3.15764e-09
|
|
|
MET
|
[NCBI]
|
3.15764e-09
|
|
|
CDKN1B
|
[NCBI]
|
3.15764e-09
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
3.15764e-09
|
|
|
SLC40A1
|
[NCBI]
|
3.15764e-09
|
|
|
ALS1
|
[NCBI]
|
2.9948e-09
|
|
|
CDKN1A
|
[NCBI]
|
2.18358e-09
|
|
|
CYBB
|
[NCBI]
|
2.18358e-09
|
|
|
PAFAH1B1
|
[NCBI]
|
2.18358e-09
|
|
|
BIRC1
|
[NCBI]
|
1.80924e-09
|
|
|
BCL2
|
[NCBI]
|
1.80924e-09
|
|
|
CDC2
|
[NCBI]
|
9.14278e-10
|
|
|
sotos syndrome
|
[NCBI]
|
1.1675e-10
|
|
|
PTGS2
|
[NCBI]
|
5.34336e-11
|
|
|
NOTCH1
|
[NCBI]
|
3.56174e-11
|
|
|
PML
|
[NCBI]
|
1.78063e-11
|
|
|
TERC
|
[NCBI]
|
1.78063e-11
|
|
|
FASN
|
[NCBI]
|
1.78063e-11
|
|
|
CXCL12
|
[NCBI]
|
1.78063e-11
|
|